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ABSTRACT 
Under iron-limiting conditions, several Gram-negative pathogens secrete hemophore (HasA) 
protein that binds heme and deliver it to the outer membrane receptors in bacteria.  Hemophore 
proteins have been structurally and biochemically characterized in their heme-free (apo) and 
heme-bound (holo) forms in Serratia marcescens (HasAs) and Pseudomonas aeruginosa 
(HasAp).  Hemophores have unique structural features which are distinguished from other 
known proteins.  The structure of HasAp (and HasAs), are composed of an “α-helical wall” on 
one side and a “β-sheet wall” on another.  Heme is bound between the two extended loops, the 
Y75 loop harboring the conserved Tyr75 ligand and the H32 loop harboring the His32 ligand.  
The major difference between the apo- and holo-HasAp is the large conformational 
rearrangements of the H32 loop upon heme binding which relocates His32 side chain ~ 30 Å 
from open to closed form.  It has been established through kinetics experiments that heme first 
loads onto the Y75 loop where it is coordinated by Tyr75, followed by the closure of the H32 
loop and coordination of heme-iron ion by His32. 
 Multiple sequence alignment of known hemophore sequences from Gram-negative 
bacteria reveals the conservation of Tyr75 but not the His32; instead in Yersinia species Gln32 is 
present at a similar position.  To investigate the role played by the Gln32 in heme coordination, 
we structurally characterized hemophore from Yersinia pestis (HasAyp) in apo- and holo-form.  
Surprisingly, the Q32 loop in apo-HasAyp is already in closed conformation and the heme is only 
coordinated by one protein provided ligand, Tyr75 from the Y75 loop.  Further, heme loading is 
fast compared to the HasAp and occurs with minimal structural changes.   
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 Analyzing the available structural information from hemophores (HasAp, HasAyp and 
HasAs), we looked for the interactions that stabilized the open H32 loop conformation in apo-
HasAp.  Our analysis revealed the presence of Arginine at position 33 (Arg33) anchoring the 
H32 loop to the body of the protein.  In order to investigate the role played by the Arg33, we 
replaced it with Alanine (Ala) and carried out mutagenesis investigations.  Results from X-ray 
crystallography, solution NMR and molecular dynamics simulations clearly indicate that single 
replacement of Arg33 to Ala shifts the open H32 loop conformation to a closed conformation 
which is very similar to the H32 loop in the wt holo-HasAp.   
 The structure of Y75 loop is conserved with Tyr75 and its hydrogen bond partner His83 
(His81 in HasAyp).  To investigate the proposed requirement for the Tyr75 – His83 unit for heme 
coordination by Tyr75, we conducted structural and biochemical study of Y75A and His83A 
HasAp mutants.  The high resolution crystal structure of Y75A and H83A mutants show the 
original α+β protein fold similar to the wt protein.  In the absence of Tyr75 in Y75A mutant, 
His83 do not coordinate the heme-iron ion instead, a formate ion occupies the same position as 
that of the side chain of Tyr75, coordinating heme iron ion by one of its oxygen atoms.  In H83A 
mutants, Tyr75 and His32 coordinate the heme-iron ion even at the pH 5.4.  Despite the severe 
changes made in the Y75 loop residues, kinetic analysis suggests that the heme loads with 
biphasic kinetics similar to the wt HasAp.  Taken together, heme loading onto to the Y75 loop is 
mainly driven by hydrophobic,  interactions onto the Y75 loop.   
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Preface 
With the growing resistance of the opportunistic pathogens to available antibacterial 
medicines, there has been an accelerated effort in the scientific community to re-design strategies 
to develop novel therapeutics, which could be efficacious and at the same time provide long-term 
resistance from bacterial infections.  Some opportunistic pathogens, such as Pseudomonas 
aeruginosa, Yersinia pestis, Escherichia coli, Mycobacterium tuberculosis, Haemophilus 
influenzae, Salmonella typhimurium, Staphylococcus aureus, Shigella dysenteriae etc., are 
commensal with the vertebrate host until the host immune system is compromised.   
A very common example of Gram-negative opportunistic pathogen is Pseudomonas 
aeruginosa, which is ubiquitously present.  In immunocompromised patients, P. aeruginosa 
infection could be potentially fatal [1].  In the United States alone, on an average 4 cases per 
1000 patients (0.4 %) released from hospitals are infected by P. aeruginosa [2].  Moreover, it’s 
been estimated that almost 50 % of the patients suffering from burns, cystic fibrosis and cancer 
do not survive P. aeruginosa infections [2].  
 Irrespective of the nature of the pathogen that invades the vertebrate host, one thing 
common between all of them is the requirement for iron which is a nutrient need to multiply and 
cause infection in the host.  Research finds that iron is necessary to successfully colonize in the 
vertebrate host during the initial phase of infections [3]. 
This strongly supports the idea that pathogenicity of the bacteria could be targeted if they 
are deprived of the essential nutrient iron.  Genes involved in the iron uptake and regulation have 
been characterized but there is a gap in the knowledge about the proteins they code, their 
structure, functions and various dynamic interactions during infection.  This brings the attention 
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for a better understanding of the mechanism by which bacteria scavenge iron from the vertebrate 
host.  Structural characterization of these proteins at atomic detail would help us to design 
inhibitors which would target specific protein-protein interactions. This in turn would help to 
design better therapeutics which would be different from the conventional therapies and would 
provide long term resistance from the bacterial infections.  
1.1 Iron: An Important Metal Ion in Biological Systems 
Iron is the fourth most abundant element in the earth’s crust [4], and is an essential nutrient 
for nearly all organisms.  It is a key element in oxidation/reduction reactions, due to its Fe
2+
/ Fe
3+
 
redox potentials which depend on the ligands that are coordinated with the iron ion.  It acts as a 
catalyst for many oxidative enzymes and is important for many physiologically important 
reactions like oxygen transport (hemoglobin and myoglobin), cytochromes in respiration, 
biosynthesis of genetic material DNA, cell division and gene regulation [5, 6].  Despite its 
abundance and significance, iron acquisition and incorporation in biological systems is difficult, 
leading to cellular toxicity from the soluble ferrous (Fe
2+
) form (0.1 M at pH 7) which generates 
highly reactive free hydroxyl radicals via Fenton-type reaction causing damage to DNA, 
proteins, lipid membranes and other cellular components, and the ferric (Fe
3+
) form (10
-18
 M at 
pH 7) which is insoluble at the physiological pH [7].  
               
             (Reaction 1; Fenton reaction) 
In addition, one-electron reduction of O2 by ferrous ions produces superoxide radicals which in 
turn reduce the ferric ions to ferrous ions: 
  
                
      (Reaction 2)  
4 
 
Summation of the above two reactions (Reaction 1 and Reaction 2) is called the Haber-Weiss 
cycle which generates the hydroxyl anions, oxygen and reactive hydroxyl radicals as the reaction 
products.  
        
                  (Reaction 3; Haber-Weiss reaction) 
As a consequence of the potential toxicity of the ferrous form and the insolubility of the 
ferric form, all living organisms have developed efficient ways of acquiring, storing and utilizing 
iron.  
1.2 Iron Uptake Mechanisms in Bacteria 
Similar to vertebrates, bacterial pathogens require iron to meet their metabolic needs and 
function normally.  Gram-positive bacteria have thick peptidoglycan lipid layer around the 
plasma membrane whereas in Gram-negative bacteria, the cell membrane is compartmentalized 
into outer membrane, periplasmic space and inner membrane.  Gram-positive and Gram-negative 
bacteria have different mechanism to uptake iron/ heme from the vertebrate host.   
1.2.1 Siderophores 
Under iron limiting conditions, bacteria produces and secretes small molecular weight 
compounds called siderophores that strongly and specifically bind ferric (Fe
3+
) iron ion [8, 9].  
Siderophores solubilize the ferric ion from organic complexes, and actively transport against the 
concentration gradient via specific cell surface receptors through the inner membrane by the 
periplasmic protein-dependent TonB transporters [10-12].  Along with siderophores secretion, 
some bacteria secrete extracellular proteases that lyse host iron-binding proteins [13, 14], or 
produce exotoxins that target iron containing proteins [15, 16] or directly bind host iron-binding 
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proteins and reduce the insoluble Fe
3+
 to the usable soluble Fe
2+
 form [17].  Two different 
mechanisms operate in Gram-negative and Gram-positive bacteria to internalize iron bound 
siderophores.   
1.2.1.1 Siderophore Uptake in Gram-negative Bacteria 
In Gram-negative bacteria, the iron-siderophore complex is first bound by the specific 
outer membrane receptor proteins such as FepA, FecA and FhuA and are actively transported 
across the outer membrane into the periplasm, using the energy dependent TonB-ExbB-ExbD 
system [18].  Once in the periplasm, they are bound by the ATP-binding cassette (ABC) 
transporters in the inner membrane and are delivered to the cytoplasm. 
In E. coli, low levels of intracellular Fe
2+
 induce the production of siderophore called 
enterobactin [19, 20].  The fur gene encodes a DNA binding protein called Ferric Uptake 
Regulator (Fur) which binds to the upstream of the specific DNA sequence and with Fe
2+
 co-
represses siderophore synthesis (Figure 1.1).  Fe
2+
 acts as a co-repressor of the transcription 
machinery.  Since concentrations of Fe
2+
 transcriptionally control the expression of genes that 
promote iron acquisition, a mutation identified in Fur leads to constitutive expression of the iron 
uptake genes in E. coli [21]. 
In Pseudomonas aeruginosa, two siderophores, pyoverdine and pyochelin [22, 23] are 
produced under the regulation of Fur [24].  Under iron limiting conditions, P. aeruginosa first 
synthesizes pyochelin and then switches to pyoverdine production under extremely low iron 
concentrations [12, 25].   Pyochelin biosynthesis employs fewer genes and has lower iron 
binding affinity (Kf = 10
5
 M
-1
) compared to pyoverdine (Kf = 10
24
 M
-1
) [25].  The high affinity of 
pyoverdine can displace iron ions from storage proteins ferritins.  It also acts as a regulator for 
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siderophore receptors on the cell membrane as well as signal molecule by triggering the 
production of virulence factors, PrpL and exotoxin A [12].   
Yersinia pestis secretes a highly potent siderophore called yersiniabactin under iron 
limiting conditions [26].  Yersiniabactin has a formation constant of 4 x 10
-36
 for ferric iron ions 
and no affinity to bind ferrous ions [26]. 
 
Figure 1.1.  Schematic representation of Fur-mediated gene expression. Figure adapted and re-drawn from reference 
[4]. 
 
1.2.1.2 Siderophore Uptake in Gram-positive Bacteria 
In Gram-positive bacteria, membrane anchored binding proteins (MABP) bind the ferri-
siderophore complexes which are then transported across the inner membrane.  Once these iron-
siderophore complexes are inside the cytosol, they are either reduced to ferrous ions or in some 
organisms siderophores are broken down to release iron ions (Figure 1.2). 
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Figure 1.2.  Schematic representation of siderophore-mediated iron uptake by (A) Gram-negative and (B) 
Gram-positive bacteria.  OMR: Outer membrane receptor, PBP: Periplasmic binding protein, ABC: ATP-
Binding Cassette proteins, MAPB: Membrane-anchored binding protein, OM: Outer membrane, PG: 
Peptidoglycan, IM: Inner membrane.  Figure adapted and re-drawn from reference [27]. 
 
1.3 Heme: Most Abundant Iron-containing Prosthetic Group 
In the vertebrates, the blood plasma concentration of free iron is kept below 10
-18
 M due to 
sequestration into high-affinity iron-binding proteins like heme in hemoglobin, iron-sulfur 
clusters, transferrin, lactoferrin and storage proteins like ferritins.  The regulation of heme 
biosynthesis and its degradation is tightly controlled as heme is tightly bound, as a prosthetic 
group, to heme proteins or to the transport proteins like hemopexin (HPX) or haptaglobin (HPT) 
[28].  However, like iron, free heme is toxic and causes oxidative damage to the cells by 
catalyzing formation of the reactive oxygen intermediates.  To avoid this deleterious effect, free 
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heme released into the blood plasma as a result of the breakdown of the erythrocytes are quickly 
scavenged for recycling by human serum albumin (HSA), HPX and hemoglobin-haptaglobin 
(Hb-HPT) complex [29, 30].  Under pathological conditions, free heme, HPX, HSA and Hb-Hp 
complex all serve as a source of heme for the invading pathogens.  The low availability of free 
heme in the vertebrate host has led to the evolution of dedicated and sophisticated mechanisms in 
bacteria for the acquisition of heme for their nutrient requirements [31]. 
Majority of iron (~ 95 %) is sequestered in the form of heme, in hemoglobin (Hb) within 
the vertebrate cells [31, 32].  Hemoglobin (Hb) is the most abundant heme protein in the 
erythrocytes that transports oxygen, carbon dioxide and nitric oxide [30].  However, as the life 
span of erythrocytes end, they undergo lysis resulting in the release of their contents into the 
plasma.  Free heme released from the lysis of Hb is sequestered rapidly by the high and low 
density lipoproteins (HDL and LDL), human serum albumin (HSA) and hemopexin (HPX) [30].  
During the initial release of heme in the plasma, around 80% is quickly sequestered in 
LDL and HDL and the remaining 20% binds to HSA and HPX, which is slowly removed from 
the LDL and HDL [30].  Final fate of the bound heme is the delivery to specific cell receptors in 
liver, spleen and macrophages [33-35].  Pathogenic bacteria can scavenge free heme, Hb, Hb-Hp 
complex, and the heme-bound HSA and HPX for their metabolic needs. 
1.4 Heme as an Iron Source for Bacteria 
1.4.1 Bacterial Heme Uptake Systems 
Heme uptake in Gram-negative bacteria can be classified into two groups: in one, there is 
direct uptake of the heme or heme associated with the host hemoproteins like hemoglobin, heme-
serum albumin, heme-hemopexin, hemoglobin-haptoglobin and myoglobin.  And in another, 
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heme uptake involves the secretion of small heme-binding proteins called hemophores that either 
bind/ extract heme from the lysed or degraded iron containing proteins and deliver it to the 
specific outer membrane receptors on the cell surface of the bacteria.  Once the heme or is 
delivered to the receptor, the cargo (heme) is shuttled to the cytosol via a series of membrane 
bound proteins like TonB-dependent outer membrane receptor, a periplasmic binding protein 
(PBP), and an ABC transporter.  Inside the cytosol, cargo is acted upon and degraded by the 
heme-degrading enzymes (heme oxygenases) to release iron ion (Figure 1.3-A) [31].  In Gram-
positive bacteria, the cargo is bound by the lipoproteins anchored in the peptidoglycan and are 
then transported to the ABC transport proteins [27, 31, 32, 36-38] (Figure 1.3-B).  Details of the 
heme uptake systems in Gram-negative bacteria will be discussed in the following sections. 
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Figure 1.3.  Schematic representation of heme uptake and degradation in (A) Gram-negative bacteria and (B) Gram-
positive bacteria (Staphylococcus aureus).  Figure adapted from reference [31]. 
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1.4.2 Mechanisms of Heme Uptake in Gram-negative Bacteria 
Extensive studies have been done to understand the heme uptake systems in Gram-
negative bacteria.  Numerous proteins and various mechanisms been suggested which are 
broadly classified by Wandersman and co-workers [39] in two groups: in the first group, heme 
uptake involves direct binding of the heme and/or heme-proteins (hemoglobin, human serum 
albumin, hemopexin and hemoglobin-haptoglobin complex) to the specific cell surface receptors 
on the outer membrane.  This class includes shuASTUV from Shigella dysenteriae [40-42],  
ChuA from Escherichia coli O157:H7 [43], phuRSRUVW from Pseudomonas aeruginosa [44-
46], hmuRSTUV from Yersinia pestis [47] and the hemR-hemSTUV system in Yersinia 
enterocolitica [48].  Genetic organization of phu (Pseudomonas heme uptake) operon in 
Pseudomonas aeruginosa involves a single outer membrane receptor (phuR) for uptake of heme, 
a periplasmic transport protein (phuT), inner membrane proteins (phuUVW) and a cytoplasmic 
protein (phuS) [49] (Figure 1.4). 
 
Figure 1.4.  Genetic organization of the heme uptake locus in Pseudomonas aeruginosa containing the phuR gene 
and the phuSTUVW operon.  The three Fur binding domains are shown as white rectangles.  Figure adapted and re-
drawn from reference [49]. 
The second group has the small secreted protein called hemophore which delivers the 
heme to its outer membrane receptor.  This hemophore/receptor pair is found in Serratia 
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marcescens (hasRADEBF) [50, 51], Pseudomonas aeruginosa (hasRADEF) [52], Pseudomonas 
fluorescens [53], Yersinia pestis (hasRADEBF) [54].  A different type of hemophore have been 
identified in Haemophilus influenzae (HuxA) (hxuCBA) [55, 56] and Porphyromonas gingivalis 
(HusA) [57] [31].  The has operon in Serratia marcescens, which is similar to that of 
Pseudomonas aeruginosa, is regulated by intracellular iron concentrations via Fur repression.  
Under iron-replete conditions, Fur protein binds Fe
2+
 at the upstream in the promoter region of 
DNA and represses the transcription of iron uptake genes (Figure 1.5-A, yellow square).  The 
two genes, homologous to E. coli extracytoplasmic function (ECF) sigma factors and sigma-
modulators, are located upstream of HasR namely, hasI (an ECF sigma factor) (Figure 1.5-A, 
green oval) and hasS (HasI antisigma factor) which codes for HasI and HasS proteins.  In 
Serratia marcescens, it has been shown by Rossi and coworkers [58] that positive and negative 
regulation of hasI and hasS genes work in cooperation with Fur-dependent mechanism to operate 
the has operon under iron-limiting conditions.  When the HasR receptor is bound with the holo-
hemophore (HasA), it activates the HasI sigma factor and inactivates the HasS, antisigma 
modulator, enabling the signal cascade.  In contrast, in iron-replete conditions, the anti-sigma 
activity of HasS is blocked and HasI induces the transcription of HasS leading to the 
accumulation of inactive HasS molecules.  As the external concentration of external heme source 
decreases or apo-hemophore is bound to the HasR, accumulated HasS blocks the expression of 
hasR [58, 59] (Figure 1.5).  
1.4.3 Hemophore-dependent Heme Acquisition Systems 
Hemophores HasA (heme acquisition system) are small proteins which are secreted to 
the extracellular milieu to capture (free or protein bound) heme and deliver it to the specific outer 
membrane receptor, HasR.  Hemophores belong to a family of highly conserved proteins with no 
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Figure 1.5.  Genetic organization of has operon in (A) Serratia marcescens, (B) Pseudomonas aeruginosa, and (C) 
Yersinia pestis.  Adapted and re-drawn:  Figure 5-A from reference [58], Figure 5-C from reference [54]. 
 
sequence homology to other known proteins.  Hemophores are secreted via the Sec-independent 
pathway also known as type I secretion pathway (TISS) which is one of the five secretion 
systems identified in Gram-negative bacteria [60-62].  TISS help transport small and large 
molecules from the cytoplasm to the extracellular medium.  The architecture of the TISS consists 
of three components: (a) cytoplasmic membrane bound ATP-binding cassette (ABC) class of 
protein, comprised of a nucleotide binding domain (NBD), (b) an adaptor or a membrane fusion 
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protein (MFP) consisting of a cytoplasmic membrane anchor, (c) an outer membrane protein 
(OMP) belonging to TolC type receptors family (Figure 1.6). 
This secretion apparatus is also known as ABC exporter and used by many different 
families of proteins for the secretion of specific proteins, including virulence factors, hydrolytic 
enzymes and hemophores. [60, 61].  
 
Figure 1.6.  Schematic representation of the type I secretion pathway with the ABC/MFP complex either (A) not 
preformed or (B) preformed.  C-terminus of the polypeptide interacts with the ABC protein and secretion of the 
polypeptide.  Figure adapted and re-drawn from reference [60].  OMP: Outer membrane protein, MFP: Membrane 
fusion protein, IM: Inner membrane, OM: Outer membrane. 
Hemophores (HasA) are secreted by ABC secretion pathway into the extracellular 
medium in a Sec-independent manner.  Similar to other proteins secreted by this pathway, 
hemophores lack N-terminal secretion signal sequence.  Instead a conserved secretion signal 
motif (Dxxx) is located within the last 50 amino acids residues near the C-terminal end [63] 
(Figure 1.7, red rectangle).  The C-terminal signal peptide is important as it directs the secretion 
of the protein and specifically interacts with the ABC protein and modulates its ATPase activity 
[62] (Figure 1.6).  Moreover, this interaction triggers the assembly of ABC, MFP and OMP 
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proteins into a functional complex.  The specific interaction of C-terminal signal peptide with the 
ABC protein implies that the protein is fully synthesized before being exported out in the 
extracellular medium [62].  In case of hemophores, synthesis and secretion are coupled, a 
chaperone SecB binds and slows down folding of HasA, keeping the newly synthesized 
polypeptide chain in a conformation that is competent for secretion [61].  Two problems arise in 
the event of uncoupling between the synthesis and secretion; (i) HasA folds in the cytoplasm and 
binds heme from other cytoplasmic proteins, and (ii) folded HasA interacts with the transporter 
in vivo, and inhibits secretion of newly synthesized HasA molecules [64, 65]. 
Haemophilus influenzae, which lack the heme biosynthetic pathway, utilizes heme-
hemopexin complex as a heme source.  It secretes a truncated (21 residues of the signal peptide) 
hemophore HuxA which strongly binds the HPX with or without heme.  The bound HPX 
complex to the HuxA is then transferred to the outer membrane receptor, HuxC, for 
internalization [55, 66].  
1.4.4 Structural Characterization of Hemophore HasA  
The apparatus consists of a secreted hemophore HasA and an outer membrane receptor 
HasR.  The receptor HasR can bind heme directly but the efficiency of the heme uptake is 
increased ~ 100 fold in conjugation with hemophore HasA [50].  The HasA from Serratia 
marcescens (HasAs) was the first hemophore to be identified and thoroughly characterized from 
structural and functional point of view [67].  Recent biochemical and biophysical 
characterization of hemophores has been done for Pseudomonas aeruginosa (HasAp) [68-70] 
and Yersinia pestis (HasAyp) [36]. 
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                                       10        20        30        40            50         
                                       |         |         |         |             |          
Yersinia pestis               MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia pseudotuberculosis   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia mollaretii           MSTTIKYNSEFADHSITSYLNNWAENFGDIDQA--ATKDR----GQFAGGG-MLDGTQYS 
Yersinia bercovieri           MSVTVQYNSEFADYTVSSYLSNWAETFGDMNQA--ETKDR----GQFAGGDTIFSGTQYS 
Yersinia rohdei               MSVTIKYNENFANTSISSYLNEWAEGFGDINQA--ATKIR----GDFAGGG-WFNGTQYS 
Yersinia pestis bv. Antiqua   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Pseudomonas aeruginosa        MSISISYSTTYSGWTVADYLADWSAYFGDVNHRPGQVVDG-SNTGGFNPGP--FDGSQYA 
Serratia marcescens           MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGNVTD--ANSGGFYGGS--LSGSQYA 
Pseudomonas fluorescens       MSISISYSATYGGNTVAQYLTDWSAYFGDVNHRPGEVVDG-TNTGGFNPGP--FDGTQYA 
Erwinia carotovora            MSFAITYDAYYANYSIANYLTEWSAAFGDVNHTTGNTQVGGNNTGGFYGGDTFIDGSQYA 
Pectobacterium carotovorum    MSFAITYDAYYANYSIASYLTEWSAAFGDVNHTAGNTQVGGNNTGGFYGGDTFIDGTQYA 
                                                             #                     
 
                                 60        70          80        90       100        110        
                                 |         |           |         |         |          |         
Yersinia pestis               IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia pseudotuberculosis   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia mollaretii           IGSSHGTDMGMIVEGTLSYAFA---AHAFHGQITGMQFGHELIANSNG---VGKAFADVQ 
Yersinia bercovieri           IGSSHDTDMGMIVEGNLNYAFM---AHTFHGQITNIQFGKDLVVNTDGA--VGKHLNDLQ 
Yersinia rohdei               VKSSYDTNVAMITEGTLTYSFMP--QHTFFGQMDSIQFGKDLIPNPSGT--DDKVLENLQ 
Yersinia pestis bv. Antiqua   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Pseudomonas aeruginosa        LKSTASDA-AFIAGGDLHYTLFSNPSHTLWGKLDSIALGDTLTGGASSGG---YALDSQE 
Serratia marcescens           ISSTANQVTAFVAGGNLTYTLFNEPAHTLYGQLDSLSFGDGLSGGDTSP----YSIQVPD 
Pseudomonas fluorescens       IKSTASDA-AFVADGNLHYTLFSNPSHTLWGSVDTISLGDTLAGGSGSN----YNLVSQE 
Erwinia carotovora            ITSTQNDFSALIAGGDLTYSLFSPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLVEPE 
Pectobacterium carotovorum    ITSTQNDFSALIAGGDLTYSLFTPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLAEPE 
                                                ^       ^    
 
                                   120       130       140       150          160        
                                    |         |         |         |            |                   
Yersinia pestis               ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia pseudotuberculosis   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia mollaretii           VTFNGLDISGEFDAAKSVAENRDTDMQKSVHGLMKGNA---DPMLDILKAK---GIDVDT 
Yersinia bercovieri           VAFNDVDISGEFDATKPVAENRDSDMHKSVYGLMRGDA---DPMLEVLKAK---GIDVDT 
Yersinia rohdei               LSFNDVDISGTFDPTKEVEVNRDGDLHKSVHGLMRANP---EPFLELLKAK---GIDVDI 
Yersinia pestis bv. Antiqua   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Pseudomonas aeruginosa        VSFSNLGLDSPIA------QGRDGTVHKVVYGLMSGDSSALQGQIDALLKAVDPSLSINS 
Serratia marcescens           VSFGGLNLSSLQA------QGHDGVVHQVVYGLMSGDTGALETALNGILD--DYGLSVNS 
Pseudomonas fluorescens       VSFTNLGLNSLKE------EGRAGEVHKVVYGLMSGDSSALAGEIDALLKAIDPSLSVNS 
Erwinia carotovora            VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMGG---QVQPLLDALTN---AGIDINA 
Pectobacterium carotovorum    VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMSG---QVQPLLDALTN---AGIDINA 
 
 
                               170       180        190        200  205      
                                |         |          |          |    |  
Yersinia pestis               AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia pseudotuberculosis   AFKDLSIASQSPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia mollaretii           KFKDLDIASQLDTTSDVMADSPVVDTVGASDN-VEILMAA 
Yersinia bercovieri           AFKDMAIATQIPDT-EMAADAPIIETVGVYDDAADMSMAA 
Yersinia rohdei               PLKDMAIASQYDIM----ADAPIIDTVGAYDG-AEILMAA 
Yersinia pestis bv. Antiqua   AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Pseudomonas aeruginosa        TFDQLAAAGVAHAT-P-AAAAAEVGVVGVQELPHDLALAA 
Serratia marcescens           TFDQVAAA-------T---------AVGVQHADSPELLAA 
Pseudomonas fluorescens       TFDDLAAAGVAHVN-PAAAAAADVGLVGVQDVAQDWALAA 
Erwinia carotovora            SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
Pectobacterium carotovorum    SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
 
Figure 1.7.  Full-length HasA sequences aligned against the sequence of HasA from Yersinia pestis. Residue 32 (H 
or Q) is highlighted by (#) and proximal loop residues Tyr75 and His83 are highlighted by (^).  A horizontal line 
above the sequence highlights residues comprising the distal loop.  Conserved residues across the alignment are in 
red, conservative substitutions in green and semi-conservative substitutions in blue; sequence numbering is 
according to the Yersinia pestis sequence [36]. 
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1.4.4.1 Serratia marcescens hemophore: HasAs 
The first available X-ray crystal structure of heme-bound (holo) hemophore was from 
Serratia marcescens (HasAs) [71].  Structurally and biochemically, it is the most well 
characterized hemophore.  The monomeric protein is composed of 188 amino acid residues with 
a molecular mass of ~ 19 kDa.  The crystal structure determined at 1.9 Å resolution [71] of 
HasAs (PDB code: 1B2V) revealed a novel protein fold that binds b-type heme in a 1:1 
stoichiometry and with a high affinity (Kd ~ 10
-11
 M) [72].  The overall protein structure, as 
mentioned by the authors [71], could be imagined as a shape of a fish, with the mouth of the fish 
representing the heme binding site.  The protein is composed of α-, β-secondary structural 
elements, with one side comprised of four α-helices and the other, composed of seven 
antiparallel β-strands.  Heme is coordinated by a unique pair of ligands, Tyr75 and His32, with 
each axial ligand harbored between the long loops, termed as the Y75 loop and the H32 loop 
(Figure 1.8-A and 1.8-B).  Structurally, close to Tyr75 in the Y75 loop, His83 is present which 
forms a tight hydrogen bond (2.8 Å) with the Oη of Tyr75 via its Nδ1 NH group.  It has been 
proposed that this hydrogen bond interaction modulates the Tyr-Fe bond, thereby increasing the 
nucleophilic character of Tyr75 [73, 74].  Similar structural features have been characterized for 
the holo hemophore from P. aeruginosa (HasAp) (Figure 1.8-C and 1.8-D) [68].  Similar to the 
holo-hemophore, solution NMR structure of apo-HasAs [72] and X-ray crystal structure of apo-
HasAp [69] is available, which shows overall similar polypeptide fold compared to the holo-
counterpart except for the H32 loop which is wide open and folds back onto the body of the 
protein.  The axial ligand His32 is located ~ 30 Å away relative to the holo-protein (Figure 1.8-A 
and 1.8-C).  Recent crystal structure of apo- and holo-hemophore from Yersinia pestis (HasAyp) 
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presents a different conformation of the distal loop which is discussed in Chapter II of this 
dissertation.  
 
Figure 1.8.  Structural comparison of apo- and holo-HasA from (A and B) Serratia marcescens and (C and D) from 
Pseudomonas aeruginosa.  α-helices are colored cyan and β-strands in coral color.  Distal (H32) loop harboring the 
His32 ligand is colored magenta, proximal (Y75) loop harboring the Tyr75 ligand is colored green.  PDB codes: (A) 
apo-HasAs, 1Y2B, (B) holo-HasAs, 1B2V, (C) apo-HasAp, 3MOK and (D) holo-HasAp (3ELL). 
 
1.4.5 Mechanism of Heme loading 
Initially, Wolff and co-workers proposed an induced fit model involving a two-step hemin 
loading mechanism, where hemin first interacts and loads onto the Y75 loop followed by the 
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closure of the H32 loop thus coordinating the hemin-iron [72].  Gram-negative hemophore 
proteins having a His/Tyr ligand coordination to a ferric iron ion [75].  First evidence of Tyr 
ligation comes with the works of Lukat-Rogers and co-workers [75], upon reduction with 
dithionite in the presence of CO in holo-HasAs led to a TyrO-Fe(II)-CO complex formation with 
the displacement of the His32 residue from the distal loop.  Further evidence comes from the 
crystal structure of HasAs in complex with its receptor (HasR), where the Tyr75 is coordinating 
the hemin-iron and the His32 is away from the hemin-binding conformation [76].  The above-
mentioned two studies in HasAs suggested that His32 is a more labile ligand and is readily 
displaced [75].  A detailed structural investigation of the role of His32 side chain in hemin 
binding has been done using the H32A mutant of HasAp [69, 70].  The X-ray crystal structure of 
H32A holo-HasAp revealed a non-crystallographic dimeric molecule.  Each of the two subunits 
coordinate the heme-iron ion by Tyr75 and the distal face of the heme molecules are stacked 
upon each other.  The conformation of the A32 loop is identical to the H32 loop and the structure 
of each subunit is superimposable to the wt apo-HasAp structure (Figure 1.9).  Kinetics studies 
done on the wt apo-HasAp using stopped-flow, EPR and resonance Raman, identifies biphasic 
hemin loading (i) where the first phase is completed within 20 ms and Tyr75 coordinates the 
hemin-iron ion from the Y75 loop and (ii) second phase completed in ~ 1 s with the closure of 
H32 loop and coordinating the heme-iron by His32 from the distal loop (Figure 1.10).  Kinetic 
measurements done on H32A HasAp mutant revealed only the first phase corresponding to the 
hemin loading onto the Y75 loop [70]. Taken together, the structural and spectroscopic 
observations suggested that the hemin first loads onto the Y75 loop followed by the closure of 
H32 loop which is accompanied by the large conformational rearrangement [70].  
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Figure 1.9.  Crystal structure of H32A holo-HasAp dimer (PDB code: 3MOL) showing co-facial stacking of heme 
molecules.  H32 loop is colored magenta and Y75 loop in green color, missing electron density in subunit B is 
located between the asterisks [69]. 
 
 
Figure 1.10.  Schematic representation of heme loading mechanism of HasA using wt apo- and holo X-ray crystal 
structures from P. aeruginosa.  Initial binding of heme is complete within 20 ms and is coordinated by Tyr75 
followed by the closure of H32 loop thus completing the process in ~ 1 s.  H32 loop is shown in magenta, Y75 loop 
in green [77].  Figure adapted from reference [31]. 
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1.4.6 Interaction of HasA with the Receptor HasR 
The detailed mechanism of heme delivery to the receptor HasR is not clearly understood.  
Co-crystal structures of holo-HasAs and apo-HasAs bound to HasR (PDB code: 3CSL and 
3CSN) and holo-HasA bound to the I167G mutant of HasR (PDB code: 3DDR) are available, 
and provide some insight for the delivery of heme from holo-HasA to HasR (Figure 1.11). 
Protein-protein interactions have been suggested as the driving force for the heme transfer from 
the holo-HasAs to the receptor HasR, which induces conformational changes leading to the 
weakening/ or breakage of the Tyr75-Fe coordination bond and moving of the heme from HasAs 
to HasR coordinated by His189 and His609 residues [61, 76]. 
 
Figure 1.11.  Superimposed crystal structures of holo-HasA (PDB code: 1B2V) and of HasA-hemin-HasR complex 
(PDB code: 3CSL) from Serratia marcescens.  The structure of the HasA-hemin-HasR complex is shown in grey at 
80% transparency.  The HasR heme ligands His189 and His603 are shown in blue.  Figure adapted from reference 
[31]. 
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1.4.7 Hemin in Periplasm and Further Translocation 
Once in the periplasm, periplasmic binding proteins (PBP) serve a crucial function of 
capturing the heme from the outer membrane receptor, HasR for further transport across the 
periplasmic space (Figure 1.3-A).  Crystal structures are available for the PBPs of Pseudomonas 
aeruginosa (PhuT) [45], Shigella dysenteriae (ShuT) [45] and Yersinia pestis (HmuT) [78].  
Structurally, the N- and C-terminal domains are connected by a long α-helix and the heme loads 
between the two domains coordinated by a Tyr residue (figure 1.12) except for HmuT in which 
two molecules of heme are bound to the structure coordinated by Tyr70 and His167 residues 
(Figure 1.12-C).  The structural information provides an insight into the PBP heme-binding 
protein which mediates heme delivery through the ABC transporter across the inner membrane.  
 
Figure 1.12.  Crystal structures of heme binding PBPs (A) PhuT (PDB code: 2R79), (B) ShuT (PDB code: 2RG7) 
and, (C) HmuT (PDB code: 3NU1).  The structure of HmuT (C) has two heme molecules coordinated by Tyr70 and 
His167 ligands.  Figure adapted from reference [31]. 
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1.4.8 Iron Release and Fate of Heme in the Cytosol 
Once the macrocycle is in the cytoplasm, chaperone PhuS sequesters the heme and 
transfers it to the heme degrading enzyme (heme oxygenase, HO) (Figure 1.3).  HO enzymes 
catalyze the breakage of the heme macrocycle releasing the iron for the metabolic needs or for 
storage in the bacteria.  The HO mediated degradation of heme to release iron is summarized in 
scheme 1.  Briefly, the process begins with the reduction of Fe
3+
 iron ion to Fe
2+
 which enables 
an oxygen molecule to bind at the distal site, forming an oxyferrous complex (Fe
2+
-O2).  The 
oxyferrous complex upon accepting a second electron and a proton is converted into an activated 
ferric hydroperoxy (Fe
3+
-OOH) oxidizing species.  Recent findings in Pseudomonas aeruginosa 
demonstrate that the electron donor is a ferredoxin NADP
+
 reductase (pa-FPR), a NADPH-
dependent flavoenzyme [31, 79].  The Fe
3+
-OOH intermediate in HO reacts with α-meso carbon 
in heme to produce ferric α-meso-hydroxyheme that undergoes a rapid O2-dependent elimination 
of carbon monoxide (CO) to form verdoheme.  Verdoheme is subsequently oxidized to Fe
3+
-
biliverdin by an oxygen molecule breaking the macrocycle to release iron ion [31].  
 
Scheme 1.  Schematic representation of the heme degradation carried out by the heme oxygenase (HO) enzymes.  
Scheme adapted from reference [31]. 
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1.5 Research Problem and Rationale 
The ubiquitous role of iron is important for many physiological functions.  Despite its 
importance, the redox pair of Fe
2+
/ Fe
3+
 poses unique challenges to the living cells.  The 
insolubility of the ferric form (Fe
3+
) at physiological pH and the toxicity of the ferrous form 
(Fe
2+
) generating free radicals via a Fenton-type reaction, are overcome by sequestering iron in 
high affinity heme binding proteins in vertebrate cells.  Similar to iron, heme is also toxic to cells 
and is quickly sequestered by hemopexin and serum albumin heme binding proteins, keeping the 
free iron levels below 10
-18
 M in the plasma. 
Low concentrations of free or bound iron in blood plasma poses a significant challenge 
for the pathogenic bacteria.  The need to thrive in a hostile environment has led Gram-negative 
pathogens to evolve various iron/ heme scavenging strategies.  These strategies can be broadly 
classified into (a) secretion of small molecular weight molecules called “siderophores” which 
bind ferric-iron with a high affinity, (b) direct binding of the iron-complexed proteins to the outer 
membrane receptors and (c) secretion of heme-binding proteins called “hemophores” that bind 
the heme and subsequently deliver it to their cognate outer membrane receptor.  It has been 
established that iron acquisition is critical to bacterial survival during the course of infection.  
Hemophore dependent heme acquisition system has been structurally characterized in Serratia 
marcescens [71, 80], Pseudomonas aeruginosa [53, 68, 69, 81] and Yersinia pestis [36].   
Yersinia pestis is a Gram-negative rod-shaped bacterium belonging to the 
Enterobacteriaceae family.  It is a causative agent of bubonic plague and has a dual, mammal/ 
flea, life cycle.  Similar to other Gram-negative pathogenic bacteria, Yersinia pestis also requires 
iron for its metabolic needs.  An iron deficient environment in the mammalian hosts poses a 
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challenge to acquire and utilize iron for its metabolic needs.  Y. pestis uses heme and a wide 
variety of host heme containing protein complexes including hemoglobin, hemopexin, 
hemoglobin-haptoglobin, myoglobin and serum albumin as sources to iron.  
1.5.1 Organization of Chapters in this Dissertation 
Chapter 2: Structurally characterized hemophores have an unusual set of heme binding 
ligand (His/Tyr) which bind and coordinates the heme between the proximal (Y75) and the distal 
(H32) loops.  With the first X-ray crystal structure from S. marcescens and then from P. 
aeruginosa, this coordination pair was thought to operate in all Gram-negative pathogens with an 
induced fit binding of the heme macrocycle sandwiched between the His32 and Tyr75 residues.  
A closer look at the multiple sequence alignment (Figure 7) of hemophores from different Gram-
negative pathogens reveals that the Y75 loop residues, Tyr75 and its hydrogen bond partner 
His83 (His81 in HasAyp), are conserved across the alignment, whereas the His32 is not.  Instead 
in Yersinia species, there is Gln32 present instead of His32 in the distal loop.  Given the 
structural similarity between the known hemophore Serratia marcescens (HasAs) and 
Pseudomonas aeruginosa (HasAp), hypotheses were formulated for Yersinia pestis: (a) the heme 
iron would be coordinated by a novel set of ligands (Gln32/Tyr75), (b) there will be structural 
compensation for His32 to Gln32 residue change and (c) the kinetics of heme loading be similar 
to that of HasAp or completely different. 
In order to investigate above hypotheses, we used chromatographic methods to isolate 
and purify the hemophore from Yersinia pestis (KIM10+).  Crystals were grown for both apo- 
and holo-HasAyp proteins which were then characterized by X-ray crystallography to elucidate 
the structural features.  The detailed results and discussions are presented in Chapter II of this 
dissertation.  
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Chapter 3: X-ray crystal structure of wt apo-HasAp structure shows that the H32 loop is 
wide open and the His32 is located approximately ~ 30 Å away from the heme binding site.  
Similar observation was complemented from the solution NMR study of the apo-protein.  These 
two analyses suggest that the H32 loop is conformationally stable and do not show flexibility in 
the apo-form.  The stability of the H32 loop in the apo-protein could be visualized as a “zipper-
like” network of interactions holding the H32 loop in the wide open conformation.  Upon heme 
loading, the intramolecular interaction triggers the H32 loop closure, suggesting a large 
conformational rearrangement in the H32 loop thus, coordinating the heme-iron by His32.  
Combining the available structural information from Serratia marcescens, Pseudomonas 
aeruginosa and Yersinia pestis hemophores, the conformational changes were mapped onto the 
apo-HasAp protein structure to understand the H32 loop “rigid” open structure.  Mapping the 
structural changes shows the presence of Arg33 in a very strategic location over the body of the 
hemophore HasAp.  Hypotheses were formulated suggesting that Arg33 is the key to anchoring 
the open conformation of the His32 loop.  To test the hypotheses, we replaced Arg33 with 
Ala33.  The mutated protein was purified and then screened for crystal growth.  Uniformly 
labeled 
15
N-mutated proteins were prepared, which were investigated using solution NMR 
spectroscopy.  Chapter III discusses the detailed structural investigation of R33A HasAp mutant 
proteins. 
Chapter 4: The amino acid sequence of known hemophores (Figure 7) suggests a strong 
conservation of Tyr75 and His83 (His81 in HasAyp) residues.  From the available crystal 
structures (HasAp, HasAyp and HasAs), the location of these two residues on the Y75 loop is 
near to each other (Figure 8 A-D).  Tyr75 (Oη) engages in a hydrogen bond interaction with the 
His83 (Nδ) (His81 in HasAyp) and the interaction is thought to increase the phenolate character of 
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Try75.  It has been proposed that this hydrogen bond interaction between the Tyr75 and His83 
(His81 in HasAyp) is essential for proximal heme coordination by Tyr75 [68, 73, 74].  Given the 
structural conservation of Tyr75 and His83 and the proposed requirement for the Tyr75-His83 
hydrogen bond in heme coordination by Tyr75, we carried out structural and spectroscopic 
investigation of the Y75 loop conserved residues in the P. aeruginosa.  To investigate this 
hydrogen bond requirement, we replaced Tyr75 and His83 for Alanine.  Detailed structural and 
kinetic investigations of the Y75A and H83A mutants and discussion of the observations are 
summarized in Chapter IV. 
Chapter 5: The importance of current findings in the context of past and present 
knowledge is discussed.  Future directions and avenues for further research in this area are 
suggested along with the dissertation summary. 
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Chapter 2 
 
 
The Hemophore HasA from Yersinia pestis (HasAyp) Coordinates Hemin with 
a Single Residue, Tyr75, and with Minimal Conformational Change 
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Summary 
Under iron-limiting conditions several Gram-negative pathogens secrete a hemophore (HasA) to 
scavenge hemin from various iron binding/ containing proteins in the vertebrate host and deliver 
it to the specific outer membrane receptor (HasR) for internalization.  Structurally characterized 
hemophores from Serratia marcescens (HasAs) and Pseudomonas aeruginosa (HasAp) bind 
hemin between two loops (Y75 and H32), which harbor the axial ligands His32 and Tyr75.  In 
both the organisms, the hemophore has similar apo- and holo structures except the H32 loop 
which shows a large conformational rearrangement and relocates His32 ~ 30 Å from an open 
(apo) to a closed (holo) upon binding of the heme.  Hemin binding to the Y75 loop triggers 
closing of the H32 loop and enables binding of His32.  Amino acid sequence alignment of HasA 
proteins from Yersinia species show conservation of Tyr75 and His83 in the Y75 loop, but no 
conservation of the His32 residue, instead contain a Gln at position 32.  In order to understand 
the structural compensation in the absence of His32, we investigated and carried out the 
structural characterization of the hemophores from Yersinia pestis (HasAyp) in the heme-free 
(apo-) and heme-bound (holo-) forms.  Surprisingly, the Q32 loop in apo-HasAyp is already in 
the closed conformation but no residue from the Q32 loop binds hemin in holo-HasAyp.  
Moreover, Tyr75 is the only endogenous protein provided hemin ligand in holo-HasAyp.  In 
agreement with the minimal reorganization between the apo- and holo-structures, hemin binding 
to apo-HasAyp occurs on a sub-millisecond timescale undetected by conventional stopped-flow 
measurements. 
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2.1 Introduction 
Although iron is important for many crucial biological functions, its chemical properties present 
unique challenges to living cells, which have to overcome the insolubility of Fe(III) and the 
toxicity of Fe(II) by sequestering iron in heme, iron-sulfur clusters or iron binding proteins.  The 
very low concentrations of free iron in host cells pose significant challenges to pathogenic 
bacteria, which have evolved efficient strategies to scavenge iron, including secretion of 
hemophores, siderophores, hemolysins, proteases and cytotoxins [1, 2].  Given that ~70% of total 
iron is bound to hemoglobin, heme is an important iron source.  Thus, a strategy used by bacteria 
to acquire heme is the deployment of hemophores, which are small proteins secreted in the 
extracellular milieu of the vertebrate hosts to capture free or protein-bound heme and deliver it to 
the outer membrane receptor of bacteria.  The heme is then transferred from the outer membrane 
receptor to the cytosol via specific interactions with the proteins in the periplasm and the inner 
membrane [2, 3], where the macrocycle is degraded by heme-degrading enzymes to release the 
iron [1, 4, 5].  The released iron then can be either used for the metabolic purpose or stored in 
iron storage proteins like BfrB in the bacteria [6].  The HasA-type hemophore was first identified 
in Serratia marcescens [7] and then shown to be conserved in several Gram negative pathogens 
including, Pseudomonas aeruginosa, Pseudomonas fluorescens, Yersinia pestis, Yersinia 
pseudotuberculosis, Erwinia carotovora and Pectobacterium carotovorum [8-12].  Hemophores 
from S. marcescens (HasAs) [13, 14] and P. aeruginosa (HasAp) [8, 15] have been structurally 
characterized in their apo- and heme-bound (holo) forms and are found to be nearly identical.  
The X-ray crystal structure reveals a novel protein fold composed of a α+β type fold with the 
wall of α-helices on one side and wall of β-strand on the another.  The hemophore protein binds 
heme in a 1:1 stoichiometry and the hemin iron in holo-HasAp (and HasAs) is coordinated by 
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His32 and Tyr75.  Each axial ligand is harbored in a loop, termed either the H32 or Y75 loop. 
From the solution NMR studies of apo-HasAs [14] and X-ray crystal structure of apo-HasAp [8], 
the main difference between the apo- and holo-structures is a large rearrangement of the H32 
loop, which relocates His32 ~30 Å upon loading of the heme (Figure 2.1). 
 
 
Figure 2.1.  Structure of (A) holo-HasAp (PDB code: 3ELL) and (B) apo-HasAp (PDB code: 3MOK) showing the 
proximal (Y75) and distal (H32) ligands.  The Y75 loop is shown in green, the H32 loop is in magenta and the heme 
is in red.  Heme loads onto the Y75 loop; triggers closure of the H32 loop, and enables the His32 to coordinate the 
heme iron.  Figure adapted from reference [16]. 
 
To probe which axial ligand (His32 or Tyr75) from the hemophore first comes in contact 
with the heme, structural and spectroscopic studies were carried out with the WT and H32A 
HasAp [8, 17].  A detailed spectroscopic investigation identifies biphasic hemin loading: (i) first 
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phase where hemin loads onto the Y75 loop within a few milliseconds and is likely rapidly 
coordinated by Tyr75, followed by a (ii) second phase where the coordination by His32 takes 
place, which is significantly slower (hundreds of milliseconds to second scale) [18].  In the X-ray 
crystal structure of H32A holo-HasAp in complex with imidazole, hemin-iron is coordinated by 
Tyr75 and imidazole, the H32 loop is near the distal heme face and adopts a conformation very 
similar to that of WT holo-HasAp; NMR studies suggest that this conformation is maintained in 
solution [8].  These findings led to the conclusion that hemin loading onto the Y75 loop triggers 
closing of the H32 loop.  Results from targeted molecular dynamic simulations allowed 
identification of motions that are likely important for transmitting the presence of heme in the 
Y75 loop to the H32 loop in order to initiate its closing [8].   
Given the unusual His/Tyr coordination of the hemin-iron and the induced fit closing of 
the H32 loop upon hemin loading onto the Y75 loop of HasAp or HasAs, it is intriguing that 
His32 is not conserved amongst HasA proteins.  Multiple sequence alignment of hemophore 
sequences from different Gram-negative pathogens reveals that the Y75 loop residues, Tyr75 and 
His83 (His81 in HasAyp), is conserved across the alignment whereas His32 is not conserved.  
Instead in Yersinia species, (Figure 2.2) there is a Gln at position 32 and do not have a His 
residue close in the sequence that could coordinate the hemin iron.  These observations suggest 
that if the hemophore structures of Yersinia species are similar to HasAp and HasAs, then the 
hemin iron would be axially coordinated by an unprecedented set of ligands, Gln32 and Tyr75.  
In order to understand how the structures of hemophores compensate for the absence of H32, we 
carried out the structural characterization of the hemophore from Yersinia pestis KIM10+ 
(HasAyp) in its heme-free (apo-) and heme-bound (holo-) forms.   
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                                       10        20        30        40            50         
                                       |         |         |         |             |          
Yersinia pestis               MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia pseudotuberculosis   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia mollaretii           MSTTIKYNSEFADHSITSYLNNWAENFGDIDQA--ATKDR----GQFAGGG-MLDGTQYS 
Yersinia bercovieri           MSVTVQYNSEFADYTVSSYLSNWAETFGDMNQA--ETKDR----GQFAGGDTIFSGTQYS 
Yersinia rohdei               MSVTIKYNENFANTSISSYLNEWAEGFGDINQA--ATKIR----GDFAGGG-WFNGTQYS 
Yersinia pestis bv. Antiqua   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Pseudomonas aeruginosa        MSISISYSTTYSGWTVADYLADWSAYFGDVNHRPGQVVDG-SNTGGFNPGP--FDGSQYA 
Serratia marcescens           MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGNVTD--ANSGGFYGGS--LSGSQYA 
Pseudomonas fluorescens       MSISISYSATYGGNTVAQYLTDWSAYFGDVNHRPGEVVDG-TNTGGFNPGP--FDGTQYA 
Erwinia carotovora            MSFAITYDAYYANYSIANYLTEWSAAFGDVNHTTGNTQVGGNNTGGFYGGDTFIDGSQYA 
Pectobacterium carotovorum    MSFAITYDAYYANYSIASYLTEWSAAFGDVNHTAGNTQVGGNNTGGFYGGDTFIDGTQYA 
                                                             #                     
 
                                 60        70          80        90       100        110        
                                 |         |           |         |         |          |         
Yersinia pestis               IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia pseudotuberculosis   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia mollaretii           IGSSHGTDMGMIVEGTLSYAFA---AHAFHGQITGMQFGHELIANSNG---VGKAFADVQ 
Yersinia bercovieri           IGSSHDTDMGMIVEGNLNYAFM---AHTFHGQITNIQFGKDLVVNTDGA--VGKHLNDLQ 
Yersinia rohdei               VKSSYDTNVAMITEGTLTYSFMP--QHTFFGQMDSIQFGKDLIPNPSGT--DDKVLENLQ 
Yersinia pestis bv. Antiqua   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Pseudomonas aeruginosa        LKSTASDA-AFIAGGDLHYTLFSNPSHTLWGKLDSIALGDTLTGGASSGG---YALDSQE 
Serratia marcescens           ISSTANQVTAFVAGGNLTYTLFNEPAHTLYGQLDSLSFGDGLSGGDTSP----YSIQVPD 
Pseudomonas fluorescens       IKSTASDA-AFVADGNLHYTLFSNPSHTLWGSVDTISLGDTLAGGSGSN----YNLVSQE 
Erwinia carotovora            ITSTQNDFSALIAGGDLTYSLFSPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLVEPE 
Pectobacterium carotovorum    ITSTQNDFSALIAGGDLTYSLFTPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLAEPE 
                                                ^       ^    
 
                                   120       130       140       150          160        
                                    |         |         |         |            |                   
Yersinia pestis               ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia pseudotuberculosis   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia mollaretii           VTFNGLDISGEFDAAKSVAENRDTDMQKSVHGLMKGNA---DPMLDILKAK---GIDVDT 
Yersinia bercovieri           VAFNDVDISGEFDATKPVAENRDSDMHKSVYGLMRGDA---DPMLEVLKAK---GIDVDT 
Yersinia rohdei               LSFNDVDISGTFDPTKEVEVNRDGDLHKSVHGLMRANP---EPFLELLKAK---GIDVDI 
Yersinia pestis bv. Antiqua   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Pseudomonas aeruginosa        VSFSNLGLDSPIA------QGRDGTVHKVVYGLMSGDSSALQGQIDALLKAVDPSLSINS 
Serratia marcescens           VSFGGLNLSSLQA------QGHDGVVHQVVYGLMSGDTGALETALNGILD--DYGLSVNS 
Pseudomonas fluorescens       VSFTNLGLNSLKE------EGRAGEVHKVVYGLMSGDSSALAGEIDALLKAIDPSLSVNS 
Erwinia carotovora            VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMGG---QVQPLLDALTN---AGIDINA 
Pectobacterium carotovorum    VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMSG---QVQPLLDALTN---AGIDINA 
 
 
                               170       180        190        200  205      
                                |         |          |          |    |  
Yersinia pestis               AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia pseudotuberculosis   AFKDLSIASQSPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia mollaretii           KFKDLDIASQLDTTSDVMADSPVVDTVGASDN-VEILMAA 
Yersinia bercovieri           AFKDMAIATQIPDT-EMAADAPIIETVGVYDDAADMSMAA 
Yersinia rohdei               PLKDMAIASQYDIM----ADAPIIDTVGAYDG-AEILMAA 
Yersinia pestis bv. Antiqua   AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Pseudomonas aeruginosa        TFDQLAAAGVAHAT-P-AAAAAEVGVVGVQELPHDLALAA 
Serratia marcescens           TFDQVAAA-------T---------AVGVQHADSPELLAA 
Pseudomonas fluorescens       TFDDLAAAGVAHVN-PAAAAAADVGLVGVQDVAQDWALAA 
Erwinia carotovora            SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
Pectobacterium carotovorum    SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
Figure 2.2.  Full-length HasA sequences aligned against the sequence of HasA from Yersinia pestis. Residue 32 (H 
or Q) is highlighted by (#) and proximal loop residues Tyr75 and His83 are highlighted by (^). A horizontal line 
above the sequence highlights residues comprising the distal loop.  Conserved residues across the alignment are in 
red, conservative substitutions in green and semi-conservative substitutions in blue; sequence numbering is 
according to the Yersinia pestis sequence.  Sequence alignment done using CLUSTAL W [19], figure adapted from 
reference [16]. 
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2.2 Experimental Methods 
2.2.1 Cloning of the HasAyp Gene 
A synthetic gene coding for full-length Yersinia pestis HasA (HasAyp) was synthesized 
and sub-cloned into the pET11a expression vector by GenScript (Piscataway, NJ).  Silent 
mutations to introduce codons favored by Escherichia coli were engineered into the HasAyp gene 
[20].  Restriction sites NdeI and BamHI were introduced at the 5’ and 3’ ends of the gene, 
respectively (Table 2.1), to facilitate sub-cloning into the pET11a vector.  The recombinant 
plasmid harboring the HasAyp gene was then transformed into the E. coli BL21-GOLD (DE3) 
competent cells (Stratagene, La Jolla, CA). A gene coding for truncated HasAyp (full-length – 12 
residues) was constructed by appropriately placing a stop codon in the recombinant pET11a 
plasmid harboring the gene coding for full-length HasAyp using the QuickChange mutagenesis 
kit from Stratagene (La Jolla, CA).  The oligonucleotides were synthesized by Integrated DNA 
Technologies, Inc. and were used without further purification. The primers used were 5'-
GCCCCGATGGTTGATACGGTTTAAGTTGTTGATTGTCACGATATG-3' and 5'- 
CATATCGTGACAATCAACAACTTAAACCGTATCAACCATCGGGGC-3'; the underlined 
codons represent mismatches that introduce a stop codon after Val 193 (see Table 2.1).  The 
mutation was confirmed by sequencing (ACGT, Inc., IL) and the recombinant DNA plasmid was 
transformed into Escherichia coli BL21-GOLD (DE3) competent cells for subsequent protein 
expression. 
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5’ NdeI                
GGC CAT ATG TCT ACC ACC ATC CAA TAC AAC AGC AAC TAT GCG GAC TAC TCT 
  M S T T I Q Y N S N Y A D Y S 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
                 
ATC TCC TCG TAC CTG CGT GAA TGG GCA AAC AAC TTC GGC GAT ATT GAT CAG 
I S S Y L R E W A N N F G D I D Q 
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 
                 
GCG CCG GCC GAA ACG AAA GAC CGT GGC TCA TTT TCG GGT AGC TCT ACC CTG 
A P A E T K D R G S F S G S S T L 
33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 
                 
TTC AGC GGC ACG CAA TAT GCA ATT GGT AGT TCC CAT TCT AAC CCG GAA GGC 
F S G T Q Y A I G S S H S N P E G 
50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 
                 
ATG ATC GCT GAA GGT GAT CTG AAA TAC TCT TTT ATG CCG CAG CAT ACC TTC 
M I A E G D L K Y S F M P Q H T F 
67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 
                 
CAC GGC CAG ATC GAT ACG CTG CAA TTT GGT AAA GAC CTG GCA ACC AAT GCT 
H G Q I D T L Q F G K D L A T N A 
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 
                 
GGC GGT CCG AGT GCA GGC AAA CAC CTG GAA AAA ATT GAT ATC ACG TTT AAC 
G G P S A G K H L E K I D I T F N 
101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 
                 
GAA CTG GAT CTG AGC GGC GAA TTC GAC AGC GGT AAA TCT ATG ACC GAA AAT 
E L D L S G E F D S G K S M T E N 
118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 
                 
CAT CAG GGT GAT ATG CAC AAA AGC GTC CGC GGC CTG ATG AAA GGT AAC CCG 
H Q G D M H K S V R G L M K G N P 
135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 
                 
GAC CCG ATG CTG GAA GTG ATG AAA GCC AAA GGC ATT AAT GTT GAT ACC GCG 
D P M L E V M K A K G I N V D T A 
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 
                 
TTC AAA GAC CTG AGT ATC GCC TCC CAA TAT CCG GAT TCA GGT TAC ATG TCG 
F K D L S I A S Q Y P D S G Y M S 
169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 
                 
GAC GCC CCG ATG GTT GAT ACG GTT GGT GTT GTT GAT TGT CAC GAT ATG CTG 
D A P M V D T V G V V D C H D M L 
186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 
    BamHI 3’           
CTG GCT GCC TAA GGA TCC GGG           
L A A -              
203 204 205               
 
Table 2.1.  DNA and corresponding amino acid sequence of full-length HasAyp. NdeI and BamHI restriction 
endonuclease sites were introduced at the 5’ and 3’ end for sub-cloning.  The carrot symbol (^) indicates the place 
where a stop codon was introduced to express full length minus 12 residues (FL-12) HasAyp. Figure adapted from 
reference [16]. 
 
^
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2.2.2 Protein Expression and Purification 
HasAyp was expressed using previously described methods and was isolated using a 
protocol reported for the purification of apo-HasAp [8] with a few modifications: supernatant 
from cell lysis was loaded onto a Q-sepharose Fast Flow column (2.6 cm i.d. x 15 cm, GE 
Healthcare) pre-equilibrated with 20 mM Tris-HCl (pH 7.6) at 4 °C.  The column was then 
washed with 2 column volumes of the same buffer and the protein eluted with the same buffer 
using a linear NaCl gradient (0-400 mM).  Fractions containing the HasAyp protein, as 
determined by SDS-PAGE, were pooled and dialyzed against 50 mM sodium phosphate buffer 
(pH 7.0) containing 900 mM ammonium sulfate before loading onto a Phenyl Sepharose 6 Fast 
Flow (GE Healthcare) column (2.6 cm i.d. x 12 cm) pre-equilibrated with the same buffer at 25 
°C.  The protein was eluted in stepwise manner: (a) 50 mM sodium phosphate/750 mM 
ammonium sulfate (pH 7.0) was used to elute weakly bound proteins, including holo-HasAyp and 
(b) a linear gradient of sodium phosphate (50 - 20 mM)/ammonium sulfate (750 - 0 mM), pH 
7.0, was used to elute apo-HasAyp.  Fractions containing apoprotein were pooled and 
concentrated to a volume of ~ 1 mL using 10 kDa molecular weight cut-off (MWCO) Amicon 
ultracentrifuge filters (Millipore, MA) before loading onto a Sephadex G-75 (2.6 cm i.d. x 90 
cm, GE Healthcare) size exclusion column pre-equilibrated and eluted with sodium phosphate (µ 
= 0.1, pH 7.8) buffer.  
 Apo-HasAyp purified to homogeneity was analyzed by electrospray ionization mass 
spectrometry.  The mass spectra indicated that the full-length protein is cleaved at the C-terminus 
during purification, with the shortest protein corresponding to full-length – 12 residues, not 
including the initiator Met (Figure 2.3-A).  C-terminal cleavage of hemophores is common 
feature and may have functional relevance [12, 21].  Both HasAs and HasAp are secreted in the 
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extracellular milieu where it undergoes the C’-terminus proteolytic cleavage that removes the 
last 12-20 amino acid residues.  In case of HasAs, a single C’-terminus cleavage removes the last 
12 residues, whereas in HasAp, last 21 residues are cleaved [12, 22].  A stop codon was 
introduced after Val 193 (Table 2.1) to express truncated apo-HasAyp consisting of full-length – 
12 residues (FL-12).  The mass spectrum (Figure 2.3-B) shows that FL-12, devoid of the initial 
initiator Met, can be purified to homogeneity. 
 
Figure 2.3.  (A) Mass spectroscopic analysis of protein obtained upon expression and purification of full-length 
apo-HasAyp (expected MW = 22,099 Da) indicated that the protein is cleaved at the C-terminus, with the shortest 
protein corresponding to full-length – 12 (FL-12) residues, not including the initiator methionine. (B) Mass 
spectroscopic analysis of protein obtained upon expression and purification of FL-12 apo-HasAyp showed that the 
truncated protein devoid of the initiator methionine (expected MW = 20,874 Da) can be purified to homogeneity 
(experimental MW = 20,873). Figure adapted form reference [16]. 
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To prepare holo-HasAyp, a solution of apo-HasAyp (FL-12) in sodium phosphate buffer (µ 
= 0.1, pH 7.8) was titrated with a solution of hemin (1 mM) in dimethyl sulfoxide.  The resultant 
solution was incubated overnight at 4 °C, concentrated to ~ 1 mL using 10 kDa MWCO Amicon 
ultracentrifuge filters and loaded onto a Sephadex G-75 (2.6 cm i.d., x 90 cm) size exclusion 
column pre-equilibrated and eluted with sodium phosphate (µ = 0.1, pH 7.8) buffer.  The 
homogeneity of the protein was assessed by SDS-PAGE and mass spectrometry.  The UV-Vis 
spectrum of HasAyp (Figure 2.4) exhibits a Soret maximum at 403 nm (ε403 = 116.8 mM
-1
 cm
-1
) 
and bands at 498, 535 and 620 nm. 
 
Figure 2.4.  Electronic absorption spectrum of heme-reconstituted holo-HasAyp. 
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2.2.3 Crystallization 
Crystallization experiments were carried out with apo- and holo-HasAyp (FL-12) using 
the sitting drop vapor diffusion method and Compact Jr. Crystallization plates (Emerald 
BioSystems). Equal volumes (0.75 µL) of protein and crystallization solution were mixed and 
equilibrated against 75 µL of reservoir solution. 
2.2.3.1 Apo-HasAyp Crystallization 
Crystals showing tetragonal morphology were obtained within one week from a solution 
of apo-HasAyp (63 mg/mL) in sodium phosphate buffer (µ = 0.1, pH 7.8) and the Index HT 
screen (Hampton Research) (appendix I) condition H2 (0.2 M potassium sodium tartarate 
tetrahydrate, 20% (w/v) PEG 3350) (Figure 2.5-A).  These crystals were cryo-protected by 
transferring to a solution containing 80% crystallization solution and 20% (v/v) PEG 400 for 
approximately 30 s before freezing in liquid nitrogen.  Crystals with hexagonal morphology were 
obtained upon mixing the same protein solution with the Index HT screen (Hampton Research) 
condition C9 (1.1 M sodium malonate pH 7.0, 0.1 HEPES pH 7.0 and 0.5% (v/v) Jeffamine ED-
2001 pH 7.0) (Figure 2.5-B).  These crystals were transferred to a solution containing 80% 
crystallization solution and 20% (v/v) PEG 400 for approximately 30 s before freezing in liquid 
nitrogen. 
2.2.3.2 Holo-HasAyp Crystallization 
A cluster of thin needles grew within 3-4 days from 32 mg/mL holo-HasAyp in sodium 
phosphate buffer (µ = 0.1, pH 7.8) and the Wizard III screen (Emerald BioSystems) condition 3 
(20% (w/v) PEG 3350, 200 mM magnesium formate dihydrate).  These crystals diffracted to low 
resolution.  Therefore, refinement of the crystallization conditions was carried out using the 
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pHaT Buffer (Emerald Biosystems) (appendix II) screen.  Thick, needle like crystals were 
obtained within 1-2 days using pHat Buffer Screen condition C10 (0.5 M CHES/ NaOH, pH 8.8) 
(Figure 2.5-C).  The crystals were cryo-protected by transferring to a solution containing 80% 
crystallization solution and 20% DMSO for approximately 30 s prior to freezing in liquid 
nitrogen. 
 
         
 
Figure 2.5.   Crystal images of (A) tetragonal crystal form, (B) hexagonal crystal form of apo-HasAyp, and (C) 
crystal of holo-HasAyp formed in a compact Jr. sitting drop vapor diffusion plates.  
 
A B 
C 
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2.3.4 X-ray Data Collection, Structure Solution and Refinement 
Data for apo-HasAyp
tet
, apo-HasAyp
hex
 and holo-HasAyp were collected at 100 K at the 
Advanced Photon Source (APS) IMCA-CAT, beamline 17-ID using a Dectris Pilatus 6M pixel 
array detector.  The diffraction data were integrated with XDS [23] via the XDSAPP [24] 
interface and the Laue class and data scaling were performed with Aimless [25].  Structure 
solution of the apo-protein was obtained by molecular replacement with Phaser [26] via the 
Phenix [27] interface using the holo-HasAs structure (PDB: 1DK0) as a search model. 
Automated model building and structure refinement was conducted using Phenix and manual 
model building was carried out with Coot [28].  The final apo-HasAyp
tet
 structure was used as the 
search model for subsequent molecular replacement searches for the apo-HasAyp
hex
 and holo-
HasAyp data.  Crystals of apo-HasAyp
tet
 were indexed in a tetragonal P lattice with the most 
probable Laue class 4/mmm and space groups P41 21 2 or P43 21 2.  Molecular replacement 
searches were conducted in all space groups with 422 point symmetry and the top solution was 
obtained in P41 21 2 with one molecule in the asymmetric unit.  The model was refined with 
anisotropic atomic displacement parameters for all atoms.  A sodium ion was modeled near the 
C-terminus which is coordinated to the backbone carbonyls of L172, A175 and F169.  For apo-
HasAyp
hex
 the crystals were indexed in a hexagonal lattice P with the most probable Laue class 
6/m and space group P63.  Indeed, the top molecular replacement solution was obtained in P63 
although space groups with 6 point symmetry were tested.  The electron density maps contained 
features consistent with a tris molecule (from the buffer) on a crystallographic 3-fold as well as 
four malonate and three polyethylene glycol (PEG) molecules (from crystallization solution).  
TLS refinement [29] was incorporated in the latter stages of structure refinement.  Holo-HasAyp 
crystals were indexed in a C-centered lattice (space group C2).  Molecular replacement was 
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conducted in this space group searching for 10 molecules in the asymmetric unit which were 
positioned by Phaser.  Following subsequent rounds of refinement, large difference electron 
density peaks (Fo-Fc) greater than 3 were observed on the distal sites of the heme molecules.  
These sites were originally assigned as water molecules, however residual positive electron 
density above the 3contour level was observed around these water molecules following 
refinement.  Chloride ions were ultimately assigned at these sites based on the electron density, 
the coordination environment (positively charged Arg residues) and expected non-bonded 
distances to the heme Fe-atoms [30].  The average distance between the Cl
-
 and heme-Fe atoms 
is 2.82 Å.  Table 2.2 summarizes the crystallographic details for the three refined structures. 
 
Table 2.2.  X-ray diffraction and refinement statistics for HasAyp structures 
 Apo-HasAyp
tet
 Apo-HasAyp
hex
 Holo-HasAyp 
Data Collection    
Unit-cell parameters 
(Å, 
o
) 
a=70.34, c=74.84 a=75.07, c=129.30 a=139.40, b=69.56, 
c=232.30, =100.1 
Space group P41212 P63 C2 
Resolution (Å)
1
 41.42-1.10 (1.12-1.10) 45.83-1.60 (1.63-1.60) 47.05-2.20 (2.24-2.20) 
Wavelength (Å) 1.0000 1.0000 1.0000 
Temperature (K) 100 100 100 
Observed reflections 638,353 552,152 379,425 
Unique reflections 76,552 54,313 109,337 
<I/(I)>
1
 21.8 (2.9) 18.2 (2.1) 9.9 (2.0) 
Completeness (%)
1
 100 (100) 100 (100) 98.2 (97.7) 
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Multiplicity
1
 8.3 (8.2) 10.2 (10.3) 3.5 (3.6) 
Rmerge (%)
1, 2
 4.2 (75.5) 7.6 (1.257) 8.7 (66.8) 
Rmeas (%)
1, 4
 4.5 (80.5) 8.1 (1.323) 10.3 (78.4) 
Rpim (%)
1, 4
 1.5 (27.6) 2.5 (41.2) 5.5 (40.8) 
CC1/2 
1, 5
 1.000 (0.802) 0.999 (0.688) 0.996 (0.686) 
Refinement    
Resolution (Å) 33.04-1.10 37.54-1.60 38.62-2.20 
Reflections 
(working/test) 
72,634 / 3,844 51,507 / 2,761 103,819 / 5,497 
Rfactor / Rfree (%)
3
 13.9 / 14.6 16.1 / 19.0 16.6 / 22.3 
No. of atoms 
(Protein/Heme/Water) 
1,458/-/220 2,754 / - / 259 13,624 / 430 / 720 
Model Quality    
R.m.s deviations     
Bond lengths (Å) 0.010 0.009 0.012 
Bond angles (
o
) 1.214 1.046 1.158 
Average B-factor (Å
2
)    
All Atoms 16.9 25.9 31.8 
Protein 15.2 25.1 31.6 
Heme - - 35.4 
Water 28.5 32.4 33.7 
Coordinate error, 
maximum likelihood 
(Å) 
0.08 0.16 0.29 
Ramachandran Plot     
Most favored (%) 98.45 98.35 98.08 
Additionally allowed 
(%) 
1.55 1.38 1.92 
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1) Values in parenthesis are for the highest resolution shell. 
2) Rmerge = hkli |Ii(hkl) - <I(hkl)>| / hkli Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection and 
<I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = hkl ||Fobs (hkl) | - |Fcalc (hkl) || / hkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% of 
randomly selected reflections that were not included in the refinement. 
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge[25, 31].  Rpim = precision-indicating (multiplicity-
weighted) Rmerge[32, 33].  
5) CC1/2 is the correlation coefficient of the mean intensities between two random half-sets of data [34, 35]. 
 
2.2.5 Spectroscopic and Kinetic Analyses of HasAyp 
Kinetic measurements (EPR, Resonance Raman and Stopped-flow experiments) were 
done by our collaborators, Dr. Hirotoshi Matsumura and Dr. Pierre Moënne-Loccoz at Oregon 
Health and Science University at Portland, Oregon, USA and details can be found in reference 
[16].  Results relevant to the analysis are presented in this dissertation with due 
acknowledgement.  
 
 
2.3 Results and Discussion 
2.3.1 The Q-32-bearing loop in apo-HasAyp is in the closed conformation.  
2.3.1.1 Apo-HasAyp: Tetragonal crystal form 
Crystals for apo-HasAyp were obtained from 70 unique conditions upon setting up for the 
screening.  Diffraction data were collected for the tetragonal and hexagonal crystal forms as 
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discussed in the Experimental section.  The tetragonal crystal form (apo-HasAyp
tet
), which has 
one molecule in the asymmetric unit, was refined to a resolution of 1.1 Å (Table 2.2).  Electron 
density was observed from S2 to M184, except for T48 and L49, which were not modeled.  Apo-
HasAyp exhibits the α + β fold characteristic of HasAp and HasAs [13, 15], which is composed 
of a “β-sheet wall” of nine anti-parallel β-strands connected by hairpins and an “α-helix wall” 
composed of three α-helices and a 310-helix (Figure 2.6-A).  The structure of the Y75 loop, 
extending from Tyr75 to Phe83, is identical to the Y75 loops in HasAp and HasAs, with Tyr75 
(Oη) hydrogen bonded (2.6 Å) to His81 (Nδ).  
2.3.1.2 Apo-HasAyp: Hexagonal crystal form 
The hexagonal crystal form (HasAyp
hex
), which exhibits two molecules in the asymmetric 
unit and was refined to 1.6 Å resolutions (Figure 2.6-B).  Both molecules in the asymmetric unit 
are nearly identical (Cα-RMSD = 0.76 Å), exhibit well defined electron density for residues S2 to 
D180 and contain a PEG molecule between the Q32 and Y75 loops.  Superposing the HasAyp
tet
 
structure with the structures of molecules A and B of HasAyp
hex
 reveals near identical 
architectures (Figure 2.6-C), except for the apparent absence of PEG or other exogenous 
molecules between the Q32 and Y75 loops of apo-HasAyp
tet
.  Residues Ser2 to Asp180 from the 
three apo-structures were used to calculate Cα-RMSD values using the secondary structure 
matching algorithm in the program Superpose [36] via the CCP4 interface [37].  Interestingly, 
the loop bearing Gln32, extending from Asn26 to Ser42, adopts a different conformation from 
that seen in apo-HasAp and apo-HasAs (Figure 2.6-D).   
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Figure 2.6.  Crystal structure of (A) apo-HasAyp
tet
 (PDB code: 4JER) with the Q32 loop shown in magenta and the 
Y75 loop in green; Gln32, Tyr75 and His81 are shown in sticks. (B) apo-HasAyp
hex
 (PDB code: 4JES), molecule A 
is shown in light blue and molecule B is shown in cyan. In both the molecules the Y75 loop is in yellow with Tyr75 
and His81 rendered in sticks and the Q32 loop in magenta with Gln32 in sticks. (C) Superimposed crystal structures 
of apo-HasAyp
tet
 (coral), apo-HasAyp
hex
, molecule A (blue) and apo-HasAyp
hex
, molecule B (cyan). (D) Superimposed 
crystal structure of apo-HasAp (PDB code: 3MOK) and apo-HasAyp
tet
 (PDB code: 4JER) where, the H32 loop is 
shown in coral in apo-HasAp and the Q32 loop in apo-HasAyp
tet
 in magenta.  Figure adapted from reference [16]. 
 
2.3.2 The structures of apo- and holo-HasAyp are nearly identical.  
The crystal structure of holo-HasAyp was solved to a resolution of 2.2 Å.  Ten molecules 
were present in the asymmetric unit cell with a well-defined electron density traced from Ser2 to 
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Asp180 for each of the molecules; superposing all ten chains results in a Cα-RMSD of 0.50 Å.  
Figure 2.7-A illustrates the surprising observation that unlike HasAp or HasAs, the Q32- loop in 
HasAyp does not change conformation upon binding hemin (Cα-RMSD = 0.56 Å).  As in the 
previously characterized hemophores, the hemin iron in HasAyp is coordinated by Tyr75, which 
also forms a hydrogen bond (2.7 Å) with the Nδ of His81 (His83 in HasAs and HasAp).  Despite 
the similar coordinating environment of the proximal binding site, the environment of the distal 
site in HasAyp is distinct (Figure 2.7-B) in that the 6
th
 coordination site is not occupied by a 
protein-provided ligand. 
 
Figure 2.7.  (A) Crystal structure of holo-HasAyp (PDB code: 4JET).  Q32 loop is shown in green, the Y75 loop in 
coral and the chloride ion in ice-blue color.  The hemin iron is coordinated by only one protein provided ligand, 
Tyr75, and (B) superimposition of apo-HasAyp (magenta) with holo-HasAyp (green), shows minimum structural 
rearrangement upon hemin binding [16]. 
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Note that Gln32, which we hypothesized may coordinate the hemin iron, is located 
approximately 14 Å away (Cα) from the heme iron, in a position very similar to the one it 
occupies in the apo-form (Figure 2.8).  Gln32 is clearly not part of the heme-binding pocket.  
The most significant change in the Q32 loop upon hemin binding is the relocation of the Arg40 
side chain (Figure 2.9).  This small reorganization protects the hemin distal face immediately 
after it binds to HasAyp, a situation that contrasts with apo-HasAp or apo-HasAs, where the 
hemin distal face is exposed to the aqueous environment prior to closing of the H32 loop.   
 
Figure 2.8.  Zoomed-in view comparing the heme-binding pockets of holo-HasAyp (green) and holo-HasAp 
(orange); a chloride ion (purple sphere) in the distal pocket of HasAyp is in the position occupied by the side chain of 
H32 in holo-HasAp and holo-HasAs.  Structures were superimposed using the program Superpose [36]. 
 
59 
 
Electron density immediately above the hemin iron was best modeled as a chloride ion 
(Figure 2.9).  The modeled Cl
-
 is not within binding distance of Fe (III) (Fe-Cl = 2.8 Å). 
 
Figure 2.9.  View of the heme-binding pocket in the superimposed structures of apo-HasAyp
tet
 and holo-HasAyp 
illustrate the minor structural differences between apo- (magenta) and holo- (green) HasAyp. The distal site in the 
holo protein is coordinated by a chloride ion; the Fo – Fc omit map contoured at 3σ is shown in orange mesh 
representation.  Figure adapted from reference [16]. 
 
Kinetic measurements (resonance Raman and EPR) show that in solution the heme iron 
(III) in holo-HasAyp adopts a 6-coordinate high-spin state [16] (Figure 2.10).  Although attempts 
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to detect Fe (III)-Cl and Fe (III)-OH stretching frequencies were unsuccessful we presume that 
the sixth ligand might be a solvent molecule and/or a loosely bound chloride ion.  Because HasA 
sequences with Gln32 contain Arg40 but those with His32 do not (Figure 2.9), we hypothesize 
that Arg40 may stabilize the chloride ion observed in the holo-HasAyp structure. 
 
Figure 2.10.  (A) X-band EPR spectrum of holo-HasAyp at 300 µM, g values of rhombic high-spin ferric heme 
signals are given (B) RR spectrum of holo-HasAyp at 300 µM, prominent porphyrin skeletal modes supporting the 6-
coordinate high-spin state and the two vinyl stretching mode are labeled. Spectroscopic measurements were done by 
our collaborators Dr. Hirotoshi Matsumura and Dr. Pierre Moënne-Loccoz at Oregon Health and Science University 
(OHSU), Portland, Oregon, USA [16]. 
 
A closer look at the amino acid sequence alignment of the known hemophores suggests 
that the Q32 loop of HasAyp is 3-residues shorter than the H32 loop of HasAp and HasAs (Figure 
2.2).  This absence of three residues in the HasAyp sequence may decrease the conformational 
flexibility of the Q32 loop compared to the H32 loop in the HasAp.  Structurally the three extra 
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residues (Ser41Asn42Thr43) in HasAp are present near the ‘hinge 2’ (N-terminus of β2 strand) 
region (Figure 2.11).  
 
Figure 2.11.  Superimposed crystal structures of: (A) apo-HasAp (PDB code: 3MOK) and apo-HasAyp
tet
 (PDB code: 
4JER). (B) holo-HasAp (PDB code: 3ELL) and holo-HasAyp (PDB code: 4JET).  The Q32 loop of HasAyp
tet
 is 
shown in magenta, and the H32 loop of HasAp in coral, with the three extra residues (Ser41Asn42Thr43) 
highlighted in blue.  Figure adapted from reference [16].  
 
In contrast to the large differences observed in the H32 loop, the structure of the Y75 
loop is conserved amongst the three hemophores.  As pointed out previously [8] and comparing 
the proximal loop residues in the structures of HasAp, HasAyp and HasAs, it is clear that the Y75 
loop forms a conserved hydrophobic surface for hemin to interact with the hemophore (Figure 
2.12).  Accordingly, upon hemin binding to HasAyp causes minimal changes to the Y75 loop; and 
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the only largest change observed is a rearrangement of the Phe83 side chain to accommodate the 
incoming hemin (Figure 2.9). 
 
Figure 2.12.  Top view of the hemin-binding pocket. Residues that form a hydrophobic (sticky) platform for 
macrocycle capture onto the Y75 loop and residues that interact with hemin propionates are highlighted in sphere 
rendering. (A) holo-HasAs (PDB code: 1B2Y) (B) holo-HasAp (PDB code: 3ELL) and holo-HasAyp (PDB code: 
4JET).  Figure adapted from reference [16]. 
 
2.3.3 HasAyp loads hemin from solution faster than HasAp  
Kinetic measurements (Stopped-flow spectroscopy), done by our collaborators Dr. 
Hirotoshi Matsumura and Dr. Pierre Moënne-Loccoz at Oregon Health and Science University 
(OHSU), Portland, Oregon, USA, reveal that hemin capture by apo-HasAyp is complete within 
the millisecond dead time of the apparatus and is thus much faster than in apo-HasAp (Figure 
2.13).  These observations support the idea that apo-HasAyp adopts a closed configuration in 
solution and that minimal reorganization occurs upon binding hemin (Figure 2.14 A-D).  This 
distinctive behavior of HasAyp is likely to also affect hemin transfer to the receptor protein, 
which in S. marcescens is thought to modulate hemin binding affinity to HasAs via interaction 
with the H32 loop [38]. 
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Figure 2.13.  Stopped-flow absorption spectra obtained upon reacting 5 M hemin with 30 M apo-HasAyp at 4 °C 
(red trace, 1 ms; grey traces, 2 to 19 ms; back trace, 20 ms).  The capture of hemin and formation of holo-HasAyp is 
completed within the millisecond mixing time of the instrument.  Spectroscopic measurements are done by our 
collaborators Dr. Hirotoshi Matsumura and Dr. Pierre Moënne-Loccoz at Oregon Health and Science University, 
Portland, Oregon, USA [16]. 
 
 
Figure 2.14.  Comparison of (A) and (B) H32 loop reorganization in HasAp upon heme binding to that of (C) and 
(D) Q32 loop of HasAyp. Heme is shown in sticks representation.  PDB codes: (A) apo-HasAp, 3MOK, (B) holo-
HasAp, 3ELL, (C) apo-HasAyp, 4JER, and (D) holo-HasAyp, 4JET. 
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2.3.4 Spontaneous cleaving of the C-terminus in FL-12 
Mass spectral analysis of apo-FL-12 stored at -20 °C for several months showed that FL-
12 had been cleaved predominantly at Ser183, producing a protein that corresponds to full-length 
minus 21 residues (FL-21).  Additional investigation showed that apo-FL-12 is nearly 
quantitatively converted to apo-FL-21 upon incubation at 4 °C for a week.  In comparison, holo-
FL-12 is stable to C-terminal cleavage even if the protein is incubated at 4 °C for two weeks.  
These observations, which indicate that the apo-FL-12 protein has a propensity to undergo 
relatively slow additional cleavage of its C terminal domain to produce apo-FL-21, prompted us 
to carry out mass spectrometric analysis of protein in the single crystals obtained from the wells 
that produced the samples used for X-ray diffraction.  Consistent with the observations in 
solution, it was found that apo-FL-12 obtained from the single crystals was cleaved at Ser185 
(FL-21), whereas holo-FL-12 obtained from the corresponding single crystals remained as the 
FL-12 protein.  C-terminal cleavage of hemophores is common [39, 40] and may have functional 
significance.  These observations are in agreement with reports indicating that HasAp secreted to 
the extracellular environment undergo proteolytic cleavage of their C-terminal residues [22].  
The most abundant form of HasAp secreted by P. aeruginosa is the truncated protein missing 15-
21 C-terminal residues [22].  In contrast, the most abundant form of HasAp secrete by quorum 
sensing-impaired mutants of P. aeruginosa is full-length HasAp [22]. 
2.4 Conclusion 
In this chapter, we characterized a novel hemophore from Yersinia pestis, which show 
completely different structural features in the distal (Q32) loop compared to the HasAp and 
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HasAs.  The Q32 loop does not show a large conformational rearrangement.  Instead it is already 
in a closed conformation and minimum structural changes occur upon hemin binding.   
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Chapter 3 
 
 
Replacing Arginine 33 for Alanine in the Hemophore HasA from 
Pseudomonas aeruginosa Causes Closure of the H32 Loop in the Apo-Protein 
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Summary 
Under iron limiting conditions several Gram-negative bacteria secrete a hemophore that binds 
heme in the vertebrate host and shuttles it to specific outer membrane receptor.  Structural and 
biochemical characterization of hemophores from Serratia marcescens (HasAs), Pseudomonas 
aeruginosa (HasAp) and Yersinia pestis (HasAyp) are available in heme-bound (holo) and heme-
free (apo) forms.  Heme is bound between two extended loops, the Y75 loop harboring the Tyr75 
ligand and the H32 loop harboring the His32 ligand.  Heme first loads onto the Y75 loop where 
it is coordinated by Tyr75 which triggers a large conformational rearrangement in the H32 loop 
relocating His32 side chain ~ 30Å, from an open to close form thus, coordinating the heme-iron 
ion by His32.  X-ray crystal structure and solution NMR studies have established that the H32 
loop in wt and mutant apo-HasAp is quite stable and folded back over the body of the protein.  
Given the overall protein fold similarity in HasAp, HasAs and HasAyp, we analyzed the 
stabilizing interactions in the H32 loop in wt apo-HasAp.  To understand the open H32 loop 
structure in apo-HasAp, we replaced arginine at position 33 with an alanine (R33A) in 
Pseudomonas aeruginosa.  Results obtained from solution NMR studies suggest a completely 
different organization of the H32 loop in R33A apo-protein.  Further, X-ray crystal structures of 
R33A apo-HasAp reveal that replacement of arginine 33 for alanine shifts the H32 loop from an 
open to a closed conformation similar to that seen in wt holo-HasAp.  Additional evidence from 
molecular dynamics simulation studies also suggest the closed loop conformation of the H32 
loop in the R33A apo-protein.   
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3.1 Introduction 
Iron and iron-binding proteins are essential components required for physiologically 
important functions like biosynthesis of DNA, gene regulation, electron transport chains of 
respiratory enzymes, and degradation of xenobiotics [1, 2].  In biological fluids the concentration 
of free-iron is kept at vanishingly low levels (~ 10
-18
 M) by sequestration of the micronutrient in 
iron-binding proteins such as transferrin and lactoferrin [3].  The low concentration of free iron 
in vertebrate hosts poses a challenge for pathogenic bacteria.  Therefore, bacteria have developed 
sophisticated mechanisms to scavenge iron from its host [4].  
One such mechanism employed by some Gram-negative pathogens is the secretion of 
small (~ 19 kDa) hemophores known as heme acquisition system A (HasA) proteins into the 
vertebrate host upon infection.  Secreted hemophore proteins capture heme from damaged or 
lysed heme containing proteins and deliver it to a specific outer membrane receptor (HasR) on 
the bacteria [4].  Extensive structural and biochemical studies of hemophore proteins from Gram-
negatives such as Serratia marcescens (HasAs) [5, 6], Pseudomonas aeruginosa (HasAp) [4, 7] 
and Yersinia pestis (HasAyp) [8] have been reported.  The X-ray crystal structures of heme-bound 
(holo) hemophores from S. marcescens (HasAs) [5] and P. aeruginosa (HasAp) [7] revealed a 
unique fold, with one side of the protein packed with “α-helical wall” and another with 
antiparallel β-sheets [5].  The two sides of the secondary structural elements (α-helix and β-
strands) are connected by two long loops.  The loop which harbors the proximal ligand (Tyr75) 
is called the Y75 loop and the other, which harbors the distal ligand (His32), is called the H32 
loop.  The heme macrocycle is bound between the two loops and the heme-iron is coordinated by 
the axial ligands, His32 and Tyr75 [5, 7].  Structural characterization of the heme-free (apo) 
hemophore in solution using NMR (HasAs; [6]) and X-ray crystallography (HasAp [4]), showed 
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similar secondary structural features as that of the holo-counterpart, except for the H32 loop.  In 
the apo-protein, the H32 loop is in an “open” conformation and is folded back over the body of 
the protein (Figure 3.1-A).  Upon heme loading, the H32 loop undergoes a large conformational 
rearrangement which relocates the His32 ligand ~ 30 Å, from the “open” to a “closed” state, thus 
enabling coordination of the heme-iron by His32 from the distal site [4, 9] (Figure 3.1-B).  
Amino acid sequence analysis (Figure 3.2) indicates that Tyr75 is conserved among the HasA 
sequences but that there is no conservation of His32 [4, 8]; instead in Yersinia species, Gln32 is 
present at the equivalent position.  Structural studies on apo- and holo-HasAyp [8] indicate that 
Tyr75 coordinates the heme-iron from the proximal site similar to HasAp and HasAs but there is 
no conformational rearrangement of the Q32 loop upon heme loading. Instead, the Q32-bearing 
loop is already in closed conformation and undergoes minimum structural changes upon heme 
binding [8].   
Hemophores (HasAp, HasAyp and HasAs) belong to three different species of Gram-
negative bacteria, yet they all show similar protein fold and function in heme uptake and delivery 
to the outer membrane receptor in bacteria.  Although they have similar function, it is interesting 
that the heme coordination is different in HasAp (and HasAs), in which there is large 
rearrangement of the H32 loop upon heme loading, from HasAyp, where only one ligand (Tyr75) 
coordinates the heme-iron ion and no rearrangements occurs in the Q32 loop [4, 6, 8].  Solution 
NMR and X-ray crystallography provide evidence that the H32 loop in the wt apo-HasAp is 
conformationally stable and do not show flexibility in solution [4, 6, 8].  The stability of the long 
H32 loop in the apo-protein can be visualized as a “zipper-like” network of interactions holding 
the loop in the open conformation (Figure 3.8-A).  Combining the available structural 
information from hemophores (HasAp and HasAs), we asked what interactions stabilize the H32 
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loop.  To address this question, detailed comparative analysis of interactions along the H32 loop 
in the wt apo-HasAp was carried out, which showed that arginine at position 33 (Arg33) is 
anchored to the body of the protein by a network of salt bridge and H-bond interactions with 
Glu113 and Asp22.  Consequently we replaced Arg33 for Alanine (R33A) in HasAp.  Results 
from solution NMR spectroscopy and X-ray crystal structures of R33A apo-HasAp indicate that 
the single residue replacement shifts the H32 loop in the apo-protein to a conformation very 
similar that seen in the H32 loop of wt holo-HasAp.  Additional complementary insight into the 
H32 loop transition from open to closed form is stems from molecular dynamics simulations 
studies, which map the relocation of the H32 loop.    
 
Figure 3.1.  Crystal structure of (A) apo-HasAp ( DB code: 3MOK) and (B) holo-HasAp ( DB code: 3 LL) 
showing the Y75 loop (green) and H32 loop (magenta).  Heme is shown in crimson red.  Heme loads onto the Y75 
loop which triggers the closure of the H32 loop, thus coordinating the heme iron by His32 [4, 7, 9]. 
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                                       10        20        30        40         50         
                                       |         |         |         |          |          
Pseudomonas aeruginosa        MSISISYSTTYSGWTVADYLADWSAYFGDVNHRPGQVVDG-SNTGGFNPGP--FDGSQYA 
Serratia marcescens           MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGNVTD--ANSGGFYGGS--LSGSQYA 
Pseudomonas fluorescens       MSISISYSATYGGNTVAQYLTDWSAYFGDVNHRPGEVVDG-TNTGGFNPGP--FDGTQYA 
Erwinia carotovora            MSFAITYDAYYANYSIANYLTEWSAAFGDVNHTTGNTQVGGNNTGGFYGGDTFIDGSQYA 
Pectobacterium carotovorum    MSFAITYDAYYANYSIASYLTEWSAAFGDVNHTAGNTQVGGNNTGGFYGGDTFIDGTQYA 
Yersinia pestis               MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia pseudotuberculosis   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
Yersinia mollaretii           MSTTIKYNSEFADHSITSYLNNWAENFGDIDQA--ATKDR----GQFAGGG-MLDGTQYS 
Yersinia bercovieri           MSVTVQYNSEFADYTVSSYLSNWAETFGDMNQA--ETKDR----GQFAGGDTIFSGTQYS 
Yersinia rohdei               MSVTIKYNENFANTSISSYLNEWAEGFGDINQA--ATKIR----GDFAGGG-WFNGTQYS 
Yersinia pestis bv. Antiqua   MSTTIQYNSNYADYSISSYLREWANNFGDIDQAPAETKDR----GSFSGSSTLFSGTQYA 
                                                             #                     
 
                                60         70        80        90       100           110  
                                |          |         |         |         |            |    
Pseudomonas aeruginosa        LKSTASDA-AFIAGGDLHYTLFSNPSHTLWGKLDSIALGDTLTGGASSGG---YALDSQE 
Serratia marcescens           ISSTANQVTAFVAGGNLTYTLFNEPAHTLYGQLDSLSFGDGLSGGDTSP----YSIQVPD 
Pseudomonas fluorescens       IKSTASDA-AFVADGNLHYTLFSNPSHTLWGSVDTISLGDTLAGGSGSN----YNLVSQE 
Erwinia carotovora            ITSTQNDFSALIAGGDLTYSLFSPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLVEPE 
Pectobacterium carotovorum    ITSTQNDFSALIAGGDLTYSLFTPPAHTLYGDLDSLSFGNVLQGGTTAGT--TYSLAEPE 
Yersinia pestis               IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia pseudotuberculosis   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
Yersinia mollaretii           IGSSHGTDMGMIVEGTLSYAFA---AHAFHGQITGMQFGHELIANSNG---VGKAFADVQ 
Yersinia bercovieri           IGSSHDTDMGMIVEGNLNYAFM---AHTFHGQITNIQFGKDLVVNTDGA--VGKHLNDLQ 
Yersinia rohdei               VKSSYDTNVAMITEGTLTYSFMP--QHTFFGQMDSIQFGKDLIPNPSGT--DDKVLENLQ 
Yersinia pestis bv. Antiqua   IGSSHSNPEGMIAEGDLKYSFMP--QHTFHGQIDTLQFGKDLATNAGGP-SAGKHLEKID 
                                                ^           
 
                                   120             130       140       150       160       
                                    |               |         |         |         |        
Pseudomonas aeruginosa        VSFSNLGLDSPIA------QGRDGTVHKVVYGLMSGDSSALQGQIDALLKAVDPSLSINS 
Serratia marcescens           VSFGGLNLSSLQA------QGHDGVVHQVVYGLMSGDTGALETALNGILD--DYGLSVNS 
Pseudomonas fluorescens       VSFTNLGLNSLKE------EGRAGEVHKVVYGLMSGDSSALAGEIDALLKAIDPSLSVNS 
Erwinia carotovora            VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMGG---QVQPLLDALTN---AGIDINA 
Pectobacterium carotovorum    VTFSGLDLSTDVAN---LTVSDRGVVHDVIYGLMSG---QVQPLLDALTN---AGIDINA 
Yersinia pestis               ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia pseudotuberculosis   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
Yersinia mollaretii           VTFNGLDISGEFDAAKSVAENRDTDMQKSVHGLMKGNA---DPMLDILKAK---GIDVDT 
Yersinia bercovieri           VAFNDVDISGEFDATKPVAENRDSDMHKSVYGLMRGDA---DPMLEVLKAK---GIDVDT 
Yersinia rohdei               LSFNDVDISGTFDPTKEVEVNRDGDLHKSVHGLMRANP---EPFLELLKAK---GIDVDI 
Yersinia pestis bv. Antiqua   ITFNELDLSGEFDSGKSMTENHQGDMHKSVRGLMKGNP---DPMLEVMKAK---GINVDT 
 
 
                               170       180         190       200  205 
                                |         |           |         |    | 
Pseudomonas aeruginosa        TFDQLAAAGVAHAT-P-AAAAAEVGVVGVQELPHDLALAA 
Serratia marcescens           TFDQVAAA-------T---------AVGVQHADSPELLAA 
Pseudomonas fluorescens       TFDDLAAAGVAHVN-PAAAAAADVGLVGVQDVAQDWALAA 
Erwinia carotovora            SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
Pectobacterium carotovorum    SLDSLSFAT-ATSD-AALSADTVVDVVGVAETAD--LLAA 
Yersinia pestis               AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia pseudotuberculosis   AFKDLSIASQSPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
Yersinia mollaretii           KFKDLDIASQLDTTSDVMADSPVVDTVGASDN-VEILMAA 
Yersinia bercovieri           AFKDMAIATQIPDT-EMAADAPIIETVGVYDDAADMSMAA 
Yersinia rohdei               PLKDMAIASQYDIM----ADAPIIDTVGAYDG-AEILMAA 
Yersinia pestis bv. Antiqua   AFKDLSIASQYPDS-GYMSDAPMVDTVGVVDC-HDMLLAA 
 
Figure 3.2.  Multiple sequence alignment of full-length hemophore sequences aligned against the sequence of HasA 
from Pseudomonas aeruginosa. Residue 32 (H or Q) is highlighted by (#) and proximal loop residue Tyr75 is 
highlighted by (^).  Conserved residues across the alignment are in red, conservative substitutions in green and 
semi-conservative substitutions in blue; sequence numbering is according to the P. aeruginosa sequence. Sequence 
alignment is done using CLUSTAL W [10]. 
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3.2 Experimental Procedures 
3.2.1 Cloning and Site-directed mutagenesis 
Truncated form of HasAp missing the last 21 C-terminal residues was used to construct 
the R33A mutant [7].  The primers were synthesized by Integrated DNA Technologies, Inc. and 
were used with the QuickChange site-directed mutagenesis kit (Stratagene; La Jolla, CA).  
Primers used for the R33A mutation were 5`-
TATTTTGGCGATGTGAACCATGCGCCGGGCCAGGTGGTGGATGGC-3` and 5`-
GCCATCCACCACCTGGCCCGGCGCATGGTTCACATCGCCAAAATA-3`, where the 
underlined codons represent target substitutions.  The recombinant gene harboring the mutation 
was transformed into XL1-Blue Competent cells (Stratagene) for amplification, and the DNA 
sequence was verified by ACGTInc (Wheeling, Ilinois).  The recombinant DNA plasmid with 
the mutation was transformed into E. coli BL21-GOLD (DE3) competent cells for subsequent 
protein expression.   
3.2.2 Protein Expression and Purification 
Previously reported protocols [4] were used to express, purify and reconstitute with heme 
the R33A HasAp protein.  Briefly, overnight culture of a single colony of freshly transformed 
cells in 50 mL of Luria-Bertani (LB) medium (100 µg/mL ampicillin) was used to inoculate 1 L 
of fresh M9 minimal medium [11].  The resultant culture was incubated at 37 °C with continuous 
shaking at 235 rpm to an OD600 of 0.8 – 0.9.  Subsequently, temperature was lowered to 30 °C 
and protein expression was induced by the addition of isopropyl β-D-thiogalactopyranoside 
(IPTG) to a final concentration of 1 mM.  The cells were cultured for 5 h and were harvested by 
centrifugation at 4800 rpm and stored at -20 °C.  The harvested cell pellets were resuspended in 
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20 mM Tris.HCl (pH 7.6), 3 mL/g cell paste, and disrupted by sonication in the presence of 
DNase (Sigma-Aldrich, St. Louis, MO), and the cell debris were separated by centrifugation at 
19, 500 rpm at 4 °C for 40 min.  
3.2.3 Purification of Apo-protein 
The clarified supernatant from cell lysis was loaded onto a Q-sepharose Fast Flow 
column (2.6 cm i.d. x 15 cm, GE Healthcare) pre-equilibrated with 20 mM Tris-HCl (pH 7.6) at 
4 °C.  The column was then washed with 2 column volumes of the same buffer and the protein 
eluted with the same buffer using a linear NaCl gradient (0-600 mM).  Fractions containing the 
HasAp protein, as determined by SDS-PAGE, were pooled and dialyzed against 50 mM sodium 
phosphate buffer (pH 7.0) containing 0.7 M ammonium sulfate before loading onto a Phenyl 
Sepharose 6 Fast Flow (GE Healthcare) column (2.6 cm i.d. x 12 cm) pre-equilibrated with the 
same buffer at 25 °C.  The protein was eluted in stepwise manner: (a) 50 mM sodium 
phosphate/0.5 M ammonium sulfate (pH 7.0) was used to elute weakly bound proteins, including 
holo-HasAp and (b) a linear gradient of sodium phosphate (50 - 20 mM) (pH 7.0)/ammonium 
sulfate (500 -0 mM) was used to elute apo-HasAp.  Fractions containing apoprotein were pooled 
and concentrated to a volume of ~ 1 mL using 10 kDa molecular weight cut-off (MWCO) 
Amicon ultracentrifuge filters (Millipore, MA) before loading onto a Sephadex G-75 (2.6 cm i.d. 
x 90 cm, GE Healthcare) size exclusion column pre-equilibrated and eluted with sodium 
phosphate (µ=0.1, pH 7.8) buffer. 
3.2.4 Preparation of R33A holo-HasAp 
To prepare R33A holo-HasAp, solution of apo-protein in sodium phosphate buffer (μ = 
0.1, pH 7.8) was titrated with a 1 mM hemin solution in dimethyl sulfoxide under constant 
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stirring.  The resultant heme-reconstituted solution was incubated overnight at 4 °C, concentrated 
to ~ 1 mL using a 10 kDa molecular weight cut-off Amicon ultracentrifuge filter devices, and 
passed through a G-75 Sephadex (GE Healthcare) column (2.6 cm i.d. x 90 cm; GE Healthcare) 
pre-equilibrated and eluted with sodium phosphate (μ = 0.1, pH 7.8) buffer. 
3.2.5 Crystallization and Data Collection 
Purified apo- and holo-proteins were used for crystal screening using the sitting drop 
vapor diffusion method in Compact Jr. Crystallization plates (Emerald Biosciences, WA).  Equal 
volumes (0.5 μL) of each, protein and crystallization solution were mixed and equilibrated 
against 100 μL of the reservoir volume. 
3.2.5.1 R33A apo-HasAp 
R33A apo-HasAp was concentrated to 50 mg/ml in 100 mM sodium phosphate buffer 
(pH 7.8), and the solution used to screen for crystal growth at 18 °C.  Prism shaped (Figure 3.3-
A) crystals of apo R33A-HasAp were obtained in about 43 days from the Crystal Screen 
(Hampton Research) condition # G10 (0.05 M Cd(SO4)2 hydrate, 0.1 M HEPES pH 7.5, 1.0 M 
sodium acetate trihydrate) (appendix III).  Crystals were cryo-protected and transferred to a 
solution containing 80% crystallization solution and 20% glycerol before freezing in liquid 
nitrogen for data collection.   
3.2.5.2 R33A holo-HasAp 
Plate shaped (Figure 3.3-B) protein crystals of R33A holo-HasAp (20 mg/ml in 100 mM 
sodium phosphate pH 7.8) were obtained within 72 h from Emerald Biosciences Wizard III & IV 
condition # 32 (2100 mM DL malic acid, pH 7) (appendix IV).  The crystals were then cryo-
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protected by transferring to a solution containing 80% crystallization solution and 20% glycerol 
before freezing in liquid nitrogen for data collection.   
Initial collection of diffraction data and model building were done in-house using a 
Rigaku RU-H3R rotating anode generator equipped with Osmic Blue focusing mirror and an R-
axis IV
2+
 image plate detector.  High-resolution diffraction data were acquired at 100K at the 
Advanced Photon Source (APS) IMCA-CAT beamline 17ID using a Dectris Pilatus 6M pixel 
array detector. 
 
  
Figure 3.3.  (A)  rism shaped crystals of R33A apo-HasAp obtained from Hampton Research crystal screen 
condition  10 (0.05 M Cd(SO4)2 hydrate, 0.1 M H   S pH 7.5, 1.0 M sodium acetate trihydrate), red arrow points 
to the crystals in the well, and (B) plate shaped crystals of R33A holo-HasAp obtained from  merald Biosciences 
wizard III and IV condition 32 (2100 mM DL malic acid, pH 7).  
 
 
A B 
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3.2.6 Structure Solution and Refinement 
Diffraction intensities were integrated and scaled using the XDS [12] and Scala [13] 
packages, respectively and the Laue class was checked using Pointless [14].  Structure solutions 
for apo- and holo-proteins were obtained by molecular replacement with Phaser [15] via the 
Phenix [16] interface, using the coordinates from the structure of wt HasAp (PDB code: 3ELL).  
Structure refinement and manual model building for apo- and holo-proteins were performed with 
Phenix [16] and Coot [17] respectively.  Structure validation was carried out using Molprobity 
[18] and figures were prepared using CCP4mg [19] and PyMol [20].  X-ray data collection and 
refinement statistics are summarized in Table 3.2.   
3.2.6.1 Structural Refinement: R33A apo-HasAp 
 Initial structure solution and refinement were done using in-house diffraction data 
collected with Cu-Kα radiation.  Crystals were indexed in Primitive Tetragonal Bravais lattice 
with Laue class of 4/mmm and space groups P41212 or P43212.  All space groups with 422 point 
symmetry were searched during the molecular replacement.  Top solution was obtained in 
P41212.  The Matthews – cell content analysis module [21, 22] via CCP4 [19] package calculated 
two molecules in the asymmetric unit.  This information was used while performing molecular 
replacement via Phenix [16] package, which calculated one molecule in the asymmetric unit as 
the correct solution with ~ 70% solvent content.  During the refinement, large anomalous 
difference electron density peaks (Fo – Fc) greater than 20σ were observed that were assigned as 
cadmium ions from the crystallization solution.  Consequently, data for the structure refinement 
were collected at two different wavelengths at the APS synchrotron facility.  The one collected at 
a higher wavelength (λ = 1.7396 Å, 7,150.1 eV) yielded strong anomalous electron density and 
another collected at lower wavelength (λ = 1.0000 Å, 12,394 eV) yielded an appreciable 
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anomalous signal for cadmium ions.  Using the two diffraction data set, anomalous Fourier 
difference electron density maps were calculated using CCP4 [16] and three cadmium ions were 
assigned during the structure refinement (Figure 3.4).  Table 3.1 lists the peak height of each of 
the three cadmium ions from the anomalous Fourier difference electron density maps. 
Table 3.1.  Anomalous peak heights for three cadmium ions in R33A apo-HasAp. 
 Anomalous peak height 
Wavelength Cadmium ion # 1 Cadmium ion # 2 Cadmium ion # 3 
1.0000 Å  27.79 26.13 10.50 
1.7396 Å  47.74 43.36 17.76 
 
 
Figure 3.4.  Crystal structure of R33A apo-HasAp showing the position of cadmium ions (green spheres).  
Anomalous difference Fourier electron density map contoured at 15σ is shown in blue (λ = 1.0000 Å) and coral (λ = 
1.7396 Å).  H32 loop is shown in cyan color.   
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3.2.6.2 Structural Refinement: R33A holo-HasAp 
Crystals for R33A holo-HasAp protein were indexed in a Bravais lattice of Primitive 
Orthorhombic with a probable Laue class of mmm and space groups of P212121 or P21212.  
Molecular replacement searches, using Phenix, were conducted in all space groups with 222 
point symmetry and the top solution was obtained in P212121 with one molecule in the 
asymmetric unit.  Refinement and subsequent refinement was conducted with anisotropic atomic 
displacement parameter for all atoms.  Three sodium ions were modeled to the final structure.  
Table 3.2 summarizes the crystallographic details for the structures.   
 
3.2.7 NMR Spectroscopy 
I would like to thank and acknowledge Dr. Huili Yao, Research Associate, Rivera Lab, 
University of Kansas, Lawrence, KS, USA for conducting the NMR experiments for this work.  
Results relevant to the analysis are presented in this dissertation with due acknowledgement. 
 Uniformly labeled U-
15
N-R33A HasAp were prepared with minor modification of the 
above described protocol:  Overnight culture was resuspended in M9 media with 1.0 g of 
15
NH4Cl.  IPTG (final concentration of 1 mM) was added when the culture reached an OD600 ~ 
0.9, cells were harvested and the protein was purified as described above.   
3.2.8 Molecular Dynamics Simulations 
 I would like to thank and acknowledge Dr. Wonpil Im and Dr. Qi, Yifei, Center for 
Bioinformatics and Department of Molecular Biosciences, University of Kansas, Lawrence, KS, 
USA, for performing the molecular dynamics simulations for this work.  Results relevant to the 
analysis are presented in this dissertation with due acknowledgement.   
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 The simulation systems were built using the Quick MD Simulator module in CHARMM-
GUI [23].  The protein was solvated in a 81 Å × 81 Å × 81 Å TIP3 water box and buffered with 
0.15 M NaCl.  For both wild type and R33A apo-protein, three independent simulation runs, 
each with a different initial velocity, were generated using NAMD [24].  The simulations were 
performed with a time step of 2 fs in NPT ensemble with the temperature maintained at 300 K 
using Langevin dynamics, and pressure maintained at 1.01325 bar with the Nose-Hoover piston 
method [25, 26].  The van der Waals interactions were switched off at 10-12 Å [27], and the 
electrostatic interactions were calculated using the particle-mesh Ewald method [28].  
 
Table 3.2.  X-ray diffraction and refinement statistics for R33A HasAp 
 R33A apo-HasAp R33A holo-HasAp 
Data Collection   
Unit-cell parameters 
(Å, 
o
) 
a=92.78, c=95.71 a= 34.17, b= 47.17, 
c=101.37 
Space group P41212 P212121 
Resolution (Å)
1
 66.62-1.94 (2.05-1.94) 47.16-1.05 (1.07-1.05) 
Wavelength (Å) 1.0000 1.0000 
Temperature (K) 100 100 
Observed reflections 406,207 485,013 
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Unique reflections 31,392 75,527 
<I/(I)>
1
 21.1 (2.4) 15.5 (3.3) 
Completeness (%)
1
 100 (99.8) 97.8 (94.4) 
Multiplicity
1
 12.9 (13.1) 6.4 (6.2) 
Rmerge (%)
1, 2
 8.0 (147.6) 5.9 (51.1) 
Rmeas (%)
1, 4
 8.3 (153.6) 7.0 (61.1) 
Rpim (%)
1, 4
 2.3 (42.0) 2.8 (24.1) 
CC1/2 
1, 5
 1.000 (0.928) 0.998 (0.861) 
Refinement   
Resolution (Å) 33.31-1.94 34.53-1.05 
Reflections 
(working/test) 
31,257 / 1,578 75,450 / 3,776 
Rfactor / Rfree (%)
3
 19.08 / 22.30 13.42 / 14.68 
No. of atoms 
(Protein/Heme/Water) 
2,488/-/59 2696 / 146 / 204 
Model Quality   
R.m.s deviations    
Bond lengths (Å) 0.021 0.008 
Bond angles (
o
) 1.152 1.080 
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Average B-factor (Å
2
)   
All Atoms 52.99 11.33 
Protein 52.95 10.65 
Heme - 10.16 
Cadmium 54.13 - 
Water 52.91 20.87 
Coordinate error, 
maximum likelihood 
(Å) 
0.22 0.06 
Ramachandran Plot    
Most favored (%) 93.75 98.45 
Additionally allowed 
(%) 
6.25 1.55 
 
1) Values in parenthesis are for the highest resolution shell. 
2) Rmerge = hkli |Ii(hkl) - <I(hkl)>| / hkli Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection 
and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = hkl ||Fobs (hkl) | - |Fcalc (hkl) || / hkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% 
of randomly selected reflections that were not included in the refinement. 
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge. [13, 29] Rpim = precision-indicating 
(multiplicity-weighted) Rmerge[30, 31]. 
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3.3 Results 
3.3.1 Purification of R33A apo- and holo-HasAp 
A Previously reported protocol [4], which utilizes hydrophobic affinity chromatography 
to separate the apo- from the holo-protein, was used to purify R33A apo-HasAp.  R33A holo-
protein was prepared from the purified apo-protein by heme reconstitution in vitro, as described 
in the experimental section.  Protein homogeneity was checked using SDS PAGE which showed 
a single band corresponding to a molecular mass of ~ 19 kDa.  The experimental molecular mass 
determined by electrospray ionization mass spectrometry is 18,673 Da., which is in good 
agreement with the molecular mass calculated from the amino acid sequence, 18,674 Da, without 
the initiator methionine. 
3.3.2 UV-vis Spectroscopic Characterization of R33A holo-HasAp 
Similar to the wt holo-HasAp [7], R33A mutants exist as 6-coordinate high spin/low spin 
(6c HS/LS) equilibrium mixtures.  The UV-vis absorption spectrum exhibits a Soret peak at 407 
nm (ε407 = 144.2 mM
-1
 cm
-1
) with the visible bands at 495, 540, 577, and 616 nm.  The Soret and 
616 nm bands are indicative of high-spin heme iron whereas the bands at 577 and 540 nm are 
indicative of the low-spin species (Figure 3.5). 
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Figure 3.5.  Superimposed electronic absorption spectrum of heme reconstituted wt (red) and R33A (black) holo-
HasAp. 
 
3.3.3 NMR Spectroscopic Characterization of the R33A Apo- and Holo-HasAp in Solution 
Previous solution NMR studies done using mutant apo-HasAp do not show changes in 
the HSQC spectrum compared to the HSQC spectrum of the wt providing strong evidence for the 
stability of the H32 loop in the apo-protein [4, 7].  In order to investigate the topological location 
of the H32 loop in the R33A mutant protein, we conducted solution NMR experiments.  To this 
end, we prepared uniformly labeled U-
15
N-R33A apo- and holo-HasAp proteins according to the 
method described in the Experimental section.  Figure 3.6 presents the superimposed 
15
N-HSQC 
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spectrum of R33A apo-and holo-proteins with the corresponding wt proteins.  To our surprise, 
we observed that the superimposed HSQC spectrum of the R33A apo-protein shows several 
cross peaks that do not match with the cross peaks in the wt apo-protein (Figure 3.6-A).  This 
observation suggested that the H32 loop may no longer be organized as observed in the wt apo-
protein.  HSQC spectra taken at different temperatures (15 °C and 25 °C) also do not strongly 
affect or shift the cross peaks in the mutant apo-protein, suggesting that the observable 
resonances originate from well-structured portions of the protein.  Furthermore, when we 
reconstitute the R33A apo-protein with hemin, the HSQC spectrum of the resultant holo-protein 
becomes superposable with that of holo wt HasAp, suggesting that upon heme binding the loop 
gets organized as observed in the wt holo-protein (Figure 3.6-B).  These results strongly 
suggested that a portion of the apo-R33A mutant is distinct from its wt apo counterpart. We 
surmised that the most likely difference is in the H32 loop, and therefore we decided to 
investigate the mutant proteins using X-ray crystallography.  The results from these experiments 
are discussed in the next section.  
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Figure 3.6.  Superimposed 
1
H, 
15
N-HSQC spectra of (A) wt apo-HasAp (red) with R33A apo-HasAp (blue) and, (B) 
wt holo-HasAp (red) with R33A holo-HasAp.  Spectra were taken at 32 °C using a 600MHz Bruker spectrometer.  
Acquisition parameters are as follows: 2048 (
1
H) × 256 (
15
N) complex points; 10.7 kHz (
1
H) and 2.4 kHz (
15
N) 
spectral widths; 32 scans per increment; d1=1sec.  NMR spectroscopic measurements were done by Dr. Huili Yao, 
Research associate, Rivera Lab, University of Kansas, Lawrence, KS, USA. 
 
 
3.3.4 Structural Characterization of R33A Apo-HasAp 
3.3.4.1 Different Conformation of the H32 Loop in the Crystal Structure of R33A Apo-HasAp 
The X-ray crystal structure of R33A apo-HasAp having one molecule in the asymmetric 
unit was refined to a resolution of 1.94 Å (Table 3.2).  Electron density was traced from Ser2 to 
Ala184, except for five residues (Gly35 to Asp39) located in the His32 loop, for which no 
92 
 
electron density was observed.  Overall, the polypeptide fold of R33A apo-HasAp is very similar 
to the wt (apo or holo) protein except for the H32 loop (Figure 3.7-A).  The mutant apo-protein 
has α+β arrangement similar to that of the wt (apo- or holo) HasAp, which is composed of a “α-
helical wall” on one side and the “β-sheet wall” on the other [4, 7].  The proximal, Y75 loop is 
similar to the wt apo-HasAp in conformation, with identical Tyr75 and His83 conformation.  The 
most surprising structural feature of the R33A apo-HasAp structure is the H32 loop, which 
adopts a significantly different conformation compared to wt apo-HasAp (Figure 3.7-B).  In fact, 
the conformation of the H32 loop is very similar to the “closed” conformation observed in the 
crystal structure of wt holo-HasAp (Figure 3.7-C).  Due to missing electron density from Gly35 
to Asp39 (marked by an asterisks, Figure 3.7-A), the His32 loop is not completely defined but 
the segments of the loop with clear electron density show similar conformation adopted near the 
C-terminus end of the α1 helix ( ly28), and the N-terminus end of the β2 strand ( ly45) in the 
wt holo-HasAp.  Structural superimposition of R33A apo-HasAp with wt holo-HasAp reveals 
near identical conformation of the observable portion of the H32 loop in the R33A mutant, near 
the loop hinges located at Gly28 (C’-end of α1) and at Gly45 (beginning of β2) (Figure 3.7-C).  
Similar observations of closed conformation of the H32 loop in apo-R33A HasAp is seen when 
the structure is superimposed with apo- and holo-HasAyp, in which the Q32 loop is already in the 
closed conformation [8] (Figure 3.7-D).   
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Figure 3.7.  (A) Crystal structure of R33A apo-HasAp.  Superimposed R33A apo-HasAp with (B) wt apo-HasAp 
( DB code: 3MOK), (C) wt holo-HasAp ( DB code: 3 LL) and (D) apo-HasAyp (ice-blue color,  DB code: 4  R), 
holo-HasAyp (gold color,  DB code: 4  T).  The H32 loop in R33A apo-HasAp is shown in magenta and wt apo- 
and holo-HasAp is shown in coral color.  Missing electron density is shown by asterisks in R33A apo-HasAp. 
 
In wt apo-HasAp, the H32 loop is held in an open position by various backbone and side-
chain hydrogen bonding interactions, which can be thought of as a “zipper” that runs along the 
loop (Table 3.3 and Figure 3.8).  The X-ray crystal structure as well as solution NMR studies [4, 
7] suggest that the H32 loop in wt HasAp is stable and does not show dynamic behavior.  It is 
therefore interesting that despite the zipper-like set of interactions stabilizing the loop against the 
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body of the protein, replacement of a single residue, Arg33 allows the loop to detach from the 
body of the protein and adopt the closed loop conformation.  This is due to important salt bridge 
interactions between the Arg33 (NH1, NH2) and  lu113 (Oε1, Oε2) from β7 strand, hydrogen 
bond interaction between Arg33 (NH2, Nε) and Asp22 (Oδ2) from α1 helix.  Moreover, the 
aliphatic portion of the Arg33 side chain interacts hydrophobically with the side chain of Tyr26 
(Figure 3.8-A).  In the wt apo-protein, Glu113 and Asp96 have their charges stabilized by salt 
bridge and H-bond interactions with the Arg33 and Gln36 side-chains.  In the mutant apo-
protein, these stabilizing interactions are lost.  In the absence of Arg33, the H32 loop moves 
towards its closed conformation and the negative charge of Asp96 and Gln113 are stabilized by 
coordinating to a cation, in this case Cd ion (from the crystallization solution) (Figure 3.8-B).   
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Table 3.3.  List of interaction in the H32 loop with the body of the protein 
H32 loop residues Distance (Å) Interacting residues 
Asp29 (N) 3.2 Tyr26 (O) 
His32 (Nε) 2.8 Asp22 (Oδ) 
Arg33 (NH) 2.8  lu113(Oε) 
Arg33 (NH) 3.0 Asp22 (Oδ) 
Val37(O) 3.1 Asp64 (Oδ) 
Asp39 (N) 2.9 Asp64 (Oδ) 
 ly40 (N) 2.9 Asp64 (Oδ) 
Asn42 (Nδ) 2.8  ly100 (O) 
Thr43 (O) 3.2 Lys59 (N) 
 ly45 (N) 2.8 Ala57 (O) 
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Figure 3.8.  Network of hydrogen bond interaction in the H32 loop in (A) wt apo-HasAp ( DB code: 3MOK) and 
(B) R33A apo-HasAp.  Residues from protein body are shown in orange color and H32 loop residues are colored 
green in wt and magenta in R33A, cadmium ion is shown as sphere (limon color). 
 
3.3.4.2 Similar Conformation of the H32 Loop in the Crystal Structure of R33A Holo-HasAp 
The crystal structure of R33A holo-HasAp having one molecule in the asymmetric unit 
was refined using diffraction data to 1.05 Å resolution.  The overall mutant holo-protein structure 
is nearly identical to that of wt holo-protein, with an Cα-RMSD [32] of 0.22 Å.  The heme iron is 
coordinated proximally by the Tyr75 and distally by His32 residues (Figure 3.9-A).  The Y75 
loop in the mutant protein adopts similar conformation as of wt holo-protein.  In the H32 loop, 
residues Val38 to S41 adopt different conformation compared to the wt.  It is important to note 
that in the X-ray crystal structure of R33A apo-protein these residues were disorganized and 
therefore not modeled due to absence of electron density.  However, despite the minor 
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conformational changes in the H32 loop, His32 imidazole side-chain (Nδ atom) still coordinates 
the heme-iron ion and occupies nearly same conformation as in the wt holo-protein. 
An important difference between the wt and the mutant holo-structure is the orientation 
of the heme molecule.  In the wt holo-protein and in other mutants whose structures have been 
elucidated (Y75A, H83A), heme binds to the hemophore in only one orientation [4, 7, 33].  This 
is the first example of a mutant HasAp which binds heme in two orientations, which differ by a 
180° rotation about the α-γ meso axis (Figure 3.9-B).  The Fo-Fc electron density omit map 
contoured at 3σ cutoff shows the two orientation of the heme molecule (Figure 3.9-B).  
 
Figure 3.9.  (A) Superimposed structures of wt holo-HasAp, (coral) ( DB code: 3 LL) and R33A holo-HasAp 
(magenta) and (B) Fo-Fc electron density omit map contoured at 3σ showing two orientation of the heme molecule 
(crimson red and green).  
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3.4 Discussion 
3.4.1 Wt holo-HasAp and R33A holo-HasAp have similar UV-vis Spectra  
R33A HasAp was expressed and purified to homogeneity.  The R33A holo-HasAp 
protein was prepared from the purified apo-form by an in vitro reconstitution with hemin.  The 
purity and the molecular weight of the proteins were assessed with the help of SDS 
polyacrylamide gel electrophoresis and ESI/MS.  Similar to the wt holo-HasAp, UV-vis 
spectroscopy suggests R33A holo-HasAp exists in solution as a mixture of LS and HS species, 
suggesting no change in the structure of the mutant holo protein or coordination of the heme.   
3.4.2 New Set of Cross Peaks Observed in the HSQC Spectrum of R33A Apo-HasAp 
compared to Wt Apo-HasAp 
 The most interesting feature of the R33A apo-protein is the conformation of the H32 
loop.  It is surprising that a single residue (Arg33) replacement can bring severe changes to the 
H32 loop in the apo-protein structure.  This is also manifested in the new set of cross peaks 
observed in the HSQC spectrum of R33A apo-HasAp relative to the HSQC spectrum of the wt 
apo-protein (see Figure 3.6-A).  In the wt apo-HasAp, the H32 loop is held open by various 
interactions along the loop that have been compared to a “zipper (see Table 3.3 and Figure 3.8).  
The stability of the H32 loop is evident from the solution NMR studies, where the HSQC of wt 
apo-HasAp as well as the mutant apo-HasAp, all show no evidence of conformational disorder in 
solution, even in HSQC spectra taken at different temperatures [4].  Further, electron density 
defining the His32 loop in the crystal structure of wt apo-HasAp is well defined and does not 
show indications of conformational disorder.  Once the hemin is loaded onto the Y75 loop of wt 
HasAp, the proximal side is rapidly coordinated by the Tyr75 residue and an intramolecular 
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cascade of rearrangements occurs within the protein molecule which eventually breaks the 
various interactions in the H32 loop and enables the closure of the H32 loop, facilitating binding 
of His32 to the distal site of the hemin-iron.       
3.4.3 Crystal Structure Shows the H32 Loop in the Mutant Apo-protein is in its Closed 
Conformation 
Crystal structure of R33A apo- and holo-HasAp reveals an overall similar arrangement of 
secondary structural elements (α-helices and β-strands) of the polypeptide compared to the wt 
protein.  The data also shows that replacing arginine at position 33 for alanine results in a 
structure where the H32 loop is closed, or at least in a conformation that is very similar to the 
conformation observed in the wt holo-HasAp (see Figure 3.7-C).  Traceable electron density for 
the H32 loop in the crystal structure of R33A apo-protein clearly reveals the position of the hinge 
regions and inner portions of the loop (except for Gly35 to Asp39), which are superimposable to 
equivalent sections in the His32 loop of wt holo-HasAp (see Figure 3.7-B and C).  
3.4.4 Molecular Dynamics Simulation Results Show Closed Conformation of H32 Loop in 
Mutant Apo-Protein 
Molecular dynamics (MD) simulation experiments were performed to provide additional 
insight into the dynamic motion of the H32 loop.  Figure 3.10 shows the results from the three 
independent MD (R33A1, R33A2 and R33A3) experiments, which corroborate the propensity of 
the H32 loop in R33A apo-HasAp to adopt the closed conformation.  Analyzing the root mean 
square deviation (RMSD) as a function of time during the MD simulation of apo R33A- and apo 
wt apo-HasAp provides two important observations: (a) similar to solution NMR and crystal 
structure studies, the His32 loop in the wt apo-protein remains stable throughout the length of the 
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simulation, whereas (b) the loop in the apo R33A mutant starts to begin its transition at different 
time points, depending on the system.  However, all systems converge on a closed loop at the 
end of the simulations (Figure 3.10-A). 
Superimposing the crystal structures of wt (green) and R33A (magenta) apo-protein with 
R33A1 (cyan) (Figure 3.10-B) reveals very similar organization of the H32 loop in the mutant 
apo-protein and R33A1.  Similarly, superimposition with crystal structure of the wt holo-protein 
(orange in Figure 3.10-C) also identifies similarity in the organization of the H32 loop of R33A1.  
Comparing the crystal structure of R33A apo-HasAp with the simulation structures (R33A1, 
R33A2 and R33A3) provides a snapshot of the H32 loop conformation (Figure 3.10 D-F).  In the 
crystal structure of R33A apo-HasAp, no electron density could be modeled for residues Gly35 – 
Asp39 in the H32 loop, but from the R33A1 simulation structure those residues can be estimated 
and compared with the wt holo-HasAp (Figure 3.10-C).  Assuming that the conformation of the 
H32 loop is similar to the R33A1 (Figure 3.10-C), we could speculate that the closed loop 
conformation would affect the heme loading in the mutant apo-protein.  MD simulation results 
provide additional evidence that replacing Arg33 to alanine triggers a switch for the open H32 
loop to closed conformation. 
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Figure 3.10.  (A) RMSD plot showing the comparison of wt and R33A HasAp over the course of simulation, (B) 
conformation of H32 loop in superimposed crystal structure of wt apo-HasAp ( DB code: 3MOK, green), crystal 
structure of R33A apo-HasAp (magenta) and R33A1 structure from MD simulation (cyan), (C) crystal structure of 
wt holo-HasAp ( DB code: 3 LL, orange) with crystal structure of R33A apo-HasAp (magenta) and R33A1 (cyan) 
and superimposed crystal structure of R33A apo-HasAp with simulation structures (D) R33A3 (brown), ( ) R33A2 
(yellow), (F) R33A1 (cyan).  Molecular dynamics simulation experiments were performed by our collaborators Dr. 
Wonpil Im and Dr. Qi, Yifei, Center for Bioinformatics and Department of Molecular Biosciences, University of 
Kansas, Lawrence, KS, USA.   
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3.4.5 Heme Loading Organizes the H32 Loop in R33A Similar to the Wt holo-HasAp  
The X-ray crystal structure of R33A holo-HasAp is almost identical (Cα-RMSD = 0.22 
Å) to the wt holo-HasAp and even the heme binding site is very similar, except for few residues 
in the H32 loop (see Figure 3.9-A).  This is also seen in solution where HSQC NMR spectra 
show complete superimposition of cross peaks from the R33A holo-HasAp spectrum with the 
cross peaks from wt holo-HasAp (see Figure 3.6-B).  It is interesting to note that heme loading 
onto apo H33A HasAp organizes the H32 loop in a very similar conformation as seen in the wt 
holo-protein.  A significant difference observed between the wt and R33A holo-HasAp is the 
orientation of the heme.  In the wt Serratia marcescens hemophore (HasAs), heme binds to the 
protein in two orientations that differ by a 180 ° rotation about the α-γ-meso axis [5] whereas in 
the wt Pseudomonas aeruginosa hemophore the heme is bound in only one orientation [4, 7, 33].  
Hence, this is the first observation in a mutant HasAp protein where the heme binds in two 
orientations which are flipped by 180° along the α-γ meso axis (see Figure 3.9-B and Figure 
3.10-C).  At this point we can only speculate that the closed H32 loop conformation in the R33A 
apo-protein do not sample any particular conformation of the heme and once the heme is loaded, 
it is quickly coordinated by the His32 side-chain.  Additional study may be required to conclude 
significance of heme binding in one orientation in the wt and other mutants of HasAp.   
3.4.6 Extra Amino Acid Residues in the H32 Loop in HasAp 
 From the amino acid sequence alignment (Figure 3.2), we observe that P. aeruginosa has 
three additional residues in the H32 loop (
41
SNT
43
) compared to HasAyp [8] and two residues 
compared to HasAs [5].  Structural studies in HasAyp [8] suggest that the three residues less in 
the Q32 loop may decrease the conformational flexibility of the Q32 loop [8].  Additional study 
may be required to investigate in P. aeruginosa that the three extra residues in the H32 loop 
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might play a role in making specific interactions upon heme uptake and the transfer of the heme 
to its cognate receptor on the outer membrane of the bacteria. 
3.5 Conclusion 
In conclusion, this is the first attempt to understand the stabilizing forces that maintain 
the open H32 loop structure in HasA protein from P. aeruginosa.  In order to gain insights about 
the structural mechanisms, we have explored the apo-HasAp open structure and replaced Arg33 
with an Alanine.  The results are intriguing as the epicenter of this severe structural change was 
held by a single Arg33 residue whose replacement caused the closure of the H32 loop adopting a 
conformation which is similar to the H32 loop in wt holo-HasAp.   
104 
 
3.6 Bibliography 
1. Nobles CL, Maresso AW. The theft of host heme by Gram-positive pathogenic bacteria. 
Metallomics : integrated biometal science. 2011 Aug;3(8):788-96. 
2. Grigg JC, Ukpabi G, Gaudin CF, Murphy ME. Structural biology of heme binding in the 
Staphylococcus aureus Isd system. Journal of inorganic biochemistry. 2010 
Mar;104(3):341-8. 
3. Bullen JJ, Rogers HJ, Spalding PB, Ward CG. Iron and Infection: The Heart of the Matter. 
FEMS Immunol Med Microbiol. 2005;43:325-30. 
4. Jepkorir G, Rodriguez JC, Rui H, Im W, Lovell S, Battaile KP, Alontaga AY, Yukl ET, 
Moenne-Loccoz P, Rivera M. Structural, NMR spectroscopic, and computational 
investigation of hemin loading in the hemophore HasAp from Pseudomonas aeruginosa. 
Journal of the American Chemical Society. 2010 Jul 21;132(28):9857-72. 
5. Arnoux P, Haser R, Izadi N, Lecroisey A, Delepierre M, Wandersman C, Czjzek M. The 
crystal structure of HasA, a hemophore secreted by Serratia marcescens. Nature structural 
biology. 1999 Jun;6(6):516-20. 
6. Wolff N, Izadi-Pruneyre N, Couprie J, Habeck M, Linge J, Rieping W, Wandersman C, 
Nilges M, Delepierre M, Lecroisey A. Comparative analysis of structural and dynamic 
properties of the loaded and unloaded hemophore HasA: functional implications. J Mol 
Biol. 2008 Feb 15;376(2):517-25. 
7. Alontaga AY, Rodriguez JC, Schonbrunn E, Becker A, Funke T, Yukl ET, Hayashi T, 
Stobaugh J, Moenne-Loccoz P, Rivera M. Structural characterization of the hemophore 
HasAp from Pseudomonas aeruginosa: NMR spectroscopy reveals protein-protein 
105 
 
interactions between Holo-HasAp and hemoglobin. Biochemistry. 2009 Jan 13;48(1):96-
109. 
8. Kumar R, Lovell S, Matsumura H, Battaile KP, Moenne-Loccoz P, Rivera M. The 
hemophore HasA from Yersinia pestis (HasAyp) coordinates hemin with a single residue, 
Tyr75, and with minimal conformational change. Biochemistry. 2013 Apr 23;52(16):2705-
7. 
9. Yukl ET, Jepkorir G, Alontaga AY, Pautsch L, Rodriguez JC, Rivera M, Moenne-Loccoz 
P. Kinetic and spectroscopic studies of hemin acquisition in the hemophore HasAp from 
Pseudomonas aeruginosa. Biochemistry. 2010 Aug 10;49(31):6646-54. 
10. McWilliam H, Li W, Uludag M, Squizzato S, Park YM, Buso N, Cowley AP, Lopez R. 
Analysis Tool Web Services from the EMBL-EBI. Nucleic acids research. 2013 
Jul;41(Web Server issue):W597-600. 
11. Rodriguez-Maranon MJ, Qiu F, Stark RE, White SP, Zhang X, Foundling SI, Rodriguez V, 
Schilling CL, 3rd, Bunce RA, Rivera M. 13C NMR spectroscopic and X-ray 
crystallographic study of the role played by mitochondrial cytochrome b5 heme 
propionates in the electrostatic binding to cytochrome c. Biochemistry. 1996 Dec 
17;35(50):16378-90. 
12. Kabsch W. Xds. Acta crystallographica Section D, Biological crystallography. 2010 
Feb;66(Pt 2):125-32. 
13. Ahn HC, Le YTH, Nagchowdhuri PS, Derose EF, Putnam-Evans C, London RE, Markley 
JL. NMR Characterization of an Amyloidogenic Conformational Ensemble of the PI3K 
SH3 Domain. Protein Sci. 2006;15:2552-7. 
106 
 
14. Kabsch W. Automatic-Indexing of Rotation Diffraction Patterns. J Appl Crystallogr. 1988 
Feb 1;21:67-71. 
15. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser 
crystallographic software. J Appl Cryst. 2007;40:658-74. 
16. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung 
LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, 
Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive 
Python-based system for macromolecular structure solution. Acta crystallographica 
Section D, Biological crystallography. 2010 Feb;66(Pt 2):213-21. 
17. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta 
crystallographica Section D, Biological crystallography. 2004 Dec;60(Pt 12 Pt 1):2126-
32. 
18. Lovell SC, Davis IW, Arendall WB, 3rd, de Bakker PI, Word JM, Prisant MG, Richardson 
JS, Richardson DC. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. 
Proteins. 2003 Feb 15;50(3):437-50. 
19. Potterton L, McNicholas S, Krissinel E, Gruber J, Cowtan K, Emsley P, Murshudov GN, 
Cohen S, Perrakis A, Noble M. Developments in the CCP4 molecular-graphics project. 
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2288-94. 
20. Schrodinger, LLC. The PyMOL Molecular Graphics System, Version 1.3r1. 2010. 
21. Kantardjieff KA, Rupp B. Matthews coefficient probabilities: Improved estimates for unit 
cell contents of proteins, DNA, and protein-nucleic acid complex crystals. Protein Sci. 
2003 Sep;12(9):1865-71. 
22. Matthews BW. Solvent Content of Protein Crystals. J Mol Biol. 1968;33:491-7. 
107 
 
23. Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for 
CHARMM. Journal of computational chemistry. 2008 Aug;29(11):1859-65. 
24. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, 
Kale L, Schulten K. Scalable molecular dynamics with NAMD. Journal of computational 
chemistry. 2005 Dec;26(16):1781-802. 
25. Feller SE, Zhang Y, Pastor PR, Brooks BR. Constant pressure molecular dynamics 
simulation: The Langevin piston method J Chem Phys. 1995;103:4613. 
26. Martyna GJ, Tobias DJ, Klein ML. Constant pressure molecular dynamics algorithms. J 
Chem Phys. 1994;101. 
27. Steinbach PJ, Brooks BR. New spherical-cutoff methods for long-range forces in 
macromolecular simulation. Journal of computational chemistry. 1994;15(7):667-83. 
28. Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle 
mesh Ewald method J Chem Phys. 1995;103:8577. 
29. Evans PR. An Introduction to Data Reduction: Space-Group Determination, scaling and 
intentisy statistics. Acta Cryst. 2011;D67:282-92. 
30. Diederichs K, Karplus PA. Improved R-factors for Diffraction Data Analysis in 
Macromolecular Crystallography. Nat Struct Biol. 1997;4:269-75. 
31. Weiss MS. Global indicators of X-ray data quality. J Appl Cryst. 2001;34:130-5. 
32. Krissinel E, Henrick K. Secondary-structure matching (SSM), a new tool for fast protein 
structure alignment in three dimensions. Acta crystallographica Section D, Biological 
crystallography. 2004 Dec;60(Pt 12 Pt 1):2256-68. 
33. Kumar R, Matsumura H, Lovell SW, Yao H, Rodriguez JC, Battaile KP, Moenne-Loccoz 
P, Rivera M. Replacing the Axial Ligand Tyrosine 75 or its Hydrogen Bond Partner 
108 
 
Histidine 83 Minimally Affects Hemin Acquisition by the Hemophore HasAp from 
Pseudomonas aeruginosa. Biochemistry. 2014, 52, 2112-25. 
 
 
109 
 
Chapter 4 
 
Replacing the Axial Ligand Tyrosine 75 or its Hydrogen Bond Partner 
Histidine 83 minimally affects hemin acquisition by the Hemophore HasAp 
from Pseudomonas aeruginosa 
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Summary 
Hemophores from Pseudomonas aeruginosa (HasAp), Serratia marcescens (HasAsm), and 
Yersinia pestis (HasAyp) bind hemin between two loops.  One of the loops harbors conserved 
axial ligand Tyr75 (Y75 loop) in all three structures, whereas the second loop (H32 loop) 
contains axial ligand His32 in HasAp and HasAsm, but a non-coordinating Gln32 in HasAyp.  
Hemin binding to the Y75 loop of HasAp or HasAsm causes a large rearrangement of the H32 
loop that enables His32 coordination. The Q32 loop in apo-HasAyp is already in the closed 
conformation, such that hemin binding to the conserved Y75 loop occurs with minimal structural 
rearrangement and without coordinative interaction with the Q32 loop. In this study, structural 
and spectroscopic investigations of the hemophore HasAp were conducted to probe (i) the role of 
the conserved Tyr75 loop in hemin binding, and (ii) the proposed requirement of the His83-
Tyr75 hydrogen bond to enable hemin coordination by Tyr75. High-resolution crystal structures 
of H83A holo-HasAp obtained at pH 6.5 (0.89 Å) and 5.4 (1.25 Å) show that Tyr75 remains 
coordinated to the heme iron, and that a water molecule can substitute for His83 Nδ to interact 
with the Oη atom of Tyr75, likely stabilizing the Tyr75-Fe interaction. NMR spectroscopy 
revealed that in apo-Y75A and H83A HasAp, the Y75 loop is disordered, and that disorder 
propagates to nearby elements of secondary structure, suggesting that the His83 Nδ to Tyr75 Oη 
interaction is important to the organization of the Y75 loop in apo-HasA.  Kinetic analysis of 
hemin loading carried out with stopped flow UV-vis and rapid-freeze-quench resonance Raman 
show that both mutants load hemin with biphasic kinetic parameters that are not significantly 
dissimilar from those previously observed with wild type HasAp.  When the structural and 
kinetic data are taken together a tentative model emerges, which suggests that HasA hemophores 
utilize hydrophobic, - stacking, and van der Waals interactions to load hemin efficiently, while 
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axial ligation likely functions to slow hemin release, thus enabling the hemophore to meet the 
challenge of capturing hemin under inhospitable conditions and deliver it selectively to its 
cognate receptor. 
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4.1 Introduction 
Iron-containing proteins are integral components of fundamental physiological processes 
such as DNA synthesis, gene regulation, respiration, oxygen transport, and degradation of 
xenobiotics [1, 2].  The relative availability of iron in the host environment is an important 
determinant of virulence, which is why iron bioavailability is associated with sepsis [3] and an 
innate response of the immune system is to deploy iron-binding proteins such as lactoferrin and 
transferrin to lower free-iron to vanishingly small concentrations (≈ 10
-18
 M) in plasma [4].  In 
spite of the iron-limiting conditions imposed by the host, pathogenic bacteria can establish 
infections, which is a manifestation of the molecular mechanisms evolved by pathogens to 
procure iron from their host.  Approximately 95% of all iron in mammals is found in hemoglobin 
heme [5].  Consequently, hemoglobin and other host proteins that scavenge hemoglobin or heme 
from blood plasma, such as hemopexin, haptoglobin and serum albumin, are a source of iron for 
pathogenic bacteria [6]. Indeed, pathogenic bacteria are able to overcome the extremely low 
levels of free iron within their mammalian hosts by deploying several iron and heme-iron 
acquisition systems [7-9].  Some Gram negative bacteria deploy has (heme acquisition system), 
which is characterized by the secretion of the hemophore HasA to bind and sequester 
extracellular heme and deliver it to a specific outer membrane receptor, HasR for subsequent 
internalization [7, 10, 11]. 
HasA hemophores from Serratia marcescens (HasAsm) [12, 13], Pseudomonas aeruginosa 
(HasAp) [14, 15] and Yersinia pestis (HasAyp) [16] have been structurally characterized in their 
heme-free (apo) and heme-bound (holo) forms.  The structures of HasAp, HasAyp and HasAsm 
are composed of an “α-helix wall” packed against a “β-sheet wall” and two extended loops 
which bridge the α-helix and β-sheet walls.  The heme iron of HasAp and HasAsm is coordinated 
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by Tyr75 and His32, with each axial ligand harbored in distinct loops, termed the Y75 and H32 
loops (Figure 4.1-A). This combination of axial ligands has been observed only in hemoglobin M 
Saskatoon [17], hemoglobins from invertebrates [18, 19], and heme d1 in cytochrome cd1 
reductase [20], whereas examples of heme proteins that utilize Tyr as the only protein provided 
ligand, which include hemoglobins M [17, 21] methemalbumin [22], catalase [23], HasAyp [16], 
Isd hemophores secreted by Gram positive organisms [2], and heme-binding periplasmic-binding 
proteins [24, 25], are relatively more abundant. The main difference between apo- and holo-
HasAp (or HasAsm) is a large reorganization of the H32 loop, which relocates the His32 side 
chain approximately 30 Å (Figure 4.1-B).  The role played by His32 in heme binding has been 
investigated using the H32A mutant of HasAp [14, 26].  The X-ray crystal structure of the holo 
form revealed a non-crystallographic dimer linked by cofacial interaction of two heme 
molecules, which are coordinated by Tyr75; each subunit is nearly identical in structure to the 
apo-protein, including the open conformation of the H32 loop.  These observations suggested 
that heme loads onto the Y75 loop while the H32 loop is in the open (apo-like) conformation. 
Subsequent closure of the H32 loop in wild type (wt) HasAp excludes water from the heme 
environment and provides the sixth ligand to the heme [14].  This idea found additional support 
in the structure of monomeric holo-H32A in complex with imidazole, which revealed the heme-
iron coordinated by Tyr75 and an exogenous imidazole.  While the H32 loop is not completely 
defined in the imidazole complex, segments with clearly discernible electron density indicate a 
closed loop conformation similar to that seen in wt holo-HasAp. Moreover, the plane of the 
coordinated imidazole in H32A holo-HasAp is nearly superimposable with the His32 imidazole 
plane in wt HasAp.  Solution NMR studies of H32A holo-HasAp and its imidazole complex 
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provided corroborating evidence that loading of hemin on the Y75 loop triggers closure of the 
H32 loop, even in the absence of the His32 side chain [14]. 
Kinetic studies of heme binding to wt apo-HasAp using rapid-mixing techniques coupled to 
electronic absorption, EPR and resonance Raman spectroscopic methods identified two distinct 
kinetic phases [26].  The spectroscopic changes in the first phase, which is complete within 20 
ms, are indicative of efficient heme loading onto the Y75 loop, while the slower phase, which 
lasts ≈1 s at 4 °C, reflects closure of the H32 loop and coordination of the heme-iron by His32; 
accordingly, the H32A variant exhibits only the first millisecond phase corresponding to the 
loading of hemin onto the Y75 loop [26].  Taken together, our structural and kinetic 
investigations clearly demonstrate that hemin loads onto the Y75 loop within a few ms, where it 
is coordinated by Y75, and triggers closure of the H32 loop and coordination of the heme within 
the second timescale.  A recent study carried out with the H32A mutant of HasAsm arrived to a 
similar model for heme loading [27]. 
Amino acid sequence alignments of HasA proteins from Yersinia species show conservation 
of Tyr75 and His83 in the Y75 loop, but no conservation for His32 [16]. Structural 
characterization of HasA from Yersinia pestis, apo- and holo-HasAyp, where residue 32 is a 
glutamine, led to three important observations: (i) the Gln32 bearing loop adopts a closed 
conformation in apo-HasAyp (Figure 4.1-C), (ii) Tyr75 is the only endogenous heme ligand in 
holo-HasAyp, and (iii) heme binding to apo-HasAyp occurs on a sub-millisecond timescale with 
minimal structure reorganization (Figure 4.1-D) [16]. This study of HasAyp highlights variations 
in the coordination state of hemin in HasA hemophores, but it also underscores a strong 
structural conservation of the proximal loop, which includes the invariant Tyr75 ligand, and its 
hydrogen bond partner His81 (Figure 4.1).  The function of this hydrogen bond, which is thought 
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to increase the phenolate character of Tyr75, has been proposed to be essential for proximal 
hemin coordination by Tyr75 [15, 28, 29]:  
 
Figure 4.1.  HasA hemophores display structural conservation of the proximal loop (coral) but divergence in the 
structure and function of the distal loop (green).  Structures of (A) apo-HasAp ( DB code: 3MOK) and (B) holo-
HasAp ( DB code: 3 LL) illustrate the large conformational rearrangement of the distal loop (green) caused by 
heme binding, which results in heme axial ligation by His32 and Tyr75.  In contrast, the structures of (C) apo-
HasAyp ( DB code: 4  R), and (D) holo-HasAyp ( DB code: 4  T) illustrate the minimal reorganization of the 
distal loop upon heme binding and the coordination of heme by only one protein-provided ligand, Tyr75. The Cl
-
 ion 
that coordinates to the distal site is shown as a yellow sphere. Figure adapted from reference [30].  
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A low-resolution crystal structure of H83A holo-HasAsm has been reported, but poor 
electron density does not establish whether Tyr75 remains coordinated to the heme iron in H83A 
holo-HasAsm [31].  Resonance Raman and NMR spectroscopic studies, however, led the same 
authors to suggest that in the absence of His83 the Tyr75-Fe bond is severed.  Thus the H83A 
mutant of HasAsm was described as a 5-coordinate species, with His32 as the only axial ligand at 
pH ≈ 5.2, His32 and water as axial ligands at neutral pH, and His32 and a hydroxide ligand at 
basic pH [31].  A different study proposed that in the absence of Tyr75, His83 likely acts as a 
heme iron ligand [32, 33], but direct experimental support for this notion is lacking. 
Given the structural conservation of the Y75 loop in HasA hemophores, and the proposed 
requirement for the His83-Tyr75 unit for coordination of hemin by Tyr75, we carried out a 
structural and spectroscopic characterization of the Y75A and H83A HasAp mutants. Our high-
resolution crystal structures of H83A-HasAp clearly demonstrate that in the absence of His83, 
the Tyr75 ligand remains coordinated to the heme-iron at neutral pH and at pH 5.4.  These 
structures also show that in the absence of the His83 side chain, a water molecule can substitute 
for the missing Nδ of His83 to interact with the Tyr75 Oη atom and aid its coordination to the 
ferric heme iron.  NMR spectroscopic studies conducted with Y75A and H83A apo-HasAp 
demonstrate that disruption of the Tyr75 to His83 hydrogen bond induces significant 
conformational disorder in the Y75 loop, which propagates into neighboring elements of 
secondary structure. Stopped-flow UV-vis absorption and rapid freeze quench resonance Raman 
(RFQ-RR) analyses of hemin binding to Y75A and H83A apo-HasAp show biphasic kinetics 
comparable to those observed in wt HasAp. These results suggest that the importance of hemin 
iron axial ligation in the process of hemin acquisition by HasAp should not be overestimated and 
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point toward non-covalent interactions as factors dominating heme capture and the formation of 
holo-HasAp.  
 
4.2 Experimental Procedures 
I would like to thank and acknowledge Dr. Grace Jepkorir, Rivera Lab alumni, who 
started this work, prepared the site-directed mutagenesis and set up for protein crystallization. 
Also, I would like to thank and acknowledge Dr. Scott Lovell, Director, Protein Structure Lab, 
Shankel Structure Biology Center, University of Kansas, KS, for data collection and solving the 
structures of the mutants Y75A and H83A HasAp. 
4.2.1 Site-directed Mutagenesis  
Y75A- and H83A-HasAp mutants were constructed in the background of the gene coding 
for the truncated form of HasAp missing the last 21 C'-terminal residues [15].  Primers were 
synthesized by Integrated DNA Technologies, Inc. and were used without further purification in 
conjunction with the QuickChange site-directed mutagenesis kit (Stratagene; La Jolla, CA). 
Primers used to install the Y75A mutation are 5`-GGCGGCGATCTGCATGCGACCCTGTTT-
3` and 5`GCTAAACAGGGTCGCATGCAGAT-CGCCGCC-3` and those use for the H83A 
mutation are 5`-CTGTTTAGCAACCC-GAGCGCGACCCTGTGGGGC-3` and 5`-
GCCCCACAGGGTCGCGCTCGGGTTGCTAAA-CAG-3`, where the underlined codons 
represent target substitutions.  Each gene construct was transformed into XL1-Blue Competent 
cells (Stratagene) for amplification, and DNA sequence verified by SeqWright (Huston, Texas).  
Recombinant DNA plasmid with the correct sequence was transformed into E. coli BL21-GOLD 
(DE3) competent cells for subsequent protein expression.   
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4.2.2 Protein Expression and Purification.  
Expression, purification and reconstitution of Y75A- and H83A-HasAp with heme were 
carried out using previously described methods [14].  The oligomeric state of the mutant 
hemophores was determined with the aid of a gel filtration column (Superdex 75 prep grade, GE 
Healthcare), calibrated with cytochrome c (12.4 kDa), chymotrypsin (25 kDa), ovalbumin (44 
kDa), and albumin (67 kDa) standards, in 50 mM Tris-HCl (pH 7.5), 100 mM KCl buffer.  The 
preparation of wt, Y75A- and H83A-HasAp uniformly labeled with nitrogen-15 (U-
15
N-HasAp, 
U-
15
N-Y75A- and U-
15
N-H83A-HasAp) or labeled with both nitrogen-15 and carbon-13 ([U-
13
C, 
U-
15
N]-HasAp-WT, ([U-
13
C, U-
15
N]-HasAp-Y75A and ([U-
13
C, U-
15
N]-HasAp-H83A) was 
performed as previously described for wt and H32A-HasAp [14]. 
4.2.3 Crystallization and Data Collection.   
HasAp mutants in 100 mM sodium phosphate pH 7.8 (Y75A) or 100 mM Tris pH 7.6 
(H83A) were concentrated to 15 mg/mL and screened for crystal growth at 20 °C using Compact 
Jr. (Emerald biosystems) sitting drop vapor diffusion plates. Equal volumes of protein and 
crystallization solution were equilibrated against 100 µL of reservoir volume.  Crystals of Y75A 
HasAp were obtained within 24 h from Crystal Screen 2 (Hampton Research) (appendix V) 
condition #32 (1.6 M (NH4)2SO4, 100 mM HEPES pH 7.5, 100 mM NaCl).  Crystals were 
transferred to a solution containing 80% crystallization solution and 20% glycerol before 
freezing in liquid nitrogen for data collection.  Crystals of H83A-HasAp were obtained from 
three distinct conditions: (1) Wizard II  (Emerald biosystems) (appendix VIII) condition #11 
(10% isopropanol, 100 mM sodium cacodylate pH 6.5, 200 mM zinc acetate) produced non-
diffracting small crystals that grew as clusters of small needles in approximately 24 h at 20 °C.  
Refinement of the crystallization conditions was conducted using the Hampton Additive screen 
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(Hampton Research) (appendix VII).  Plate-shaped clusters that diffracted to high resolution 
were obtained from 10% isopropanol, 100 mM sodium cacodylate pH 6.5, 200 mM zinc acetate, 
3% dioxane.  These crystals were transferred to a solution containing 75% crystallization 
solution and 25% ethylene glycol before freezing in liquid nitrogen for data collection. (2) 
Crystals were obtained in approximately 3 days at 20 °C from Hampton Crystal Screen 2 
condition #23 (1.6 M (NH4)2SO4, 100 mM MES pH 6.5, 10% dioxane).  Crystals were 
transferred to a solution containing 80% crystallization solution and 20% ethylene glycol before 
freezing in liquid nitrogen for data collection. (3) Crystals were obtained in approximately 3 days 
at 20 °C from 1.6 M (NH4)2SO4, 100 mM MES pH 5.4, 10% dioxane.  Samples were transferred 
to a solution containing 80% crystallization solution and 20% ethylene glycol before freezing in 
liquid nitrogen for data collection.  High-resolution diffraction data from all crystals were 
acquired at the Advanced Photon Source IMCA-CAT beamline 17ID using a Dectris Pilatus 6M 
pixel array detector. 
4.2.4 Structure Solution and Refinement   
Diffraction intensities were integrated and scaled using the XDS [34] and Scala [35] 
packages, respectively and the Laue class was checked using Pointless [36].  Coordinates from 
the structure of wt HasAp (PDB: 3ELL) were used for molecular replacement with Molrep [37] 
searching for a single molecule in the asymmetric unit for all data sets.  Structure refinement of 
positional and anisotropic atomic displacement parameters and manual model building for both 
mutants were performed with Phenix [38] and Coot [39] respectively.  Structure validation was 
carried out using Molprobity [40] and figures were prepared using CCP4mg [41] and PyMol 
(www.pymol.org). Data collection and refinement statistics are summarized in Table 4.1.   
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4.2.4.1 Y75A Holo-HasAp  
Following initial refinement, prominent difference (Fo-Fc) electron density was observed 
near the heme on the side that would normally be occupied by Tyr 75.  Three peaks were present 
in this region that were at an angle of approximately 120
o
 and separated by approximately 1.3 Å.  
Refinement with an ethanol molecule at this site resulted in positive Fo-Fc electron density at the 
C2 atom of ethanol indicating an underestimation of electrons, whereas placement of a formate 
ion did not yield any residual electron density.  Similar electron density was observed from four 
diffraction data sets ranging from 0.95 Å to 1.30 Å resolution obtained from four unique 
crystallization conditions: Hampton Crystal Screen 2 condition #23 described above, Hampton 
Crystal Screen 2 condition #32 (1.6 M Ammonium sulfate, 0.1 M HEPES pH 7.5, 0.1 M sodium 
chloride), Hampton Crystal Screen 2 condition #42 (1.5 M Ammonium sulfate, 0.1 M Tris pH 
8.5, 12% v/v Glycerol), and Hampton Crystal Screen 1 condition #38 (1.4 M Sodium citrate 
tribasic dehydrate, 0.1 M HEPES pH 7.5).  Herein we only report the 0.95 Å resolution data 
obtained with Crystal screen 2, condition #23.  Since the electron density was not consistent with 
any of the crystallization components, protein storage buffer or purification buffers, it is likely 
that the formate ion was present in the heme used in the reconstitution of the apo-protein. 
4.2.4.2 H83A Holo-HasAp 
Condition 1 produced a monoclinic crystal form, henceforth referred to as H83A
mono
.  
Molecular replacement searches in the space groups P21 and P2 produced correlation 
coefficients of 0.62 and 0.30 respectively.  Therefore, subsequent structure refinement was 
conducted in the space group P21.  Initial structure solution and refinement were conducted using 
in-house diffraction data collected with Cu-Kα radiation.  Large peaks greater than 10σ were 
observed in the difference Fourier maps (Fo-Fc) that were tentatively assigned as zinc ions from 
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the crystallization solution.  No anomalous signal was observed at these sites using Cu-Kα data.  
An X-ray fluorescence scan indicated that zinc was indeed present in the crystal.  Consequently, 
data for structure refinement were collected at a wavelength of 1.0000 Å which still yields an 
appreciable anomalous signal for Zn ~ 2.6e
-
.  In addition, diffraction data were collected at a low 
energy remote wavelength (λ =1.28414 Å, 9,655 eV), which resulted in the disappearance of the 
anomalous difference density at the Zn sites but an increase at the heme-Fe site. Condition 2 
produced an orthorhombic crystal form (H83A
ortho
)  and condition 3 produced crystals at pH 5.4 
(H83A
pH5.4
), which were obtained from attempts to grow crystals in a pH range of 5.0 to 5.5, in 
order to explore the ligation state of Tyr75 in acidic conditions.  The structure was solved as 
described above for (H83A
ortho
). 
4.2.5 NMR Spectroscopy.  
Solution NMR spectroscopy experiments were performed by Dr. Juan C. Rodríguez and 
Dr. Huili Yao, Rivera Lab, University of Kansas, Lawrence, KS, USA and the experimental 
details can be found in reference [30].  Results relevant to the analysis are presented in this 
dissertation with due acknowledgement. 
4.2.6 Kinetics Experiments 
Kinetic measurements (EPR, Resonance Raman, Stopped-flow experiments and Rapid-
Freeze-Quench) were performed by our collaborators, Dr. Hirotoshi Matsumura and Dr. Pierre 
Moënne-Loccoz at Oregon Health and Science University (OHSU) at Portland, Oregon, USA 
and experimental details can be found in reference [30]  Results relevant to the analysis are 
presented in this dissertation with due acknowledgement. 
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Table 4.1.  X-ray data and refinement statistics for Y75A and H83A HasAp 
 Y75A-HasAp H83A
mono
-
HasAp 
H83A
ortho
-
HasAp 
H83A
pH5.4
-
HasAp 
Data Collection     
Unit-cell 
parameters (Å, 
o
) 
a=34.44, 
b=46.73, 
c=101.04 
a=34.90, 
b=66.23, 
c=41.00, β=97.1 
a=34.38, 
b=46.99, 
c=100.90 
a=34.43, 
b=46.78, 
c=101.81 
Space group P212121 P21 P212121 P212121 
Resolution (Å)
1
 40.00-0.95               
(1.00-0.95) 
66.23-1.32   
(1.39-1.32) 
100.90-0.89 
(0.94-0.89) 
101.81-1.25  
(1.32-1.25) 
Wavelength (Å) 1.0000 1.0000 0.9184 1.0000 
Temperature (K) 100 100 100 100 
Observed 
reflections 
901,848 151,394 714,733 296,237 
Unique 
reflections 
97,317 43,290 120,441 46,491 
<I/s(I)>
1
 18.7 (2.6) 7.7 (2.2) 18.0 (2.9) 12.1 (2.5) 
Completeness 
(%)
1
 
94.1 (80.0) 99.6 (99.8) 95.8 (87.2) 100 (100) 
Multiplicity
1
 9.3 (5.6) 3.5 (3.5) 5.9 (3.7) 6.4 (6.3) 
Rmerge (%)
1, 2
 5.5 (60.1) 9.5 (68.1) 5.0 (38.7) 9.2 (80.6) 
Rmeas (%)
1, 4
 5.8 (66.3) 11.2 (80.5) 5.4 (44.7) 10.0 (88.1) 
Rpim (%)
1, 4
 1.7 (27.3) 5.9 (42.3) 2.1 (21.8) 3.9 (35.1) 
Refinement     
Resolution (Å) 34.30 - 0.95 34.63 - 1.32 32.54 – 0.89 42.51-1.25 
Reflections 92,362 / 4,861 41,067 / 2,180 114,343 / 6,000 44,065 / 2,350 
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(working/test) 
Rfactor / Rfree (%)
3
 13.9 / 14.6 14.3 / 16.8 12.4 / 13.4 15.3 / 18.2 
No. of atoms 
( rotein/Heme/ 
Water) 
1,357/43/322 1,356 /43/215 1,436/43/235 1,360/43/213 
Model Quality     
R.m.s deviations      
Bond lengths (Å) 0.012 0.010 0.015 0.011 
Bond angles (
o
) 1.456 1.356 1.688 1.370 
Average B-factor 
(Å
2
) 
    
All Atoms 12.4 13.5 8.9 12.7 
 rotein 10.3 11.8 7.3 10.9 
Heme 8.0 9.2 6.5 8.6 
Zinc - 16.3 - - 
 thylene glycol - 23.3 20.0 19.9 
Formate 7.4 - - - 
Water 22.2 24.5 18.9 24.4 
Coordinate error, 
maximum 
likelihood (Å) 
0.07 0.16 0.13 0.30 
Ramachandran 
 lot  
    
Most favored 
(%) 
98.4 98.9 97.1 98.4 
Additionally 
allowed (%) 
1.6 1.1 2.4 1.6 
 
1) Values in parenthesis are for the highest resolution shell. 
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2) Rmerge = ShklSi |Ii(hkl) - <I(hkl)>| / ShklSi Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection 
and <I(hkl)> is the average intensity of all reflections with indices hkl.  
3) Rfactor = Shkl ||Fobs (hkl) | - |Fcalc (hkl) || / Shkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% 
of randomly selected reflections that were not included in the refinement. 
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge. [35, 42] Rpim = precision-indicating 
(multiplicity-weighted) Rmerge[43, 44].  
 
4.3 Results 
4.3.1 Purification of Y75A and H83A Proteins  
Similar to the wt HasAp, the bacterial expression of Y75A and H83A HasAp results in 
accumulation of a much larger proportion of apo-hemophore relative to its holo-counterpart in 
the E. coli host cells [14].  Hence, the two mutants were purified in their apo-form using a 
previously reported protocol, which utilizes hydrophobic affinity chromatography to separate 
apo and holo hemophores [14].  Holo-hemophore was prepared from its corresponding apo form 
by heme reconstitution in vitro, as described in the Experimental section and both the mutants 
adopt monomeric structures in the solution.  SDS PAGE shows that both mutant proteins migrate 
with apparent mass of ~ 19 kDa.  Mass values measured with the aid of ESI-MS are 18,667 Da 
(Y75A) and 18,693 Da (H83A), which are in good agreement with the molecular weight 
calculated from amino acid sequences, 18,668 Da (Y75A) and 18,694 Da (H83A).   
4.3.2 UV-vis and Spin State of the Heme Iron in Y75A and H83A HasAp Mutants 
Figure 4.2-A shows the electronic absorption spectra of wt (black), Y75A (red) and 
H83A (blue) HasAp. The UV-vis absorption spectrum of Y75A exhibits a Soret peak at 407 nm 
and a characteristic high-spin marker charge transfer band at 624 nm. Intense Q bands at 535 and 
568 nm also support the presence of low-spin contribution. This high-spin/low-spin equilibrium 
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is consistent with axial coordination that includes a His side chain and an exogenous ligand as 
revealed by the X-ray crystal structure of Y75A holo-HasAp (see below).  The UV-vis spectrum 
of H83A is primarily indicative of a high-spin state at room temperature with a broader Soret 
band at 405 nm, Q bands at 489 and 550 nm, and high-spin marker band at 608 nm (Figure 4.2-
A).  UV-vis spectra obtained at low-temperature confirm that the low-spin state becomes 
dominant below 100 K (Figure 4.2-B).  
 
Figure 4.2.  (A) Room temperature UV-vis spectra of wt, Y75A and H83A holo-HasAp, (B) Temperature 
dependence of UV-vis spectra of H83A holo-HasAp.  Kinetic experiments were performed by our collaborators, Dr. 
Hirotoshi Matsumura and Dr.  ierre Mo nne-Loccoz at Oregon Health and Science University (OHSU) at  ortland, 
Oregon, USA and details can be found in reference [30]. 
 
4.3.3 Homogenous Structural features of Mutants Compared to the Wt Holo-HasAp  
The structure of Y75A holo-HasAp was refined using data diffracting to 0.95 Å 
resolution (Table 4.1).  Crystals of H83A holo-HasAp were obtained from three different 
conditions (see Experimental) and the corresponding structures were refined using data 
diffracting to 0.89 Å (H83A
ortho
), 1.32 Å (H83A
mono
) and 1.25 Å (H83A
pH5.4
) resolution.  The 
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overall structure of the mutants is nearly identical to that of wt holo-HasAp (Figure 4.3).  It is 
noteworthy that in the H83A mutant, Tyr75 remains coordinated to the heme iron in both 
structures obtained at pH 6.5 (Figure 4.3-D) as well as in the structure obtained at pH 5.4 (Figure 
4.3-E).  In the Y75A HasAp structure (Figure 4.3-B), His83 remains in the position it occupies in 
the wt protein, and therefore does not coordinate the heme iron.  In the H83A
mono
 structure the 
hairpin loop adjoining β6 and β7 is disordered, as suggested by the absence of electron density, 
which is demarcated by asterisks in Figure 4.3-D.  In the H83A
ortho 
structure, strand β8 is shorter 
than in the wt protein (Figure 4.3-C).   
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Figure 4.3.  The overall structure of the Y75A and H83A mutants is very similar to that of wt HasAp ( DB code: 
3 LL).  Cα-RMSD values from comparing the wild type structure (A) to the structure of Y75A HasAp, (B) is 0.571 
Å, H83A
ortho
-HasAp (C) is 0.564 Å, H83A
mono
-HasAp (D) is 0.448 Å, and H83ApH5.4 ( ) is 0.532 Å. Secondary 
structures are colored cyan (α-helices), magenta (β-strands) and grey (loops). Loss in secondary structure is colored 
yellow (C).  Missing electron density in (D) is delimited by black asterisks.  Residues Ser2 to Ala183 were used to 
calculate the RMSD values using the secondary structure matching algorithm in the program Superpose [45] via the 
CC 4 interface [46].  
 
Surprisingly, although both mutations are on the Y75 loop, the conformation of the H32 
loop is significantly more affected than the conformation of the Y75 loop.  This is illustrated in 
Figure 4.4, which depicts the conformational changes affecting the backbone and side chains of 
residues in the H32 loop of H83A-HasAp (cyan) and Y75A-HasAp (green) relative to their 
conformations in wt HasAp (magenta).  In contrast, the structure of the Y75 loop remains nearly 
unchanged relative to the Y75 loop in wt HasAp.  Note, however, that despite the conformational 
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changes in the H32 loop, the coordinated imidazole rings of His32 in the wt and mutant proteins 
are identical, as is the seating of the heme. 
 
Figure 4.4.  Replacing Tyr75 or His83 in the Y75 loop of HasAp by a non-coordinating Alanine causes 
conformational changes in the His32 loop.  Zoomed-in views of the H32 (top) and Y75 (bottom) loops of H83A-
HasAp (cyan) and Y75A-HasAp (green) superimposed with the structure of wild type HasAp (magenta).  Figure 
adapted from reference [30]. 
 
Heme binds to the Y75A-HasAp mutant in a single orientation, which is evident from the 
Fo-Fc electron density map in Figure 4.5-A.  Given that the heme seating is also identical to that 
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observed in wt HasAp, it enables similar interactions between the heme propionates and Gly35 
and Arg129 (Figure 4.6).  Prominent difference electron density (Fo – Fc) was observed near the 
heme on the side that would normally be occupied by Tyr75 in the wt protein.  Structure 
refinement with an ethanol molecule at this site resulted in positive Fo – Fc electron density at the 
C2 atom of ethanol, indicating an underestimation of electrons.  Placement of a formate ion at 
this site did not yield residual electron density upon refinement, thus a formate ion was modeled 
at this site.  It is noteworthy that the same electron density was observed in four distinct 
diffraction data sets ranging in resolution from 0.95 Å to 1.3 Å, which were obtained from four 
different crystallization conditions (see experimental).  Herein we report only the structure 
obtained from crystals diffracting to 0.95 Å resolution.  Given that the protein is initially purified 
in its apo-form and then reconstituted with heme in vitro, we surmise that the most likely source 
of formate stems from the heme or the DMSO used to dissolve heme for the heme reconstitution 
experiments.  The plane of the modeled formate ion is aligned with the heme α-γ-meso axis, 
which enables one of the formate oxygen atoms to coordinate the heme and also form a hydrogen 
bond with Nδ of His83 (2.6 Å).  This hydrogen bonding interaction is similar to the hydrogen 
bond formed in the wt protein between the coordinated phenolic oxygen of Tyr75 and the Nδ of 
His83.  The second oxygen in the formate molecule interacts with the backbone carbonyl group 
of Thr76 (3.8 Å).  The side chain of His83, which also displays very well defined electron 
density, is placed in a position identical to that it occupies in the wt protein, where it does not 
coordinate the heme-iron. 
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Figure 4.5.  Zoomed-in views of the heme-binding sites in (A) Y75A HasAp, (B) H83A
ortho
-HasAp, (C) H83A
mono
-
HasAp, and (D) H83A
pH5.4
-HasAp.  Fo-Fc electron density omit maps contoured at 3σ are shown as blue mesh.  FMT 
is formate ion,    ethylene glycol, and the Zn
2+
 ion in (C) is shown as a sphere. Figure adapted from reference [30]. 
 
Tyr75 and His32 axially coordinate the heme-iron in the H83A
ortho
 (Figure 4.5-B), 
H83A
mono
 (Figure 4.5-C) and H83A
pH5.4
 (Figure 4.5-D) structures.  The Fo-Fc electron density 
maps show that both axial ligands exhibit very well defined electron density in all structures, as 
does the heme, which is bound to the protein in a single orientation, thus clearly demonstrating 
that Tyr75 remains coordinated to the heme iron, even at pH 5.4.  The seating of the heme is the 
same in all three structures and identical to that observed in wt HasAp, although the heme 
propionates adopt different conformations in the three structures (also see Figure 4.6).  In all 
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structures Tyr75 coordinates the heme iron in a conformation identical to that seen in wt HasAp.  
In addition to coordinating the heme iron, the phenolic oxygen of Tyr75 forms a hydrogen bond 
with a water molecule in the H83A
ortho
 and H83A
pH5.4
 structures (Figures 4.5-B and 4.5-D), or 
with the oxygen atom of an adventitious ethylene glycol (used as cryo-protectant) in the 
H83A
mono
 structure (Figure 4.5-C).  These hydrogen bonding interactions experienced by Tyr75 
in the H83A mutant effectively replace the Tyr75 Oη to His83 Nδ hydrogen bond seen in wt 
HasAp.  These observations are in agreement with the significance of the hydrogen bond 
between Tyr75 and His83 in enabling coordination of Tyr75 to the heme iron [28, 32].  
Importantly, however, our finding that Tyr75 coordinates the heme in all available structures is 
in contrast with conclusions derived from spectroscopic studies suggesting that the Tyr-Fe bond 
is severed in the H83A mutant of HasAsm [27, 31]. 
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Figure 4.6.  Heme propionate interactions in (A) wt holo-HasAp monomer B ( DB code: 3 LL), (B) Y75A-HasAp, 
(C) H83A
ortho
-HasAp, (D) H83A
mono
-HasAp; the zinc ion coordinating the heme propionate is shown as a green 
sphere and ( ) H83A
pH5.4
-HasAp.  Figure adapted from reference [30].  
During refinement of the H83A
mono
 structure, large peaks greater than 10σ were observed 
in the Fo–Fc maps, which were tentatively attributed to zinc ions from the crystallization solution.  
No anomalous signal was observed at these sites using diffraction data from Cu-Kα X-rays.  An 
X-ray fluorescence scan at the synchrotron indicated that zinc was indeed present in the crystal 
(Figure 4.7-A).  Hence, data for structure refinement that were collected at a wavelength of 
1.0000 Å yielded appreciable anomalous signal for Zn.  In contrast, diffraction data collected at a 
low energy remote wavelength (1.28414 Å), which resulted in the disappearance of the 
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anomalous difference density at the Zn sites, and increased anomalous signal at the heme-iron 
site, confirmed the presence of Zn (Figure 4.7-B).  One of the zinc ions interacts with the heme 
propionates, which induces a conformation distinct from that observed for the heme propionates 
in wt HasAp.  In the H83A
pH5.4
 structure heme propionate 6 interacts with the side chain of 
Arg129 and thus adopts a conformation similar to that in the wt protein.  In contrast, heme 
propionate 7 adopts a different conformation, which places the carboxylate group within 
hydrogen bonding distance of the backbone NH and CO groups of Arg33, Gly35 and Val37 
(Figure 4.6-E). 
 
Figure 4.7.  (A) X-ray fluorescence scan of the H83A
mono
-HasAp crystal (B) A zinc ion coordinates the heme 
propionates in H83A
mono
-HasAp.   hased anomalous difference map using data collected at λ=1.000 Å (red mesh) 
and low energy 1.28414 Å (green mesh) contoured at 4σ.  Note that the anomalous difference density increases at 
the heme Fe atom and disappears at the Zn ion site in the data acquired at low energy.  Figure adapted from 
reference [30] 
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4.3.4 Y75A and H83A Apo-HasAp have Disordered Y75 loops  
I would like to thank and acknowledge Dr. Huili Yao, Research associate, Rivera Lab, 
University of Kansas, Lawrence, Kansas, USA for performing the solution NMR experiments 
and the details can be found in reference [30].  Results relevant to the analysis are presented in 
this dissertation.   
The X-ray crystal structures of holo-Y75A and holo-H83A-HasAp indicate minimal 
changes in the structure of the Y75 loop and small changes in the H32 loop relative to the wt 
protein.  Despite considerable effort, however, we were unable to grow crystals of apo-Y75A 
and apo-H83A HasAp.  We hypothesized that conformational disorder in the apo-proteins may 
prevent crystal growth, thus we conducted NMR spectroscopic studies in solution aimed at 
probing disorder in the apo-proteins.  The 
1
H-
15
N HSQC spectrum of each of the mutant apo-
proteins, with the exception of a few cross-peaks, is nearly superimposable to the HSQC 
spectrum of wt apo-HasAp (Figure 4.8), which indicates that overall, the structures of the mutant 
apo-hemophores are similar to the structure of wt apo-HasAp.  Given the large similarity in the 
HSQC spectra of wt and mutant proteins, the sequential backbone assignments of apo-Y75A and 
apo-H83A HasAp were obtained relatively readily (for detailed backbone assignments, please 
refer reference [30]). 
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Figure 4.8.  
1
H,
15
N-HSQC spectra of wt apo-HasAp (A), Y75A apo-HasAp (B), and H83A apo-HasAp (C). Spectra 
were taken at 32 °C using a 600MHz Bruker spectrometer. Acquisition parameters are as follows: 2048 (
1
H) × 256 
(
15
N) complex points; 10.7 kHz (
1
H) and 2.4 kHz (
15
N) spectral widths; 32 scans per increment; d1=1sec.  Solution 
NMR experiments were performed by Dr. Huili Yao, Research Associate, Rivera’s Lab, The University of Kansas, 
KS, USA  Figure adapted from reference [30]. 
 
Closer inspection of the HSQC spectra show mostly small differences in the weighed 
chemical shifts (Δδweighed) obtained from comparing the chemical shifts of cross peaks in apo-
Y75A (Figure 4.9-A), or apo-H83A (Figure 4.9-B) with corresponding cross-peaks in wt apo-
HasAp.  Importantly, the comparison also reveals that several cross peaks in the spectra of the 
mutants are (Figure 4.9) (i) missing (red triangles), (ii) are broadened and have significant lower 
intensity compared to their counterparts in the spectrum of wt HasAp (blue squares), or (iii) are 
split (green rhombs).  Mapping the missing, broadened and split cross-peaks in the spectra of the 
mutants onto the X-ray crystal structure of wt apo-HasAp using the same color scheme as in the 
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plots (Figure 4.9) reveals that the Y75 loop, the neighboring α2 helix, some of the β strands near 
the loop, and a portion of the distal loop emerging from β2 are affected by conformational 
disorder in both mutants. 
 
 
Figure 4.9.   er-residue differences obtained from comparing cross-peaks in the HSQC spectrum of wt apo-HasAp 
with cross-peaks in the HSQC spectra of (A) Y75A apo-HasAp and (B) H83A apo-HasAp. Residues in the mutants 
whose cross peaks disappear are highlighted with a red triangle, residues whose cross peaks split are denoted by a 
green rhomb and residues whose cross-peaks are broadened and have decreased intensity are highlighted by a blue 
square.  These residues have been mapped on the wt apo-HasAp structure ( DB: 3MOK) using the same color code; 
purple denotes residues with no assignment, and cyan identifies prolines.          
∆𝛿𝑤𝑒𝑖𝑔ℎ𝑒𝑑 = √[(
∆𝛿𝑁
5
)
 
  (∆𝛿 )   ] /2  Solution NMR experiments were performed by Dr. Huili Yao, Research 
Associate, Rivera’s Lab, The University of Kansas, KS, USA. Figure adapted from reference [30]. 
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4.3.5 Conserved Biphasic Kinetics of Hemin loading in Y75A and H83A apo-HasAp  
Spectroscopic experiments were done by our collaborators Dr. Hirotoshi Matsumura and 
Dr. Pierre Moënne-Loccoz at Oregon Health and Science University (OHSU), Portland, Oregon, 
USA. Results relevant to the analysis are presented in this dissertation.   
In the previous work [47], the analysis of biphasic behavior of hemin loading to wt apo-
HasAp was done with a multi-step model, with the formation of reversible hemin-apoprotein 
complex proceeds quickly before slower iron(III) coordination steps begin to take place [47].  
Similar to the wt apo-HasAp [26], the stopped-flow absorption data of hemin acquisition by the 
Y75A and H83A mutants correspond to a biphasic processes 
 
ApoHasAp + hemin             [ ApoHasAp●hemin ]              HasAp(L1)-hemin               HoloHasAp 
                                 k1, k-1                                                         kcoord1                                    kcoord2 
 
 
Assuming that k1[ApoHasAp] and k-1 >> kcoord1, and kcoord1 >> kcoord2 gives eq 1 
 
k1obs = kcoord1[apoHasAp]/{(k-1+kcoord1)/k1 + [apoHasAp]} ≈ kcoord1[apoHasAp]/{Kd+[apoHasAp]}          
                                                                                                                                                    eq 1. 
 
This model explains the hyperbolic dependence of k1obs on the apo-HasAp concentration. In 
contrast, k2obs shows no dependence on the apo-HasAp concentration, as expected for an 
intramolecular reaction that corresponds to the closure of the H32 loop and coordination of the 
iron by His32.  
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This same analysis was used to extract Kd, kcoord1, and kcoord2 values from the stopped-
flow data obtained with the variant proteins (Table 4.2). The Y75A substitution results in a 4-
fold higher Kd value without significant change in the rate of the first coordination step, kcoord1. 
The second kinetic phase reflects kcoord2 and is ~3 times faster in Y75A than in wt-HasAp, but it 
remains low, i.e., in the millisecond timescale expected for a significant protein loop 
rearrangement (Table 4.2).  
 
Table 4.2.  Kinetic parameters for hemin binding to wt and mutant HasAp proteins at 4 °C. 
 Hemophore 
Kinetic 
Parameter 
WT H32A Y75A H83A 
Kd (µM) 35 61 129 30 
kcoord1 (s
-1
) 552 830 539 118 
kcoord2 (s
-1
) 5.2 n.o. 14.4 20.5 
 
The k1obs values for H83A apo-HasAp also follow a hyperbolic dependence on apo 
protein concentration as seen with the Y75A variant, but the curve for H83A rises quicker and 
achieves a lower plateau indicating lower Kd and kcoord1 values (Figure 4.10).  Compared to wt 
HasAp, the H83A substitution does not appear to change the Kd value, but kcoord1 is lowered 5-
fold. In contrast, the kcoord2 value is increased ~4 fold in the H83A variant compared to wt-HasAp 
(Table 4.2).  
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Figure 4.10.   lots of observed rate constants vs apo-HasAp concentration.  Spectroscopic experiments were 
performed by our collaborators Dr. Hirotoshi Matsumura and Dr.  ierre Mo nne-Loccoz at Oregon Health and 
Science University (OHSU),  ortland, Oregon, USA. Figure adapted from reference [30]. 
 
4.3.6 The millisecond intermediate in Y75A is likely coordinated by His83, while in H83A, 
Y75 is the likely axial ligand to the hemin iron.  
Rapid freeze quench resonance Raman (RFQ-RR) experiments were performed in an 
effort to characterize the millisecond intermediate heme-protein complexes in Y75A- and H83A-
HasAp.  The high-frequency RR spectrum of the 6-ms RFQ sample of Y75A shows porphyrin 
modes indicative of a mixture of 5cHS and 6cHS species with 3 modes at 1492 and 1481 cm
-1
, 
respectively (Figure 4.11-A).  High-spin heme iron (III) species with O-atom axial coordination 
typically exhibit intense 3 modes relative to the 4 and 2 modes [18, 48-54], and the high 3/4, 
2 intensity ratio observed in the RFQ-RR spectra of the millisecond intermediate formed in wt-
HasAp supported the notion that Y75 is the first coordinating ligand to the iron (III) [26].  In 
contrast, the RR spectra of the 6-ms samples of Y75A show weak 3 relative to the 2 and 4 
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modes which suggest that the initial coordination to the iron (III) involves an endogenous ligand, 
presumably His83, rather than a solvent molecule.  Over time, these high-spin contributions are 
replaced by 6cLS modes with 3 and 2 at 1505 and 1582 cm
-1
, respectively.  On the basis of the 
crystal structure of Y75A holo-HasAp, we assign this transition to the closure of the H32 loop on 
the heme pocket and intercalation of a solvent molecule between the heme iron (III) and His83. 
The high-frequency RR spectra of the 6-ms RFQ sample of H83A exhibit 4, 3, and 2 
modes at 1374, 1493, and 1572 cm
-1
 that are characteristic of a pure 5cHS species with an O-
atom axial ligand; they are analogous to but spectrally distinguishable from free hemin (Figure 
4.11-B).  These 5cHS porphyrin skeletal modes are also different from the 5cHS signals 
observed in the 6-ms RFQ sample of wt HasAp (Figure 4.11-C).  Longer reaction times allow for 
the conversion of this 5-coordinate complex to a mixture of 6cHS and 6cLS heme conformers. 
Attempts to detect vibrational modes involving iron (III) axial ligands, such as tyrosinate modes 
or (Fe‐OH) modes using off-Soret excitation and 18OH2/D2O solvent exchange were 
unsuccessful for both the Y75A and H83A variants. 
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Figure 4.11.  High-frequency RR spectra of RFQ samples of the reaction of 1 equivalent of hemin with (A) Y75A 
and (B) H83A apo-HasAp (protein concentration after mixing is 300 M; excitation wavelength 406 nm; all spectra 
are normalized to the intensity of the 4 feature observed between 1371 and 1377 cm
-1
). (C) RR spectra of 6-ms 
RFQ samples.  Spectroscopic experiments were performed by our collaborators Dr. Hirotoshi Matsumura and Dr. 
 ierre Mo nne-Loccoz at Oregon Health and Science University (OHSU),  ortland, USA.  Figure adapted from 
reference [30]. 
 
 
4.4 Discussion 
4.4.1 Y75A and H83A Substitutions do not affect the Structure of Holo-HasAp.  
Previous investigations of the process of hemin loading onto HasAp showed that within 
20 ms hemin binds first to the Y75 loop. This rapid process, which is believed to include the 
coordination of Tyr75 to the heme iron, is followed by a slower reorganization of the H32 loop 
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and coordination of the heme by His32, which occurs within ~ 1 s at 4 C [14, 26].  In contrast to 
the large rearrangement of the His32-bearing loop, the Y75 loop retains its structure in the apo- 
and holo-forms of the hemophore.  The structural conservation includes the Tyr75 Oη to His83 
Nδ hydrogen bond, which is thought to play a pivotal role in hemin binding by increasing the 
phenolate character of Tyr75 axial ligand and enabling it to coordinate the ferric ion in hemin.  
Yet, our high-resolution crystal structures of the Y75A and H83A holo-HasAp mutants are 
remarkably similar to that of wt holo-HasAp. In particular, in all three H83A holo-HasAp 
structures the heme iron is coordinated by both His32 and Tyr75 and the structure of the Y75 
loop is unaltered relative to wt holo-HasAp (see Figures 4.3 and 4.5).  Interestingly, the void left 
by the His83-to-Ala substitution is filled by a water molecule in the H83A
ortho
 structure at pH 6.5 
and in the structure at pH 5.4, and this crystallographically defined water molecule is hydrogen 
bonded to the phenol oxygen of the coordinated Tyr75.  In the H83A
mono
 structure the same void 
is filled with an ethylene glycol molecule that acts as a hydrogen bond partner to the coordinated 
Tyr75.  It is also noteworthy that the side chain of Tyr75 remains coordinated to heme, even at 
pH 5.4, despite the absence of the His83 side chain.  Clearly, these observations demonstrate that 
His83 and the Tyr75 Oη to His83 Nδ hydrogen bond are not essential for maintaining the 
integrity of the heme-binding pocket in holo-HasAp or the coordination of hemin-iron by Tyr75.  
In the Y75A holo-HasAp structure we observed well defined elongated electron density below 
the hemin iron, which was modeled as a formate ion (Figure 4.5A); as indicated above, the most 
likely source of this formate ion is our hemin stock.  Nevertheless, the structure of the loop, 
including the position of the His83 side chain, is superimposable with that observed in the Y75 
loop of holo wt HasAp, suggesting that in the absence of formate, the heme iron is coordinated to 
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a water molecule and His32, as has been suggested on the basis of spectroscopic studies with 
holo-Y75A HasAsm [27].   
4.4.2 Partially Disordered Y75 loop in the variant apo proteins.  
In contrast to the success we experienced growing single crystals of wt, Y75A and H83A 
holo-HasAp, we were unable to grow crystals of the apo form of these variant proteins despite 
extensive screening of conditions. Because we suspected conformational disorder as the reason 
hindering crystal growth, we turned to solution NMR and obtained the sequential backbone 
assignments of wt, Y75A and H83A apo-HasAp. As expected, the NMR spectra of wt apo-
HasAp are consistent with a well-ordered structure, which is in agreement with the well-defined 
electron density defining its X-ray crystal structure [14].  The HSQC spectra of apo-Y75A or 
apo-H83A HasAp are nearly identical to the HSQC spectrum of their wt counterpart. Detailed 
inspection, however, reveals that several cross peaks corresponding to residues in the Y75 loop, 
helix α2 and several β strands in Y75A and H83A apo-HasAp are affected by conformational 
disorder (see Figure 4.9).  The crystal structure of wt apo-HasAp (Figure 4.12) shows that Tyr75 
and His83 are involved in several hydrogen bonding and hydrophobic interactions within the 
loop.  Figure 4.12-A shows the hydrogen bond between the phenol oxygen of Tyr75 and the Nδ 
of His83, as well as the hydrogen bonds between the carbonyl oxygen of His83 and the side 
chains of Arg129 and His134 in α2, and the Leu85 carbonyl to His134 NH hydrogen bond, 
which mediate interactions between the Y75 loop and helix α2.  Also apparent is a group of 
hydrophobic interactions (Figure 4.12-B) that include the hydrophobic portions of the Tyr75 and 
His83 side chains, helix α2 (Met141), strands β5 (Leu85), β4 (Leu73), β3 (Tyr56), β2 ( he46), 
and the hairpin loop connecting β2 and β3 ( he51).  This extensive and intricate network of H-
bonding and hydrophobic interactions which propagates into a significant portion of the structure 
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stabilizes the structure of the Y75 loop in the apo-protein, but replacing Tyr75 or His83 with Ala 
results in conformational disorder of the Y75 loop in apo-HasAp. 
 
 
Figure 4.12.  Close-up view of wt apo-HasAp ( DB: 3MOK) (A) hydrophilic and (B) hydrophobic interactions 
emanating from the Tyr75 loop into helix α2 and nearby β strands.  β-strands are shown in magenta, α-helices in 
cyan and the Tyr75 loop in orange, with corresponding residues in stick representation. Figure adapted from 
reference [30]. 
 
4.4.3 Formation of Distinct Millisecond Intermediates in the Mutants 
The relatively severe changes introduced to the Y75 loop and concomitant 
conformational disorder into neighboring structural domains in Y75A and H83A apo-HasAp is 
likely to result in initial distribution of [apo-HasAp●hemin] sub-states during the process of 
hemin loading. However, rapid interconversion between these [apo-HasAp●hemin] sub-states is 
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likely to take place, and the conformational disorder observed in Y75A and H83A apo-HasAp 
does not dramatically impact the rates of hemin loading in the variants compared to the wt 
protein (Table 4.2). Both variants show Kd values for the initial [apo-HasAp●hemin] complex in 
the same micromolar range as the wt protein, and the first coordination event defined by kcoord1 
occurs in similar timeframes for all three proteins. The variants show slightly higher kcoord2 than 
the wt, but here again the differences are small. 
In contrast, the RFQ-RR analyses of the two variant proteins clearly reveal that they form 
distinct millisecond intermediates. In Y75A, the intermediate shows intensity ratio between 4 
and 3 porphyrin skeletal modes consistent with coordination of His83 to the heme iron before 
closure of the H32 loop, coordination of H32 and displacement of the H83 ligand by a water 
molecule; coordination of His 32 and rearrangement at the Fe-His83 site are not kinetically 
resolved and are possibly coupled events. In comparison, the RFQ-RR spectrum of the 
intermediate in H83A supports iron coordination by an O-atom, either from solvent or from 
Tyr75, before coordination of the second axial ligand, His32. Importantly, despite these 
differences in coordination geometry in the [HasAp-hemin] millisecond intermediates of the 
variant and wt proteins, all three proteins follow equivalent kinetic profiles. 
We have previously proposed that π-π stacking interactions between residues in the Y75 
loop and hemin contribute significantly to a “sticky” hydrophobic platform that facilitates hemin 
capture [14, 16].  Within this framework, the Tyr75 Oη to His83 Nδ hydrogen bond contributes to 
the hemin loading process by positioning the Tyr Oη to coordinate the heme iron (Figure 4.13).  
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Figure 4.13.  Zoomed-in view of the Y75 loop in wild type holo-HasAp ( DB: 3 LL) illustrating the hydrophobic 
and π-stacking interactions between the Y75 and H83 side chains with the heme. Figure adapted from reference 
[30]. 
 
In absence of a Tyr75 Oη to His83 Nδ hydrogen bond in the apo-Y75A mutant, the 
conformational disorder of residues in the Y75 loop may permit coordination of the incoming 
hemin by His83. Subsequent scission of the His83-Fe coordination bond and movement of the 
His83 side chain away from the iron and toward its position in the structure of wt holo-HasAp, is 
likely a consequence of loop reorganization driven by the establishment of productive π-π 
stacking and hydrophobic interactions between hemin and side-chains in the Y75-loop.  
Isothermal titration calorimetry measurements with HasAsm revealed ≈ 250- and ≈ 400-fold 
decrease in heme affinity in the H83A and Y75A variants relative to the wt protein [32].  Our 
pre-steady state measurements show that these mutations have little impact on the formation 
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rates of holoproteins and therefore suggest that changes in binding affinity primarily reflect 
increases in dissociation rates. Consequently, the data suggest that axial ligation plays a 
prominent role in slowing hemin loss from the hemophore, but the on-rate of hemin loading onto 
the apo hemophore is governed by non-covalent hydrophobic interactions. In this context, the 
changes in Kd and kcoord1 observed with the Y75A and H83A variants relative to wt HasAp likely 
reflect changes in hydrophobic and π-π stacking interactions between the porphyrin macrocycle 
and the Y75 loop. Hence, the data at hand suggest that HasA hemophores utilize hydrophobic 
interactions to capture hemin while controlling its release via the heme iron axial coordination. 
Future studies aimed at dissecting the thermodynamics and kinetics of hemin capture and release 
with complementary variants, such as Y75F and H83F, Y75F/H83F, and Y75A/H83A will 
contribute to establish this mechanistic model.  
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5.1 Epilogue 
The nutritional requirement of iron in opportunistic pathogens has been established for 
growth and successful colonization in vertebrate hosts [1].  However, the extremely low 
availability of free iron in the host cells poses a significant challenge for bacteria to fulfill their 
metabolic needs.  To combat the challenging environment, bacteria have evolved sophisticated 
mechanisms to scavenge iron and circumvent host iron sequestration mechanisms.  
One such sophisticated mechanism is by deploying the has (heme acquisition system) 
system comprised of a hemophore (HasA, heme binding protein) and an outer membrane 
receptor HasR [1].  Hemophores have been structurally and biochemically characterized from 
Pseudomonas aeruginosa (HasAp), Yersinia pestis (HasAyp) and Serratia marcescens (HasAs).  
Under iron limiting conditions, hemophores are secreted in the host which binds heme and 
shuttles it to the outer membrane receptor for subsequent internalization.  Once in the cytoplasm, 
the heme macrocycle is broken down by the heme oxygenase to release iron which is then either 
stored or used as an essential nutrient [2].   
Because of the fact that iron is required for growth and pathogenicity [3], infections 
caused by bacteria could be minimized or even stopped at an early stage by limiting or depriving 
the organism of iron.  To limit the progression of infection, it is essential to understand the 
mechanism of iron/heme uptake and the structural-functional relationship of various proteins that 
are activated during the process.  The insights from the structural aspects will help to better 
understand and design inhibitors/drugs which would specifically target and inhibit the heme 
acquisition from the host cells, thus curbing the progression of disease.   
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In order to better understand the structural and functional relationship, we carried out our 
investigations by characterizing a novel hemophore structure from Yersinia pestis using 
analytical tools and had the opportunity to discover new findings about this protein.  Further, 
new structural features are identified by replacing a single residue Arg33 to Alanine in HasA 
from Pseudomonas aeruginosa.  The findings and discoveries from experimental data are 
summarized below. 
5.1.1 Heme Binding Protein from Yersinia pestis (HasAyp) was Over-expressed, Purified and 
Crystallized 
 A synthetic gene encoding for a full-length HasAyp protein was cloned in E. coli.  The 
protein was overexpressed and purified using a previously developed protocol [4] with 
modifications.  Purification of full-length protein resulted in mixture of apo- and holo-protein 
truncated at C-terminus.  Following this, a gene encoding for the truncated HasAyp (full-length – 
12) residues was constructed by placing a stop codon after Val193.  The truncated HasAyp was 
purified to homogeneity was analyzed by electrospray ionization mass spectrometry (Chapter II). 
 Crystals were obtained for apo- and holo-HasAyp (full length - 12) from various 
conditions.  The crystals for apo-form grew from seventy six unique conditions and for holo-
form from eight unique conditions.  The initial diffraction data was collected in-house and the 
model was built using various crystallographic software packages.   
5.1.2 Novel Structure of the Apo- and Holo-HasAyp with Fast Kinetics of Heme Loading 
The crystal structure of HasAyp, (apo- and holo-form) shows a unique structure which is 
different from previously characterized hemophores from P. aeruginosa [4, 5] and S. marcescens 
[6, 7].  The heme ion ion is only coordinated by one protein provided ligand, Tyr75 from the 
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Y75 loop.  The distal Q32 loop in the apo-HasAyp is already in closed conformation and does not 
coordinate heme iron ion upon heme loading.  Kinetic analysis suggests that heme loading is fast 
compared to the HasAp and is completed within millisecond time scale with minimum structural 
reorganization.   
 
5.2.1 Arg33 in Apo-HasAp Anchors the H32 Loop in Open Conformation 
 Differences in the distal loop (H32 in HasAp and Q32 in HasAyp) organization lead to 
investigate the open H32 loop in HasAp.  Detailed structural analysis of wt apo-HasAp protein 
points to a unique position of Arginine at position 33 networked with salt bridges and H-bond 
interactions.  Arg33 was replaced with an Alanine at the same position with a hypothesis that it 
anchors the H32 loop in the open position.   
 R33A apo- and holo proteins were expressed, purified and screened for crystal growth.  
Apo-protein crystals were obtained after 43 days and holo-protein crystals were obtained after 72 
hours (Chapter III).   
5.2.2 Replacing Arg33 to Alanine in H32 Loop in Apo-HasAp Leads to Closure of the H32 
Loop 
The superimposed HSQC spectrum of wt apo- and R33A apo-protein shows completely 
different set of cross-peaks suggesting that H32 loop might be organized differently compared to 
the wt apo-protein, whereas upon heme reconstitution, the HSQC spectrum shows the cross 
peaks matched for the wt holo- and R33A holo-proteins.  This observation was structurally 
supported by the crystal structure of R33A apo-protein which showed that the H32 loop adopts a 
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conformation which is very similar to the wt holo-HasAp.  Moreover, the hinge regions in the 
H32 loop are already in a conformation which is superimposable with the conformation in the wt 
holo-HasAp.  Further, results from molecular dynamics simulations provide additional insights 
and shows the loop is indeed adopts a closed form similar to the wt holo-HasAp.  An interesting 
feature of the mutant holo-protein is the heme binding to the polypeptide.  This is the first 
observation of dual binding of the heme molecule to mutant HasAp protein.  From the available 
structural data, we conclude that a single Arginine at position 33 in the HasAp is the anchor 
residue holding the H32 loop in the open position and replacing it with Alanine shifts the loop in 
a conformation which is similar to the wt holo-protein.   
  
5.3.1 Severe Changes in the Axial Ligands Minimally Affect Heme Acquisition in HasAp 
from P. aeruginosa 
 Hydrogen bond between Tyr75 and His83 in the Y75 loop is proposed to modulate the 
Tyr75-Fe
3+
 coordination [7].  To investigate the role played by the hydrogen bond in 
coordinating heme iron, Tyr75 and His83 were replaced by Alanine in two separate sets of 
experiments.  Mutated proteins were purified, heme reconstituted and set up for crystal 
screening.  For the apo-proteins solution NMR experiments were carried out to probe disorder in 
the Y75 loop.   
5.3.2 Overall the Structure of Mutant Holo-Proteins is Similar to the Wt Holo-HasAp  
 Despite the severe changes introduced in the Y75 loop by replacing Tyr75 and His83 to 
alanine, the mutant holo-proteins show a high degree of similarity to the wt holo-protein.  High 
resolution crystal structures obtained for Y75A do not show His83 coordinating the hemin-iron 
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from the Y75 loop, instead a formate ion was modeled which occupies a similar position as of 
Tyr75 in the wt protein.  The plane of formate ion is aligned with the α-γ-meso axis of heme 
which allows the oxygen atom from formate ion to coordinate the heme iron ion.  Similarly, all 
the three high resolution crystal structures obtained for the H83A mutants shows that the heme 
iron is coordinated by both His32 and Tyr75 and the structure of Y75 loop is almost identical to 
that of wt holo-HasAp.  In the absence of His83, in two of the structures (H83A
ortho
 and 
H83A
pH5.4
), a water molecule occupies the site which would be normally be occupied by the side 
chain of His83 in the wt holo-protein.  This crystallographic water molecule is hydrogen bonded 
to the phenol oxygen of the coordinated Tyr75.  In the H83A
mono
 structure, the same position is 
occupied by an ethylene glycol molecule that acts as a hydrogen bond partner to the coordinated 
Tyr75.   
5.3.3 Y75 Loop is Disorder in the Mutant Apo-Proteins 
 Sequential backbone assignments of the wt, Y75A and H83A HasAp were obtained.  The 
NMR spectra of wt apo-protein were consistent with a well-ordered structure which was also 
complemented with the high resolution X-ray crystal structure.  The HSQC spectra of Y75A and 
H83A apo-proteins are nearly identical to the wt apo-protein, however, a closer inspection 
reveals several cross peaks, corresponding to residues in Y75 loop, are conformationally 
disordered in Y75A and H83A apo-protein.  Moreover, the conformational disorder propagates 
to the nearby secondary structural elements like helix α2, and several β-strands.  Replacing 
Tyr75 and His83 to alanine results in the loss of several stabilizing network of H-bonds and 
hydrophobic interaction, which otherwise kept the Y75 loop in a stable conformation in the wt 
apo-HasAp.   
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5.3.4 Heme Capture is Driven by Hydrophobic Interactions 
 Combining the structural and kinetic data suggests that heme capture is mainly driven by 
hydrophobic and  stacking interactions which are favored by the “sticky” hydrophobic 
platform provided by the Y75 loop while controlling its release via the heme-iron axial 
coordination.   
 
5.2 Future Directions 
 In the current study, we were able to show our novel findings and important results 
understanding the hemophore structures and heme loading mechanisms in Pseudomonas 
aeruginosa and Yersinia pestis.  Differences in the distal loop structure in HasAyp and HasAp 
would suggest differences in interactions and mechanisms of heme delivery to the cognate 
receptor on the bacterial outer membrane.  One of the future directions would be the study of 
hemophores with their cognate receptor.  Further, studies could be aimed at understanding the 
kinetics and thermodynamics of heme capture and release in variants like R33A and double 
mutants of Y75A/H83A, Y75F/H83A HasAp. 
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Appendices 
 Appendix I: Index HT protein crystallization screen (Hampton Research) 
A1.   0.1 M Citric acid pH 3.5, 2.0 M Ammonium sulfate   
A2.   0.1 M Sodium acetate trihydrate pH 4.5, 2.0 M Ammonium sulfate 
A3.   0.1 M BIS-TRIS pH 5.5, 2.0 M Ammonium sulfate    
A4.   0.1 M BIS-TRIS pH 6.5, 2.0 M Ammonium sulfate     
A5.   0.1 M HEPES pH 7.5, 2.0 M Ammonium sulfate     
A6.   0.1 M Tris pH 8.5, 2.0 M Ammonium sulfate     
A7.   0.1 M Citric acid pH 3.5, 3.0 M Sodium chloride    
A8.   0.1 M Sodium acetate trihydrate pH 4.5, 3.0 M Sodium chloride    
A9.   0.1 M BIS-TRIS pH 5.5, 3.0 M Sodium chloride    
A10.  0.1 M BIS-TRIS pH 6.5, 3.0 M Sodium chloride   
A11.  0.1 M HEPES pH 7.5, 3.0 M Sodium chloride    
A12.  0.1 M Tris pH 8.5, 3.0 M Sodium chloride    
B1.   0.1 M BIS-TRIS pH 5.5, 0.3 M Magnesium formate dihydrate    
B2.   0.1 M BIS-TRIS pH 6.5, 0.5 M Magnesium formate dihydrate    
B3.   0.1 M HEPES pH 7.5, 0.5 M Magnesium formate dihydrate    
B4.   0.1 M Tris pH 8.5, 0.3 M Magnesium formate dihydrate    
B5.   1.4 M Sodium phosphate monobasic monohydrate/Potassium phosphate dibasic pH 5.6 
B6.   1.4 M Sodium phosphate monobasic monohydrate/Potassium phosphate dibasic pH 6.9 
B7.   1.4 M Sodium phosphate monobasic monohydrate/Potassium phosphate dibasic pH 8.2 
B8.   0.1 M HEPES pH 7.5, 1.4 M Sodium citrate tribasic dihydrate    
B9.   1.8 M Ammonium citrate tribasic pH 7.0    
B10.  0.8 M Succinic acid pH 7.0    
B11.  2.1 M DL-Malic acid pH 7.0   
B12.  2.8 M Sodium acetate trihydrate pH 7.0    
C1.   3.5 M Sodium formate pH 7.0    
C2.   1.1 M Ammonium tartrate dibasic pH 7.0    
C3.   2.4 M Sodium malonate pH 7.0    
C4.   35% v/v Tacsimate pH 7.0    
C5.   60% v/v Tacsimate pH 7.0   
C6.   0.1 M Sodium chloride, 0.1 M BIS-TRIS pH 6.5, 1.5 M Ammonium sulfate    
C7.  0.8 M Potassium sodium tartrate tetrahydrate, 0.1 M Tris pH 8.5, 0.5% w/v Polyethylene glycol monomethyl ether 5,000    
C8.   1.0 M Ammonium sulfate, 0.1 M BIS-TRIS pH 5.5, 1% w/v Polyethylene glycol 3,350    
C9.   1.1 M Sodium malonate pH 7.0, 0.1 M HEPES pH 7.0, 0.5% v/v Jeffamine ED-2001 pH 7.0    
C10.  1.0 M Succinic acid pH 7.0, 0.1 M HEPES pH 7.0, 1% w/v Polyethylene glycol monomethyl ether 2,000    
C11.  1.0 M Ammonium sulfate , 0.1 M HEPES pH 7.0, 0.5% w/v Polyethylene glycol 8,000   
C12.  15% v/v Tacsimate pH 7.0, 0.1 M HEPES pH 7.0, 2% w/v Polyethylene glycol 3,350    
D1.   25% w/v Polyethylene glycol 1,500   
D2.   0.1 M HEPES pH 7.0, 30% v/v Jeffamine M-600 pH 7.0    
D3.   0.1 M HEPES pH 7.0, 30% v/v Jeffamine ED-2001 pH 7.0    
D4.   0.1 M Citric acid pH 3.5, 25% w/v Polyethylene glycol 3,350   
D5.   0.1 M Sodium acetate trihydrate pH 4.5, 25% w/v Polyethylene glycol 3,350    
D6.   0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350   
D7.   0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350   
D8.   0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350   
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D9.   0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
D10.  0.1 M BIS-TRIS pH 6.5, 20% w/v Polyethylene glycol monomethyl ether 5,000    
D11.  0.1 M BIS-TRIS pH 6.5, 28% w/v Polyethylene glycol monomethyl ether 2,000    
D12.  0.2 M Calcium chloride dihydrate, 0.1 M BIS-TRIS pH 5.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol    
E1.   0.2 M Calcium chloride dihydrate, 0.1 M BIS-TRIS pH 6.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol    
E2.   0.2 M Ammonium acetate, 0.1 M BIS-TRIS pH 5.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol   
E3.   0.2 M Ammonium acetate, 0.1 M BIS-TRIS pH 6.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol    
E4.   0.2 M Ammonium acetate, 0.1 M HEPES pH 7.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol    
E5.   0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 45% v/v (+/-)-2-Methyl-2,4-pentanediol    
E6.   0.05 M Calcium chloride dihydrate, 0.1 M BIS-TRIS pH 6.5, 30% v/v Polyethylene glycol monomethyl ether 550    
E7.   0.05 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 30% v/v Polyethylene glycol monomethyl ether 550    
E8.   0.2 M Potassium chloride, 0.05 M HEPES pH 7.5, 35% v/v Pentaerythritol propoxylate (5/4 PO/OH)   
E9.   0.05 M Ammonium sulfate , 0.05 M BIS-TRIS pH 6.5, 30% v/v Pentaerythritol ethoxylate (15/4 EO/OH)   
E10.  0.1 M BIS-TRIS pH 6.5, 45% v/v Polypropylene glycol P 400   
E11.  0.02 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 22% w/v Polyacrylic acid sodium salt 5,100   
E12.  0.01 M Cobalt(II) chloride hexahydrate, 0.1 M Tris pH 8.5, 20% w/v Polyvinylpyrrolidone K 15  
F1.   0.2 M L-Proline, 0.1 M HEPES pH 7.5, 10% w/v Polyethylene glycol 3,350    
F2.   0.2 M Trimethylamine N-oxide dihydrate, 0.1 M Tris pH 8.5, 20% w/v Polyethylene glycol monomethyl ether 2,000    
F3.   5% v/v Tacsimate pH 7.0, 0.1 M HEPES pH 7.0, 10% w/v Polyethylene glycol monomethyl ether 5,000    
F4.   0.005 M Cobalt(II) chloride hexahydrate, 0.005 M Nickel(II) chloride hexahydrate, 0.005 M Cadmium chloride hydrate, 
0.005 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 12% w/v Polyethylene glycol 3,350    
F5.   0.1 M Ammonium acetate, 0.1 M BIS-TRIS pH 5.5, 17% w/v Polyethylene glycol 10,000    
F6.   0.2 M Ammonium sulfate, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350    
F7.   0.2 M Ammonium sulfate, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350    
F8.   0.2 M Ammonium sulfate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350    
F9.   0.2 M Ammonium sulfate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
F10.  0.2 M Sodium chloride, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350   
F11.  0.2 M Sodium chloride, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350    
F12.  0.2 M Sodium chloride, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350    
G1.   0.2 M Sodium chloride, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
G2.   0.2 M Lithium sulfate monohydrate, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350    
G3.   0.2 M Lithium sulfate monohydrate, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350    
G4.   0.2 M Lithium sulfate monohydrate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350   
G5.   0.2 M Lithium sulfate monohydrate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
G6.   0.2 M Ammonium acetate, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350   
G7.   0.2 M Ammonium acetate, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350    
G8.   0.2 M Ammonium acetate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350    
G9.   0.2 M Ammonium acetate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
G10.  0.2 M Magnesium chloride hexahydrate, 0.1 M BIS-TRIS pH 5.5, 25% w/v Polyethylene glycol 3,350    
G11.  0.2 M Magnesium chloride hexahydrate, 0.1 M BIS-TRIS pH 6.5, 25% w/v Polyethylene glycol 3,350    
G12.  0.2 M Magnesium chloride hexahydrate, 0.1 M HEPES pH 7.5, 25% w/v Polyethylene glycol 3,350    
H1.   0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5, 25% w/v Polyethylene glycol 3,350    
H2.   0.2 M Potassium sodium tartrate tetrahydrate, 20% w/v Polyethylene glycol 3,350    
H3.   0.2 M Sodium malonate pH 7.0, 20% w/v Polyethylene glycol 3,350    
H4.   0.2 M Ammonium citrate tribasic pH 7.0, 20% w/v Polyethylene glycol 3,350    
H5.   0.1 M Succinic acid pH 7.0, 15% w/v Polyethylene glycol 3,350    
H6.   0.2 M Sodium formate, 20% w/v Polyethylene glycol 3,350   
H7.   0.15 M DL-Malic acid pH 7.0, 20% w/v Polyethylene glycol 3,350    
H8.   0.1 M Magnesium formate dihydrate, 15% w/v Polyethylene glycol 3,350    
H9.   0.05 M Zinc acetate dihydrate, 20% w/v Polyethylene glycol 3,350    
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H10.  0.2 M Sodium citrate tribasic dihydrate, 20% w/v Polyethylene glycol 3,350    
H11.  0.1 M Potassium thiocyanate, 30% w/v Polyethylene glycol monomethyl ether 2,000    
H12.  0.15 M Potassium bromide, 30% w/v Polyethylene glycol monomethyl ether 2,000    
 
 
 
Appendix II: pH buffer protein crystallization screen (Rigaku) 
1M Sodium 
Lactate / HCl 
A1  2.4 B1 2.8 C1 3.2 D1 3.6 E1 4.0 F1 4.4 G1 4.8 H1 5.2 
1M Sodium 
Acetate / 
Acetic Acid 
A2 3.4 B2 3.8 C2 4.2 D2 4.6 E2 5.0 F2 5.4 G2 5.8 H2 6.2 
1M MES / 
NaOH 
A3 4.6 B3 5.0 C3 5.4 D3 5.8 E3 6.2 F3 6.6 G3 7.0 H3 7.4 
1M Bis-Tris / 
HCl 
A4 5.2 B4 5.6 C4 6.0 D4 6.4 E4 6.8 F4 7.2 G4 7.6 H4 8.0 
1M Imidazole / 
HCl 
A5 5.4 B5 5.8 C5 6.2 D5 6.6 E5 7.0 F5 7.4 G5 7.8 H5 8.2 
1M K2HPO4/ 
NaH2PO4 
A6 5.8 B6 6.2 C6 6.6 D6 7.0 E6 7.4 F6 7.8 G6 8.2 H6 8.6 
1M HEPES / 
NaOH 
A7 6.0 B7 6.4 C7 6.8 D7 7.2 E7 7.6 F7 8.0 G7 8.4 H7 8.8 
1M Tris / HCl A8 6.6 B8 7.0 C8 7.4 D8 7.8 E8 8.2 F8 8.6 G8 9.0 H8 9.4 
1M Bicine / 
NaOH 
A9 7.0 B9 7.4 C9 7.8 D9 8.2 E9 8.6 F9 9.0 G9 9.4 H9 9.8 
0.5M CHES / 
NaOH 
A10 8.0 B10 8.4 C10 8.8 D10 9.2 E10 9.6 F10 10.0 G10 10.4 H10 10.8 
1M Glycine / 
NaOH 
A11 8.2 B11 8.6 C11 9.0 D11 9.4 E11 9.8 F11 10.2 G11 10.6 H11 11.0 
0.5M CAPS / 
NaOH 
A12 8.8 B12 9.2 C12 9.6 D12 10.0 E12 10.4 F12 10.8 G12 11.2 H12 11.6 
All formulations are made with ultrapure ASTM Type I water and sterile-filtered stock solutions.  Store at 4-25 °C 
 
 
 
Appendix III: Crystal screen (Hampton Research) 
1.    0.02 M Calcium chloride dihydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v (+/-)-2-Methyl-2,4-
pentanediol 
2.   0.4 M  otassium sodium tartrate tetrahydrate 
3.   0.4 M Ammonium phosphate monobasic 
4.   0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium sulfate 
5.   0.2 M Sodium citrate tribasic dihydrate, 0.1 M H   S sodium pH 7.5, 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
6.   0.2 M Magnesium chloride hexahydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 4,000 
7.   0.1 M Sodium cacodylate trihydrate pH 6.5, 1.4 M Sodium acetate trihydrate 
8.   0.2 M Sodium citrate tribasic dihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% v/v 2- ropanol 
9.   0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% w/v  olyethylene glycol 4,000 
10. 0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v  olyethylene glycol 4,000 
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11.  0.1 M Sodium citrate tribasic dihydrate pH 5.6, 1.0 M Ammonium phosphate monobasic 
12. 0.2 M Magnesium chloride hexahydrate, 0.1 M H   S sodium pH 7.5, 30% v/v 2- ropanol 
13. 0.2 M Sodium citrate tribasic dihydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% v/v  olyethylene glycol 400 
14. 0.2 M Calcium chloride dihydrate, 0.1 M H   S sodium pH 7.5, 28% v/v  olyethylene glycol 400 
15. 0.2 M Ammonium sulfate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% w/v  olyethylene glycol 8,000 
16. 0.1 M H   S sodium pH 7.5, 1.5 M Lithium sulfate monohydrate 
17. 0.2 M Lithium sulfate monohydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 4,000 
18. 0.2 M Magnesium acetate tetrahydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 20% w/v  olyethylene 
glycol 8,000 
19. 0.2 M Ammonium acetate, 0.1 M TRIS hydrochloride pH 8.5, 30% v/v 2- ropanol 
20. 0.2 M Ammonium sulfate, 0.1 M Sodium acetate trihydrate pH 4.6, 25% w/v  olyethylene glycol 4,000 
21.  0.2 M Magnesium acetate tetrahydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% v/v (+/-)-2-Methyl-
2,4-pentanediol 
22. 0.2 M Sodium acetate trihydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 4,000 
23. 0.2 M Magnesium chloride hexahydrate, 0.1 M H   S sodium pH 7.5, 30% v/v  olyethylene glycol 400 
24. 0.2 M Calcium chloride dihydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 20% v/v 2- ropanol 
25. 0.1 M Imidazole pH 6.5, 1.0 M Sodium acetate trihydrate 
26. 0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% v/v (+/-)-2-Methyl-2,4-
pentanediol 
27. 0.2 M Sodium citrate tribasic dihydrate, 0.1 M H   S sodium pH 7.5, 20% v/v 2- ropanol 
28. 0.2 M Sodium acetate trihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% w/v  olyethylene glycol 
8,000 
29. 0.1 M H   S sodium pH 7.5, 0.8 M  otassium sodium tartrate tetrahydrate 
30. 0.2 M Ammonium sulfate, 30% w/v  olyethylene glycol 8,000 
31.  0.2 M Ammonium sulfate, 30% w/v  olyethylene glycol 4,000 
32. 2.0 M Ammonium sulfate 
33. 4.0 M Sodium formate 
34. 0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Sodium formate 
35. 0.1 M H   S sodium pH 7.5, 0.8 M Sodium phosphate monobasic monohydrate, 0.8 M  otassium phosphate 
monobasic 
36. 0.1 M TRIS hydrochloride pH 8.5, 8% w/v  olyethylene glycol 8,000 
37. 0.1 M Sodium acetate trihydrate pH 4.6, 8% w/v  olyethylene glycol 4,000 
38. 0.1 M H   S sodium pH 7.5, 1.4 M Sodium citrate tribasic dehydrate 
39. 0.1 M H   S sodium pH 7.5, 2% v/v  olyethylene glycol 400, 2.0 M Ammonium sulfate 
40  0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2- ropanol, 20% w/v  olyethylene glycol 4,000 
41.  0.1 M H   S sodium pH 7.5, 10% v/v 2- ropanol, 20% w/v  olyethylene glycol 4,000 
42. 0.05 M  otassium phosphate monobasic, 20% w/v  olyethylene glycol 8,000 
43. 30% w/v  olyethylene glycol 1,500 
44. 0.2 M Magnesium formate dehydrate 
45. 0.2 M Zinc acetate dihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 18% w/v  olyethylene glycol 8,000 
46. 0.2 M Calcium acetate hydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5 , 18% w/v  olyethylene glycol 8,000 
47. 0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Ammonium sulfate 
48. 0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic 
49. 1.0 M Lithium sulfate monohydrate, 2% w/v  olyethylene glycol 8,000 
50. 0.5 M Lithium sulfate monohydrate, 15% w/v  olyethylene glycol 8,000 
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Appendix IV: Wizard IV protein crystallization screen (Rigaku) 
Tube Precipitation Reagent Buffer Salt Detergent 
1 16% (w/v)     8000  40 mM  otassium 
phosphate dibasic 
20% (v/v) 
Glycerol 
2 5% (v/v) M D 100 mM Tris base/ 
Hydrochloric acid pH 8.0 
100 mM Sodium 
chloride 
15% (v/v) 
Reagent alcohol 
3 5% (w/v)     1000 100 mM Sodium phosphate 
dibasic / Citric acid pH 4.2 
 40% (v/v) 
Reagent alcohol 
4  100 mM Bis Tris/ 
Hydrochloric acid pH 5.5 
200 mM 
Ammonium 
sulfate 
 
5 2% (v/v)     400 100 mM Sodium acetate/ 
Acetic acid pH 5.5 
2000 mM 
Ammonium 
sulfate 
 
6  100 mM Sodium citrate/ 
Citric acid pH 4.0 
800 mM 
Ammonium 
sulfate 
 
7 2000 mM Lithium sulfate 100 mM Sodium acetate/ 
Acetic acid pH 4.5 
100 mM 
Magnesium 
sulfate 
5% (v/v) 2-
Propanol 
8 2% (v/v)     400 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
2000 mM Lithium 
sulfate 
 
9 5% (v/v)     400 100 mM Sodium acetate/ 
Acetic acid pH 5.5 
2000 mM Lithium 
sulfate 
100 mM 
Magnesium 
sulfate 
10 50% (v/v)     200 100 mM Sodium 
cacodylate/ Hydrochloric 
acid pH 6.5 
200 mM 
Magnesium 
chloride 
 
11 40% (v/v)     300 100 mM Sodium 
cacodylate/ Hydrochloric 
acid pH 6.5 
200 mM Calcium 
acetate 
 
12 30% (v/v)  effamine M-
600 pH 7.0 
100 mM H   S/ Sodium 
hydroxide pH 7.0 
  
13 800 mM Succinic acid pH 
7.0 
   
14 40% (v/v)     400 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
200 mM Lithium 
sulfate 
 
15 50% (v/v)     400 100 mM Sodium acetate/ 
Acetic acid pH 4.5 
200 mM Lithium 
sulfate 
 
16 15% (v/v)     550 MM  100 mM M S/ Sodium 
hydroxide pH 6.5 
  
17 25% (w/v)     1500 100 mM S   buffer pH 
5.5 
  
18 25% (w/v)     1500 100 mM S   buffer pH 
8.5 
  
19 25% (w/v)     1500 100 mM MMT buffer pH 
6.5 
  
20 25% (w/v)     1500 100 mM MMT buffer pH 
9.0 
  
21 25% (w/v)     1500 100 mM MIB buffer pH 
5.0 
  
22 25% (w/v)     1500 100 mM  CB buffer pH 
7.0 
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23 12% (w/v)     1500 100 mM Sodium acetate/ 
Acetic acid pH 5.5 
2500 mM Sodium 
chloride 
1.5% (v/v) MPD 
24 2400 mM Sodium 
malonate dibasic 
   
25 30% (w/v)     2000 
MM  
 150 mM 
 otassium 
bromide 
 
26 10% (w/v)     2000 
MM  
100 mM Sodium acetate/ 
Acetic acid pH 5.5 
200 mM 
Ammonium 
sulfate 
 
27 20% (w/v)     2000 
MM  
100 mM Tris base/ 
Hydrochloric acid pH 8.5 
200 mM 
Trimethylamine n-
oxide 
 
28 20% (w/v)     3350 100 mM Bis tris propane/ 
Hydrochloric acid pH 6.5 
200 mM Sodium 
fluoride 
 
29 20% (w/v)     3350 100 mM Sodium citrate/ 
Citric acid pH 4.0 
200 mM Sodium 
citrate tribasic 
 
30 20% (w/v)     3350 100 mM Bis tris propane/ 
Hydrochloric acid pH 8.5 
200 mM Sodium 
malonate dibasic 
 
31 20% (w/v)  olyacrylic 
acid 5100 
100 mM H   S/ Sodium 
hydroxide pH 7.0 
20 mM 
Magnesium 
chloride 
 
32 2100 mM DL Malic acid 
pH 7.0 
   
33 800 mM  otassium 
phosphate dibasic 
100 mM H   S/ Sodium 
hydroxide pH 7.5 
800 mM Sodium 
phosphate 
monobasic 
 
34 20% (w/v)     6000 100 mM M S/ Sodium 
hydroxide pH 6.0 
200 mM 
Ammonium 
chloride 
 
35 20% (w/v)     6000 100 mM H   S/ Sodium 
hydroxide pH 7.0 
200 mM Sodium 
chloride 
 
36 20% (w/v)     6000 100 mM Tris base/ 
Hydrochloric acid pH 8.0 
200 mM Lithium 
chloride 
 
37 20% (w/v) 
 olyvinylpyrrolidone K15 
100 mM Tris base/ 
Hydrochloric acid pH 8.5 
100 mM Cobalt 
chloride 
 
38 50% (v/v)  thylene glycol 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
200 mM 
Magnesium 
chloride 
 
39 20% (w/v)     8000 100 mM Imidazole/ 
Hydrochloric acid pH 6.5 
 3% (v/v) M D 
40 20% (w/v)     8000 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
100 mM 
Magnesium 
chloride 
20% (v/v)     
400 
41 20% (w/v)     8000 100 mM H   S/ Sodium 
hydroxide pH 7.5 
200 mM 
Ammonium 
sulfate 
10% (v/v) 2-
propanol 
42 30% (v/v) M D 100 mM Sodium acetate/ 
Acetic acid pH 4.5 
 25% (w/v)     
1500 
43 30% (v/v) M D 100 mM Imidazole/ 
Hydrochloric acid pH 6.5 
200 mM 
Ammonium 
sulfate 
10% (w/v)     
3350 
44 30% (v/v) M D 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
500 mM Sodium 
chloride 
8% (w/v)     
8000 
45 40% (v/v) 2-propanol 100 mM Imidazole/ 
Hydrochloric acid pH 6.5 
 15% (w/v)     
8000 
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46 30% (v/v) 2-propanol 100 mM Tris base/ 
Hydrochloric acid pH 8.5 
 30% (w/v)     
3350 
47 17% (w/v)     10,000 100 mM Bis tris/ 
Hydrochloric acid pH 5.5 
100 mM 
Ammonium 
acetate 
 
48 15% (w/v)     20,000 100 mM H   S/ Sodium 
hydroxide pH 7.0 
  
 
 
 
Appendix V: Crystal screen 2 crystallization screen (Hampton Research) 
1.    2.0 M Sodium chloride, 10% w/v  olyethylene glycol 6,000 
2.   0.5 M Sodium chloride, 0.01 M Magnesium chloride hexahydrate, 0.01 M Hexadecyltrimethylammonium 
bromide 
3.   25% v/v  thylene glycol 
4.   35% v/v 1,4-Dioxane 
5.   2.0 M Ammonium sulfate, 5% v/v 2- ropanol 
6.   1.0 M Imidazole pH 7.0 
7.   10% w/v  olyethylene glycol 1,000, 10% w/v  olyethylene glycol 8,000 
8.   1.5 M Sodium chloride, 10% v/v  thanol 
9.   0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Sodium chloride 
10.  0.2 M Sodium chloride, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
11.   0.01 M Cobalt(II) chloride hexahydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 1.0 M 1,6-Hexanediol 
12.  0.1 M Cadmium chloride hydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v  olyethylene glycol 400 
13.  0.2 M Ammonium sulfate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v  olyethylene glycol monomethyl 
ether 2,000 
14.  0.2 M  otassium sodium tartrate tetrahydrate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2.0 M 
Ammonium sulfate 
15.  0.5 M Ammonium sulfate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 1.0 M Lithium sulfate monohydrate 
16.  0.5 M Sodium chloride, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2% v/v  thylene imine polymer  
17.  0.1 M Sodium citrate tribasic dihydrate pH 5.6, 35% v/v tert-Butanol 
18.  0.01 M Iron(III) chloride hexahydrate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 10% v/v  effamine M-
600 
19.  0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2.5 M 1,6-Hexanediol 
20. 0.1 M M S monohydrate pH 6.5, 1.6 M Magnesium sulfate heptahydrate 
21.  0.1 M Sodium phosphate monobasic monohydrate, 0.1 M  otassium phosphate monobasic, 0.1 M M S 
monohydrate pH 6.5, 2.0 M Sodium chloride 
22. 0.1 M M S monohydrate pH 6.5, 12% w/v  olyethylene glycol 20,000  
23. 1.6 M Ammonium sulfate, 0.1 M M S monohydrate pH 6.5, 10% v/v 1,4-Dioxane  
24. 0.05 M Cesium chloride, 0.1 M M S monohydrate pH 6.5, 30% v/v  effamine M-600  
25. 0.01 M Cobalt(II) chloride hexahydrate, 0.1 M M S monohydrate pH 6.5, 1.8 M Ammonium sulfate   
26. 0.2 M Ammonium sulfate, 0.1 M M S monohydrate pH 6.5, 30% w/v  olyethylene glycol monomethyl ether 
5,000 
 
27. 0.01 M Zinc sulfate heptahydrate, 0.1 M M S monohydrate pH 6.5, 25% v/v  olyethylene glycol monomethyl 
ether 550 
 
28. 1.6 M Sodium citrate tribasic dihydrate pH 6.5  
29. 0.5 M Ammonium sulfate, 0.1 M H   S pH 7.5, 30% v/v (+/-)-2-Methyl-2,4-pentanediol  
30. 0.1 M H   S pH 7.5, 10% w/v  olyethylene glycol 6,000, 5% v/v (+/-)-2-Methyl-2,4-pentanediol  
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31.  0.1 M H   S pH 7.5, 20% v/v  effamine M-600  
32. 0.1 M Sodium chloride, 0.1 M H   S pH 7.5, 1.6 M Ammonium sulfate  
33. 0.1 M H   S pH 7.5, 2.0 M Ammonium formate  
34. 0.05 M Cadmium sulfate hydrate, 0.1 M H   S pH 7.5, 1.0 M Sodium acetate trihydrate  
35. 0.1 M H   S pH 7.5, 70% v/v (+/-)-2-Methyl-2,4-pentanediol  
36. 0.1 M H   S pH 7.5, 4.3 M Sodium chloride  
37. 0.1 M H   S pH 7.5, 8% v/v  thylene glycol, 10% w/v  olyethylene glycol 8,000  
38. 0.1 M H   S pH 7.5, 20% w/v  olyethylene glycol 10,000  
39. 0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol  
40  0.1 M Tris pH 8.5, 25% v/v tert-Butanol  
41.  0.01 M Nickel(II) chloride hexahydrate, 0.1 M Tris pH 8.5, 1.0 M Lithium sulfate monohydrate   
42. 1.5 M Ammonium sulfate, 0.1 M Tris pH 8.5, 12% v/v  lycerol  
43. 0.2 M Ammonium phosphate monobasic, 0.1 M Tris pH 8.5, 50% v/v (+/-)-2-Methyl-2,4-pentanediol  
44. 0.1 M Tris pH 8.5, 20% v/v  thanol  
45. 0.01 M Nickel(II) chloride hexahydrate, 0.1 M Tris pH 8.5, 20% w/v  olyethylene glycol monomethyl ether 
2,000 
 
46. 0.1 M Sodium chloride, 0.1 M BICIN  pH 9.0, 20% v/v  olyethylene glycol monomethyl ether 550  
47. 0.1 M BICIN  pH 9.0, 2.0 M Magnesium chloride hexahydrate  
48. 0.1 M BICIN  pH 9.0, 2% v/v 1,4-Dioxane, 10% w/v  olyethylene glycol 20,000  
 
 
 
Appendix VI: Crystal screen 1 crystallization screen (Hampton Research)  
A1    0.02 M Calcium chloride dihydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v (+/-)-2-Methyl-2,4-
pentanediol 
A2   0.4 M  otassium sodium tartrate tetrahydrate 
A3   0.4 M Ammonium phosphate monobasic 
A4   0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium sulfate 
A5   0.2 M Sodium citrate tribasic dihydrate, 0.1 M H   S sodium pH 7.5, 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
A6   0.2 M Magnesium chloride hexahydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 
4,000 
A7   0.1 M Sodium cacodylate trihydrate pH 6.5, 1.4 M Sodium acetate trihydrate 
A8   0.2 M Sodium citrate tribasic dihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% v/v 2- ropanol 
A9   0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% w/v  olyethylene glycol 4,000 
A10  0.2 M Ammonium acetate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v  olyethylene glycol 4,000 
A11   0.1 M Sodium citrate tribasic dihydrate pH 5.6, 1.0 M Ammonium phosphate monobasic 
A12  0.2 M Magnesium chloride hexahydrate, 0.1 M H   S sodium pH 7.5, 30% v/v 2- ropanol 
B1    0.2 M Sodium citrate tribasic dihydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% v/v  olyethylene glycol 400 
B2   0.2 M Calcium chloride dihydrate, 0.1 M H   S sodium pH 7.5, 28% v/v  olyethylene glycol 400 
B3   0.2 M Ammonium sulfate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% w/v  olyethylene glycol 8,000 
B4   0.1 M H   S sodium pH 7.5, 1.5 M Lithium sulfate monohydrate 
B5   0.2 M Lithium sulfate monohydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 4,000 
B6   0.2 M Magnesium acetate tetrahydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 20% w/v  olyethylene 
glycol 8,000 
B7   0.2 M Ammonium acetate, 0.1 M TRIS hydrochloride pH 8.5, 30% v/v 2- ropanol 
B8   0.2 M Ammonium sulfate, 0.1 M Sodium acetate trihydrate pH 4.6, 25% w/v  olyethylene glycol 4,000 
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B9   0.2 M Magnesium acetate tetrahydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% v/v (+/-)-2-Methyl-
2,4-pentanediol 
B10  0.2 M Sodium acetate trihydrate, 0.1 M TRIS hydrochloride pH 8.5, 30% w/v  olyethylene glycol 4,000 
B11   0.2 M Magnesium chloride hexahydrate, 0.1 M H   S sodium pH 7.5, 30% v/v  olyethylene glycol 400 
B12  0.2 M Calcium chloride dihydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 20% v/v 2- ropanol 
C1    0.1 M Imidazole pH 6.5, 1.0 M Sodium acetate trihydrate 
C2   0.2 M Ammonium acetate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 30% v/v (+/-)-2-Methyl-2,4-
pentanediol 
C3   0.2 M Sodium citrate tribasic dihydrate, 0.1 M H   S sodium pH 7.5, 20% v/v 2- ropanol 
C4   0.2 M Sodium acetate trihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 30% w/v  olyethylene glycol 
8,000 
C5   0.1 M H   S sodium pH 7.5, 0.8 M  otassium sodium tartrate tetrahydrate 
C6   0.2 M Ammonium sulfate, 30% w/v  olyethylene glycol 8,000 
C7   0.2 M Ammonium sulfate, 30% w/v  olyethylene glycol 4,000 
C8   2.0 M Ammonium sulfate 
C9   4.0 M Sodium formate 
C10  0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Sodium formate 
C11   0.1 M H   S sodium pH 7.5, 0.8 M Sodium phosphate monobasic monohydrate, 0.8 M  otassium phosphate 
monobasic 
C12  0.1 M TRIS hydrochloride pH 8.5, 8% w/v  olyethylene glycol 8,000 
D1    0.1 M Sodium acetate trihydrate pH 4.6, 8% w/v  olyethylene glycol 4,000 
D2   0.1 M H   S sodium pH 7.5, 1.4 M Sodium citrate tribasic dihydrate 
D3   0.1 M H   S sodium pH 7.5, 2% v/v  olyethylene glycol 400, 2.0 M Ammonium sulfate 
D4   0.1 M Sodium citrate tribasic dihydrate pH 5.6, 20% v/v 2- ropanol, 20% w/v  olyethylene glycol 4,000 
D5   0.1 M H   S sodium pH 7.5, 10% v/v 2- ropanol, 20% w/v  olyethylene glycol 4,000 
D6   0.05 M  otassium phosphate monobasic, 20% w/v  olyethylene glycol 8,000 
D7   30% w/v  olyethylene glycol 1,500 
D8   0.2 M Magnesium formate dihydrate 
D9   0.2 M Zinc acetate dihydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5, 18% w/v  olyethylene glycol 8,000 
D10  0.2 M Calcium acetate hydrate, 0.1 M Sodium cacodylate trihydrate pH 6.5 , 18% w/v  olyethylene glycol 
8,000 
D11   0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Ammonium sulfate 
D12  0.1 M TRIS hydrochloride pH 8.5, 2.0 M Ammonium phosphate monobasic 
 1    2.0 M Sodium chloride, 10% w/v  olyethylene glycol 6,000 
 2   0.5 M Sodium chloride, 0.01 M Magnesium chloride hexahydrate, 0.01 M Hexadecyltrimethylammonium 
bromide 
 3   25% v/v  thylene glycol 
 4   35% v/v 1,4-Dioxane 
 5   2.0 M Ammonium sulfate, 5% v/v 2- ropanol 
 6   1.0 M Imidazole pH 7.0 
 7   10% w/v  olyethylene glycol 1,000, 10% w/v  olyethylene glycol 8,000 
 8   1.5 M Sodium chloride, 10% v/v  thanol 
 9   0.1 M Sodium acetate trihydrate pH 4.6, 2.0 M Sodium chloride 
 10  0.2 M Sodium chloride, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
 11   0.01 M Cobalt(II) chloride hexahydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 1.0 M 1,6-Hexanediol 
 12  0.1 M Cadmium chloride hydrate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% v/v  olyethylene glycol 400 
F1    0.2 M Ammonium sulfate, 0.1 M Sodium acetate trihydrate pH 4.6, 30% w/v  olyethylene glycol monomethyl 
ether 2,000 
F2   0.2 M  otassium sodium tartrate tetrahydrate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2.0 M 
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Ammonium sulfate 
F3   0.5 M Ammonium sulfate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 1.0 M Lithium sulfate monohydrate 
F4   0.5 M Sodium chloride, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2% v/v  thylene imine polymer  
F5   0.1 M Sodium citrate tribasic dihydrate pH 5.6, 35% v/v tert-Butanol 
F6   0.01 M Iron(III) chloride hexahydrate, 0.1 M Sodium citrate tribasic dihydrate pH 5.6, 10% v/v  effamine M-
600 
F7   0.1 M Sodium citrate tribasic dihydrate pH 5.6, 2.5 M 1,6-Hexanediol 
F8   0.1 M M S monohydrate pH 6.5, 1.6 M Magnesium sulfate heptahydrate 
F9   0.1 M Sodium phosphate monobasic monohydrate, 0.1 M  otassium phosphate monobasic, 0.1 M M S 
monohydrate pH 6.5, 2.0 M Sodium chloride 
F10  0.1 M M S monohydrate pH 6.5, 12% w/v  olyethylene glycol 20,000 
F11   1.6 M Ammonium sulfate, 0.1 M M S monohydrate pH 6.5, 10% v/v 1,4-Dioxane 
F12  0.05 M Cesium chloride, 0.1 M M S monohydrate pH 6.5, 30% v/v  effamine M-600 
 1    0.01 M Cobalt(II) chloride hexahydrate, 0.1 M M S monohydrate pH 6.5, 1.8 M Ammonium sulfate  
 2   0.2 M Ammonium sulfate, 0.1 M M S monohydrate pH 6.5, 30% w/v  olyethylene glycol monomethyl ether 
5,000 
 3   0.01 M Zinc sulfate heptahydrate, 0.1 M M S monohydrate pH 6.5, 25% v/v  olyethylene glycol monomethyl 
ether 550 
 4   1.6 M Sodium citrate tribasic dihydrate pH 6.5 
 5   0.5 M Ammonium sulfate, 0.1 M H   S pH 7.5, 30% v/v (+/-)-2-Methyl-2,4-pentanediol 
 6   0.1 M H   S pH 7.5, 10% w/v  olyethylene glycol 6,000, 5% v/v (+/-)-2-Methyl-2,4-pentanediol 
 7   0.1 M H   S pH 7.5, 20% v/v  effamine M-600 
 8   0.1 M Sodium chloride, 0.1 M H   S pH 7.5, 1.6 M Ammonium sulfate 
 9   0.1 M H   S pH 7.5, 2.0 M Ammonium formate 
 10  0.05 M Cadmium sulfate hydrate, 0.1 M H   S pH 7.5, 1.0 M Sodium acetate trihydrate 
 11   0.1 M H   S pH 7.5, 70% v/v (+/-)-2-Methyl-2,4-pentanediol 
 12  0.1 M H   S pH 7.5, 4.3 M Sodium chloride 
H1    0.1 M H   S pH 7.5, 8% v/v  thylene glycol, 10% w/v  olyethylene glycol 8,000 
H2   0.1 M H   S pH 7.5, 20% w/v  olyethylene glycol 10,000 
H3   0.2 M Magnesium chloride hexahydrate, 0.1 M Tris pH 8.5, 3.4 M 1,6-Hexanediol 
H4   0.1 M Tris pH 8.5, 25% v/v tert-Butanol 
H5   0.01 M Nickel(II) chloride hexahydrate, 0.1 M Tris pH 8.5, 1.0 M Lithium sulfate monohydrate 
H6   1.5 M Ammonium sulfate, 0.1 M Tris pH 8.5, 12% v/v  lycerol 
H7   0.2 M Ammonium phosphate monobasic, 0.1 M Tris pH 8.5, 50% v/v (+/-)-2-Methyl-2,4-pentanediol 
H8   0.1 M Tris pH 8.5, 20% v/v  thanol 
H9   0.01 M Nickel(II) chloride hexahydrate, 0.1 M Tris pH 8.5, 20% w/v  olyethylene glycol monomethyl ether 
2,000 
H10  0.1 M Sodium chloride, 0.1 M BICIN  pH 9.0, 20% v/v  olyethylene glycol monomethyl ether 550 
H11   0.1 M BICIN  pH 9.0, 2.0 M Magnesium chloride hexahydrate 
H12  0.1 M BICIN  pH 9.0, 2% v/v 1,4-Dioxane, 10% w/v  olyethylene glycol 20,000 
 
 
 
Appendix VII: Additive protein crystallization screen (Hampton Research)  
1.    (A1)  0.1 M Barium chloride dihydrate Multivalent 
2.    (A2) 0.1 M Cadmium chloride hydrate Multivalent 
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3.    (A3) 0.1 M Calcium chloride dihydrate Multivalent 
4.    (A4) 0.1 M Cobalt(II) chloride hexahydrate Multivalent 
5.    (A5) 0.1 M Copper(II) chloride dihydrate Multivalent 
6.    (A6) 0.1 M Magnesium chloride hexahydrate Multivalent 
7.    (A7) 0.1 M Manganese(II) chloride tetrahydrate  Multivalent 
8.    (A8) 0.1 M Strontium chloride hexahydrate Multivalent 
9.    (A9) 0.1 M Yttrium(III) chloride hexahydrate Multivalent 
10.   (A10) 0.1 M Zinc chloride Multivalent 
11.    (A11)  0.1 M Iron(III) chloride hexahydrate Multivalent 
12.   (A12) 0.1 M Nickel(II) chloride hexahydrate Multivalent 
13.   (B1) 0.1 M Chromium(III) chloride hexahydrate Multivalent 
14.   (B2) 0.1 M Praseodymium(III) acetate hydrate Multivalent 
15.   (B3) 1.0 M Ammonium sulfate Salt 
16.   (B4) 1.0 M Potassium chloride Salt 
17.   (B5) 1.0 M Lithium chloride Salt 
18.   (B6) 2.0 M Sodium chloride Salt 
19.   (B7) 0.5 M Sodium fluoride Salt 
20.  (B8) 1.0 M Sodium iodide Salt 
21.   (B9) 2.0 M Sodium thiocyanate Salt 
22.  (B10) 1.0 M Potassium sodium tartrate tetrahydrate Salt 
23.  (B11) 1.0 M Sodium citrate tribasic dihydrate Salt 
24.  (B12) 1.0 M Cesium chloride Salt 
25.  (C1) 1.0 M Sodium malonate pH 7.0 Salt 
26.  (C2) 0.1 M L-Proline Amino Acid 
27.  (C3) 0.1 M Phenol Dissociating Agent 
28.  (C4) 30% v/v Dimethyl sulfoxide Dissociating Agent 
29.  (C5) 0.1 M Sodium bromide Dissociating Agent 
30.  (C6) 30% w/v 6-Aminohexanoic acid Linker 
31.   (C7) 30% w/v 1,5-Diaminopentane dihydrochloride Linker 
32.  (C8) 30% w/v 1,6-Diaminohexane Linker 
33.  (C9) 30% w/v 1,8-Diaminooctane Linker 
34.  (C10) 1.0 M Glycine Linker 
35.  (C11) 0.3 M Glycyl-glycyl-glycine Linker 
36.  (C12) 0.1 M Taurine Linker 
37.  (D1) 0.1 M Betaine hydrochloride Linker 
38.  (D2) 0.1 M Spermidine Polyamine 
39.  (D3) 0.1 M Spermine tetrahydrochloride Polyamine 
40.  (D4) 0.1 M Hexammine cobalt(III) chloride Polyamine 
41.   (D5) 0.1 M Sarcosine Polyamine 
42.  (D6) 0.1 M Trimethylamine hydrochloride Chaotrope 
43.  (D7) 1.0 M Guanidine hydrochloride Chaotrope 
44.  (D8) 0.1 M Urea Chaotrope 
45.  (D9) 0.1 M β-Nicotinamide adenine dinucleotide hydrate Co-factor 
46.  (D10) 0.1 M Adenosine-5’-triphosphate disodium salt hydrate Co-factor 
47.  (D11) 0.1 M TCEP hydrochloride Reducing Agent 
48.  (D12) 0.01 M GSH (L-Glutathione reduced), 0.01 M GSSG (L-
Glutathione oxidized) Reducing Agent 
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49.  (E1) 0.1 M Ethylenediaminetetraacetic acid disodium salt dihydrate Chelating Agent 
50.  (E2) 5% w/v Polyvinylpyrrolidone K15 Polymer 
51.   (E3) 30% w/v Dextran sulfate sodium salt Polymer 
52.  (E4) 40% v/v Pentaerythritol ethoxylate (3/4 EO/OH) Polymer 
53.  (E5) 10% w/v Polyethylene glycol 3,350 Polymer 
54.  (E6) 30% w/v D-(+)-Glucose monohydrate Carbohydrate 
55.  (E7) 30% w/v Sucrose Carbohydrate 
56.  (E8) 30% w/v Xylitol Carbohydrate 
57.  (E9) 30% w/v D-Sorbitol Carbohydrate 
58.  (E10) 12% w/v myo-Inositol Carbohydrate 
59.  (E11) 30% w/v D-(+)-Trehalose dihydrate Carbohydrate 
60.  (E12) 30% w/v D-(+)-Galactose Carbohydrate 
61.   (F1) 30% v/v Ethylene glycol Polyol 
62.  (F2) 30% v/v Glycerol Polyol 
63.  (F3) 3.0 M NDSB-195 Non-detergent 
64.  (F4) 2.0 M NDSB-201 Non-detergent 
65.  (F5) 2.0 M NDSB-211 Non-detergent 
66.  (F6) 2.0 M NDSB-221 Non-detergent 
67.  (F7) 1.0 M NDSB-256 Non-detergent 
68.  (F8) 0.15 mM CYMAL®-7 Amphiphile 
69.  (F9) 20% w/v Benzamidine hydrochloride Amphiphile 
70.  (F10) 5% w/v n-Dodecyl-N,N-dimethylamine-N-oxide Detergent 
71.   (F11) 5% w/v n-Octyl-β-D-glucoside Detergent 
72.  (F12) 5% w/v n-Dodecyl-β-D-maltoside Osmolyte 
73.  (G1) 30% w/v Trimethylamine N-oxide dihydrate Organic, Non-volatile 
74.  (G2) 30% w/v 1,6-Hexanediol Organic, Non-volatile 
75.  (G3) 30% v/v (+/-)-2-Methyl-2,4-pentanediol Organic, Non-volatile 
76.  (G4) 50% v/v Polyethylene glycol 400 Organic, Non-volatile 
77.  (G5) 50% v/v Jeffamine M-600 pH 7.0 Organic, Non-volatile 
78.  (G6) 40% v/v 2,5-Hexanediol Organic, Non-volatile 
79.  (G7) 40% v/v (±)-1,3-Butanediol Organic, Non-volatile 
80.  (G8) 40% v/v Polypropylene glycol P 400 Organic, Non-volatile 
81.   (G9) 30% v/v 1,4-Dioxane Organic, Volatile 
82.  (G10) 30% v/v Ethanol Organic, Volatile 
83.  (G11) 30% v/v 2-Propanol Organic, Volatile 
84.  (G12) 30% v/v Methanol Organic, Volatile 
85.  (H1) 10% v/v 1,2-Butanediol Organic, Volatile 
86.  (H2) 40% v/v tert-Butanol Organic, Volatile 
87.  (H3) 40% v/v 1,3-Propanediol Organic, Volatile 
88.  (H4) 40% v/v Acetonitrile Organic, Volatile 
89.  (H5) 40% v/v Formamide Organic, Volatile 
90.  (H6) 40% v/v 1-Propanol Organic, Volatile 
91.   (H7) 5% v/v Ethyl acetate Organic, Volatile 
92.  (H8) 40% v/v Acetone Organic, Volatile 
93.  (H9) 0.25% v/v Dichloromethane Organic, Volatile 
94.  (H10) 7% v/v 1-Butanol Organic, Volatile 
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95.  (H11) 40% v/v 2,2,2-Trifluoroethanol Organic, Volatile 
96.  (H12) 40% v/v 1,1,1,3,3,3-Hexafluoro-2-propanol Organic, Volatile 
 
 
 
Appendix VIII: Wizard II protein crystallization formulation (Rigaku) 
Tube Precipitation Reagent Buffer Salt 
1 10% (w/v)     3000 100 mM Sodium acetate/ Acetic acid pH 
4.5 
200 mM Zinc acetate 
2 35% (v/v) M D 100 mM M S/ Sodium hydroxide pH 
6.0 
200 mM Lithium sulfate 
3 20% (w/v)     8000 100 mM Tris base/ Hydrochloric acid 
pH 8.5 
200 mM Magnesium 
chloride 
4 2000 mM Ammonium sulfate 100 mM Sodium cacodylate/ 
Hydrochloric acid pH 6.5 
200 mM Sodium chloride 
5 20% (v/v) 1,4-butanediol 100 mM H   S/ Sodium hydroxide pH 
7.5 
200 mM Sodium chloride 
6 10% (v/v) 2-propanol 100 mM Sodium phosphate dibasic/ 
Citric acid pH 4.2 
200 mM Lithium sulfate 
7 30% (w/v)     3000 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Sodium chloride 
8 10% (w/v)     8000 100 mM  otassium phosphate 
monobasic/ Sodium phosphate dibasic 
pH 6.2 
200 mM Sodium chloride 
9 2000 mM Ammonium sulfate 100 mM Sodium phosphate dibasic/ 
Citric acid pH 4.2 
 
10 1000 mM Ammonium phosphate 
dibasic 
100 mM Tris base/ Hydrochloric acid 
pH 8.5 
 
11 10% (v/v) 2-propanol 100 mM Sodium cacodylate/ 
Hydrochloric acid pH 6.5 
200 mM Zinc acetate 
12 30% (v/v)     400 100 mM Sodium cacodylate/ 
Hydrochloric acid pH 6.5 
200 mM Lithium sulfate 
13 15% (v/v) Reagent alcohol 100 mM Sodium citrate/ Citric acid pH 
5.5 
200 mM Lithium sulfate 
14 20% (w/v)     1000 100 mM  otassium phosphate 
monobasic/ Sodium phosphate dibasic 
pH 6.2 
200 mM Sodium chloride 
15 1260 mM Ammonium sulfate 100 mM H   S/ Sodium hydroxide pH 
7.5 
 
16 1000 mM Sodium citrate tribasic 100 mM CH S/ Sodium hydroxide pH 
9.5 
 
17 2500 mM Sodium chloride 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Magnesium 
chloride 
18 20% (w/v)     3000 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Calcium acetate 
19 1600 mM Sodium phosphate 
monobasic/ 400 mM  otassium 
phosphate dibasic 
100 mM Sodium phosphate dibasic/ 
Citric acid pH 4.2 
 
20 15% (v/v) Reagent alcohol 100 mM M S/ Sodium hydroxide pH 
6.0 
200 mM Zinc acetate 
21 35% (v/v) M D 100 mM Sodium acetate/ Acetic acid pH 
4.5 
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22 10% (v/v) 2-propanol 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
 
23 15% (v/v) Reagent alcohol 100 mM H   S/ Sodium hydroxide pH 
7.5 
200 mM Magnesium 
chloride 
24 30% (w/v)     8000 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
200 mM Sodium chloride 
25 35% (v/v) M D 100 mM H   S/ Sodium hydroxide pH 
7.5 
200 mM Sodium chloride 
26 30% (v/v)     400 100 mM CH S/ Sodium hydroxide pH 
9.5 
 
27 10% (w/v)     3000 100 mM Sodium cacodylate/ 
Hydrochloric acid pH 6.5 
200 mM Magnesium 
chloride 
28 20% (w/v)     8000 100 mM M S/ Sodium hydroxide pH 
6.0 
200 mM Calcium acetate 
29 1260 mM Ammonium sulfate 100 mM CH S/ Sodium hydroxide pH 
9.5 
200 mM Sodium chloride 
30 20% (v/v) 1,4-butanediol 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
200 mM Zinc acetate 
31 1000 mM Sodium citrate tribasic 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Sodium chloride 
32 20% (w/v)     1000 100 mM Tris base/ Hydrochloric acid 
pH 8.5 
 
33 1000 mM Ammonium phosphate 
dibasic 
100 mM Sodium citrate/ Citric acid pH 
5.5 
200 mM Sodium chloride 
34 10% (w/v)     8000 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
 
35 800 mM Sodium phosphate 
monobasic/ 1200 mM  otassium 
phosphate dibasic 
100 mM Sodium acetate/ Acetic acid pH 
4.5 
 
36 10% (w/v)     3000 100 mM Sodium phosphate dibasic/ 
Citric acid pH 4.2 
200 mM Sodium chloride 
37 1000 mM  otassium sodium 
tartrate 
100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Lithium sulfate 
38 2500 mM Sodium chloride 100 mM Sodium acetate/ Acetic acid pH 
4.5 
200 mM Lithium sulfate 
39 20% (w/v)     8000 100 mM CA S/ Sodium hydroxide pH 
10.5 
200 mM Sodium chloride 
40 20% (w/v)     3000 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
200 mM Zinc acetate 
41 2000 mM Ammonium sulfate 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Lithium sulfate 
42 30% (v/v)     400 100 mM H   S/ Sodium hydroxide pH 
7.5 
200 mM Sodium chloride 
43 10% (w/v)     8000 100 mM Tris base/ Hydrochloric acid 
pH 7.0 
200 mM Magnesium 
chloride 
44 20% (w/v)     1000 100 mM Sodium cacodylate/ 
Hydrochloric acid pH 6.5 
200 mM Magnesium 
chloride 
45 1260 mM Ammonium sulfate 100 mM M S/ Sodium hydroxide pH 
6.0 
 
46 1000 mM Ammonium phosphate 
dibasic 
100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
200 mM Sodium chloride 
47 2500 mM Sodium chloride 100 mM Imidazole/ Hydrochloric acid 
pH 8.0 
200 mM Zinc acetate 
48 1000 mM  otassium sodium 
tartrate 
100 mM M S/ Sodium hydroxide pH 
6.0 
 
 
